data_1m4f_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1m4f _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 26.0 pt . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.808 0.337 . . . . 0.0 110.853 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.776 ' HB3' ' HE2' ' A' ' 21' ' ' MET . 90.4 m 56.4 40.83 29.57 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.466 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 33.8 pt -62.18 127.23 21.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.353 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -55.27 138.36 45.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.89 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.6 p -158.75 109.56 2.08 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.904 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.79 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 39.0 m -75.2 124.88 27.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.828 0.347 . . . . 0.0 111.476 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.473 ' HA3' ' O ' ' A' ' 16' ' ' ARG . . . -63.77 93.89 0.13 Allowed Glycine 0 C--O 1.237 0.343 0 N-CA-C 111.066 -0.813 . . . . 0.0 111.066 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.667 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 17.8 p -70.55 -49.61 46.26 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -177.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.667 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 3.4 m -120.31 -55.49 2.04 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 114.282 -1.326 . . . . 0.0 113.938 -171.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -56.13 -84.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.662 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 1.3 mpt_? -91.48 119.9 31.84 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 176.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 59.2 m -75.16 52.81 0.6 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.662 ' HG2' ' HB3' ' A' ' 16' ' ' ARG . 20.6 pttp -150.49 139.4 20.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.992 -178.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.79 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 84.2 m -71.36 141.76 50.39 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.506 178.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -167.95 150.11 15.82 Favored Glycine 0 C--O 1.228 -0.259 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.728 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.776 ' HE2' ' HB3' ' A' ' 7' ' ' CYS . 75.9 mtp -73.69 128.25 35.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.816 0.341 . . . . 0.0 111.275 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 9.0 m . . . . . 0 N--CA 1.464 0.249 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.721 179.672 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.709 HD13 HG21 ' A' ' 8' ' ' ILE . 11.4 pt . . . . . 0 N--CA 1.455 -0.188 0 CA-C-O 121.02 0.438 . . . . 0.0 110.52 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.669 ' SG ' ' HB3' ' A' ' 21' ' ' MET . 49.3 t 61.34 50.61 4.65 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.514 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.709 HG21 HD13 ' A' ' 6' ' ' ILE . 23.5 pt -56.47 139.78 15.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.953 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -58.75 138.35 57.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.592 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 24.4 p -146.85 121.94 10.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.929 0.395 . . . . 0.0 110.979 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 45.9 t -136.01 126.41 26.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.297 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.539 ' HA3' ' O ' ' A' ' 16' ' ' ARG . . . -70.95 128.6 17.11 Favored Glycine 0 C--O 1.239 0.413 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.49 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.674 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 0.8 OUTLIER -54.82 -83.45 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -178.344 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.674 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -107.12 -64.44 1.19 Allowed 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 113.044 -1.889 . . . . 0.0 113.459 -172.94 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.555 ' ND1' ' H ' ' A' ' 16' ' ' ARG . 12.0 p80 -59.01 -53.71 55.28 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.12 -0.632 . . . . 0.0 109.363 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.573 ' O ' ' N ' ' A' ' 18' ' ' LYS . 7.6 mpt_? -93.24 51.73 1.68 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.942 178.122 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 68.6 m -59.26 68.04 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.308 0.575 . . . . 0.0 111.045 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.573 ' N ' ' O ' ' A' ' 16' ' ' ARG . 55.9 mtpt -146.99 129.71 16.09 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.107 -179.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 96.9 m -102.49 137.31 40.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.889 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -174.56 147.51 9.19 Favored Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.764 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.669 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 60.9 mtm -73.78 129.57 38.18 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.624 0.25 . . . . 0.0 110.866 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 5.1 m . . . . . 0 CA--C 1.532 0.254 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.76 179.856 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 23.7 pt . . . . . 0 N--CA 1.455 -0.183 0 CA-C-O 120.874 0.369 . . . . 0.0 110.738 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 79.4 m 55.28 44.16 27.94 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.13 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.435 ' CG1' ' HB2' ' A' ' 22' ' ' CYS . 37.5 pt -54.84 130.18 16.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.929 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -69.11 85.33 0.36 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.608 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.731 ' HB3' HH22 ' A' ' 16' ' ' ARG . 83.0 m -72.49 68.36 0.79 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.749 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.702 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 22.2 t -99.86 73.56 1.78 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.063 0.458 . . . . 0.0 111.731 -178.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.721 ' HA3' ' HG3' ' A' ' 16' ' ' ARG . . . -60.34 122.25 29.27 Favored Glycine 0 C--O 1.235 0.173 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.541 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.695 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 14.9 p -69.85 -52.41 25.15 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -177.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.695 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 3.1 m -121.56 -81.67 0.64 Allowed 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -171.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 -49.52 -63.63 1.05 Allowed 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.731 HH22 ' HB3' ' A' ' 10' ' ' CYS . 6.8 ptm180 -90.96 56.55 3.24 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.27 177.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.433 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 78.6 p -59.47 65.04 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.814 0.845 . . . . 0.0 112.652 -178.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.688 ' NZ ' ' HB2' ' A' ' 16' ' ' ARG . 0.4 OUTLIER -149.59 140.27 22.62 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.038 178.302 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.702 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 61.2 m -125.47 131.6 52.83 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.13 0.49 . . . . 0.0 111.871 -178.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -179.71 142.49 5.2 Favored Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.275 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.451 ' HE2' ' HB2' ' A' ' 21' ' ' MET . 67.5 mtm -65.53 125.9 26.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.943 0.402 . . . . 0.0 111.451 -179.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.435 ' HB2' ' CG1' ' A' ' 8' ' ' ILE . 94.1 m . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.787 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.6 pt . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.935 0.398 . . . . 0.0 110.535 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.63 ' SG ' ' HB3' ' A' ' 21' ' ' MET . 15.6 t 63.75 57.08 1.43 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.917 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.41 HG13 ' SG ' ' A' ' 10' ' ' CYS . 37.1 pt -54.26 131.97 17.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.092 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -72.11 89.82 1.17 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.968 0.413 . . . . 0.0 109.9 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.41 ' SG ' HG13 ' A' ' 8' ' ' ILE . 75.6 m -75.62 65.01 1.75 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.895 -179.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.755 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 34.3 t -102.65 74.21 1.34 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.116 0.484 . . . . 0.0 111.656 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.672 ' HA3' ' HG2' ' A' ' 16' ' ' ARG . . . -67.23 114.83 6.62 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.753 -0.736 . . . . 0.0 111.54 179.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.702 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -70.33 -74.31 0.14 Allowed 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 122.53 1.157 . . . . 0.0 113.557 -179.041 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.702 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -103.94 -44.36 5.05 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 112.489 -2.141 . . . . 0.0 112.434 -173.686 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 22.6 t-80 -58.12 -86.96 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.744 ' HB3' HH11 ' A' ' 16' ' ' ARG . 0.0 OUTLIER -91.3 114.87 27.51 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 176.961 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 64.0 m -74.99 63.32 1.21 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.931 0.396 . . . . 0.0 110.893 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.425 ' HE2' ' HB2' ' A' ' 16' ' ' ARG . 60.2 pttt -148.45 128.48 13.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.585 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.755 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 77.2 m -125.87 129.92 50.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.942 0.401 . . . . 0.0 110.99 179.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 176.68 146.24 5.99 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.464 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.63 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 80.4 mtp -68.25 119.66 13.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.777 0.322 . . . . 0.0 110.989 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 56.6 m . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.036 179.514 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.475 HG22 HD12 ' A' ' 6' ' ' ILE . 14.0 pt . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.742 0.306 . . . . 0.0 111.193 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 78.0 m 62.98 47.16 4.41 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.861 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 35.3 pt -82.36 140.32 16.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.635 178.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.837 ' HA ' ' HA ' ' A' ' 21' ' ' MET . 28.1 t80 -53.01 135.94 36.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.108 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -155.63 138.97 15.74 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.254 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 47.4 t -129.88 122.33 28.43 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.749 0.309 . . . . 0.0 111.477 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.832 ' HA3' ' HG2' ' A' ' 16' ' ' ARG . . . -69.25 122.67 13.05 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.498 -0.858 . . . . 0.0 111.032 178.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.69 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 17.2 p -70.59 -51.68 26.7 Favored 'General case' 0 CA--C 1.504 -0.802 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -178.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.69 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 2.8 m -121.74 -57.05 1.83 Allowed 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 113.808 -1.542 . . . . 0.0 113.141 -172.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 21.5 t-80 -58.61 -79.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.832 ' HG2' ' HA3' ' A' ' 12' ' ' GLY . 0.1 OUTLIER -91.03 73.73 6.38 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.668 178.05 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.549 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 44.4 t -59.91 68.51 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.352 0.596 . . . . 0.0 110.592 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.661 ' HB3' ' NZ ' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -150.01 137.08 19.53 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.852 -178.609 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 85.2 m -102.36 131.35 49.04 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.735 0.302 . . . . 0.0 110.934 179.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 171.33 150.52 7.13 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.451 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.837 ' HA ' ' HA ' ' A' ' 9' ' ' PHE . 86.7 mtp -51.11 140.39 16.23 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.718 0.294 . . . . 0.0 110.797 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 15.0 m . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.201 -179.477 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.515 HD12 HG23 ' A' ' 8' ' ' ILE . 21.7 pt . . . . . 0 C--O 1.231 0.129 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 48.1 m 62.16 42.73 9.32 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.336 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.515 HG23 HD12 ' A' ' 6' ' ' ILE . 26.5 pt -80.27 147.79 6.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.045 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.586 ' HA ' ' HG2' ' A' ' 21' ' ' MET . 15.3 t80 -52.67 134.42 35.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.333 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.635 ' HB2' ' H ' ' A' ' 22' ' ' CYS . 49.8 m -163.57 120.82 1.81 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.746 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.545 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 40.0 t -91.16 131.01 36.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.81 0.338 . . . . 0.0 111.184 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.465 ' HA3' ' O ' ' A' ' 16' ' ' ARG . . . -66.97 96.78 0.32 Allowed Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 178.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.68 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 17.3 p -72.08 -50.05 31.37 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -177.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.68 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 3.3 m -121.12 -58.05 1.82 Allowed 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 114.277 -1.328 . . . . 0.0 114.157 -171.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.563 ' ND1' ' HD3' ' A' ' 16' ' ' ARG . 17.1 t-80 -56.36 -77.9 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.563 ' HD3' ' ND1' ' A' ' 15' ' ' HIS . 1.4 mpp_? -91.55 118.86 30.98 Favored 'General case' 0 C--O 1.221 -0.408 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 176.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.7 m -78.15 56.75 1.7 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -147.12 128.37 14.77 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.829 -178.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.545 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 63.7 m -75.42 135.67 40.74 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.702 0.287 . . . . 0.0 110.833 178.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.459 ' H ' ' HA ' ' A' ' 11' ' ' CYS . . . -166.86 -145.67 4.56 Favored Glycine 0 C--O 1.225 -0.456 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.882 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.586 ' HG2' ' HA ' ' A' ' 9' ' ' PHE . 64.0 mtm -127.6 119.29 25.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.982 0.391 . . . . 0.0 111.238 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.635 ' H ' ' HB2' ' A' ' 10' ' ' CYS . 29.7 p . . . . . 0 C--O 1.232 0.157 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.116 179.269 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.433 ' H ' HG12 ' A' ' 6' ' ' ILE . 2.8 pt . . . . . 0 N--CA 1.456 -0.139 0 CA-C-O 120.98 0.419 . . . . 0.0 110.562 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 64.0 m 64.58 48.74 2.53 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.94 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 29.4 pt -57.9 137.15 20.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.042 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.459 ' HA ' ' HA ' ' A' ' 21' ' ' MET . 23.0 t80 -63.06 135.24 57.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.539 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -148.79 141.52 24.56 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.933 0.397 . . . . 0.0 110.17 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 47.8 t -134.47 124.57 25.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.663 -178.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.518 ' O ' ' HA ' ' A' ' 17' ' ' SER . . . -75.99 119.27 5.62 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.417 -0.897 . . . . 0.0 111.053 178.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.682 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 20.0 p -72.72 -49.75 29.15 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 122.096 0.951 . . . . 0.0 112.459 -178.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.682 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 2.9 m -121.32 -48.12 2.22 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-N 113.236 -1.802 . . . . 0.0 112.247 -172.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 36.9 m170 -61.0 -87.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.81 ' HB2' ' HD3' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -91.5 86.0 5.92 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 177.257 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.518 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 57.2 m -62.68 61.3 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -177.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.81 ' HD3' ' HB2' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -150.63 140.22 21.59 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.743 178.471 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 90.1 m -100.1 132.85 45.22 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.889 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 176.7 154.77 12.23 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.986 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.459 ' HA ' ' HA ' ' A' ' 9' ' ' PHE . 86.8 mtp -56.11 136.34 52.54 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 21.8 m . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.153 -178.793 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.497 HG22 HG23 ' A' ' 8' ' ' ILE . 41.0 mm . . . . . 0 N--CA 1.446 -0.643 0 CA-C-O 120.695 0.283 . . . . 0.0 111.431 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.7 m 64.46 47.86 2.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.118 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.497 HG23 HG22 ' A' ' 6' ' ' ILE . 35.2 pt -61.12 133.2 26.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.632 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -80.8 134.98 35.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.899 179.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.9 p -145.18 140.78 28.17 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.267 0.556 . . . . 0.0 111.267 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 52.3 t -124.21 122.52 38.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.757 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.56 ' HA3' ' O ' ' A' ' 16' ' ' ARG . . . -60.42 112.55 4.64 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.319 -0.944 . . . . 0.0 111.485 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.728 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -67.67 -75.23 0.1 Allowed 'General case' 0 CA--C 1.505 -0.756 0 CA-C-O 122.539 1.162 . . . . 0.0 113.711 -178.907 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.728 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -100.44 -45.31 5.6 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 112.338 -2.21 . . . . 0.0 112.427 -173.602 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.409 ' HB2' ' HD3' ' A' ' 16' ' ' ARG . 90.5 m-70 -60.28 -91.61 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.83 ' H ' ' HD3' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -91.38 103.84 16.43 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 177.722 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.9 p -69.41 67.43 0.2 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.002 0.429 . . . . 0.0 110.692 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.415 ' HE3' ' HG3' ' A' ' 16' ' ' ARG . 22.2 pttp -147.68 138.38 23.28 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.459 -179.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 79.0 m -100.95 138.36 38.1 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.827 178.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -177.99 157.2 21.23 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.253 -0.975 . . . . 0.0 113.258 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.421 ' HE2' ' HB2' ' A' ' 21' ' ' MET . 3.4 mpp? -59.4 144.36 47.04 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 6.9 m . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.581 -178.582 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.0 pt . . . . . 0 N--CA 1.452 -0.331 0 CA-C-O 121.259 0.552 . . . . 0.0 109.605 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.6 ' SG ' ' HB3' ' A' ' 21' ' ' MET . 23.2 t 58.03 51.56 8.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.382 179.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 31.6 pt -50.12 141.98 3.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.267 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -62.47 147.49 48.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.804 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 17.4 p -149.23 131.13 15.19 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.21 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 47.5 t -135.71 107.47 7.03 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.89 0.376 . . . . 0.0 111.489 -179.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.474 ' HA3' ' O ' ' A' ' 16' ' ' ARG . . . -85.69 114.2 3.96 Favored Glycine 0 C--O 1.239 0.432 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.534 178.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.665 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 0.9 OUTLIER -57.33 -82.58 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -178.44 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.665 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -110.14 -63.88 1.33 Allowed 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 113.142 -1.845 . . . . 0.0 113.653 -172.743 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 52.1 t60 -51.2 -60.55 2.99 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.474 ' O ' ' HA3' ' A' ' 12' ' ' GLY . 0.0 OUTLIER -91.89 79.93 5.25 Favored 'General case' 0 C--O 1.218 -0.569 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.33 176.575 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 65.1 m -67.96 57.95 0.07 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.701 0.286 . . . . 0.0 111.158 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.632 ' HB3' ' NZ ' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -149.67 122.52 8.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.209 -179.555 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 92.1 m -126.7 130.71 50.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.142 0.496 . . . . 0.0 111.654 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 176.92 -154.84 16.94 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.96 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.6 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 80.0 mtp -96.98 126.16 41.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.743 0.306 . . . . 0.0 110.918 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 49.1 m . . . . . 0 N--CA 1.463 0.176 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.638 -179.989 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.596 HD12 HG23 ' A' ' 8' ' ' ILE . 23.5 pt . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.816 0.341 . . . . 0.0 110.979 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 57.5 m 63.95 45.07 4.42 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.119 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.596 HG23 HD12 ' A' ' 6' ' ' ILE . 31.4 pt -75.26 133.62 31.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.18 178.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -70.93 133.59 46.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.718 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 3.3 p -162.82 144.32 10.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.817 0.341 . . . . 0.0 110.464 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.786 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 11.5 t -91.65 124.2 35.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.039 0.447 . . . . 0.0 110.985 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.591 ' HA2' ' HB3' ' A' ' 17' ' ' SER . . . 162.78 154.55 7.66 Favored Glycine 0 C--O 1.22 -0.747 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.961 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.618 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 4.8 t -141.1 -92.52 0.15 Allowed 'General case' 0 CA--C 1.51 -0.595 0 CA-C-O 123.236 1.493 . . . . 0.0 111.635 178.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.618 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.5 OUTLIER -122.13 -123.7 0.27 Allowed 'General case' 0 N--CA 1.425 -1.677 0 CA-C-N 111.185 -2.734 . . . . 0.0 108.503 -176.542 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.431 ' H ' ' HB2' ' A' ' 14' ' ' CYS . 46.8 m170 -61.17 -49.81 75.69 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 176.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.802 ' H ' ' HD2' ' A' ' 16' ' ' ARG . 0.4 OUTLIER -91.68 137.07 32.66 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.942 176.795 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.591 ' HB3' ' HA2' ' A' ' 12' ' ' GLY . 60.8 m -80.19 130.03 34.93 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.694 0.283 . . . . 0.0 111.319 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.566 ' H ' ' C ' ' A' ' 12' ' ' GLY . 13.7 mmmm -119.8 118.57 31.18 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.935 0.398 . . . . 0.0 110.86 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.786 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 85.4 m -62.57 127.75 32.77 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.417 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 174.4 -179.53 45.68 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.891 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.444 ' HB3' ' HE1' ' A' ' 21' ' ' MET . 93.9 mmm -63.32 135.27 56.91 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.724 0.297 . . . . 0.0 110.35 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 8' ' ' ILE . 20.6 m . . . . . 0 C--N 1.327 -0.377 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.167 -179.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.53 HG13 ' CG2' ' A' ' 8' ' ' ILE . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.143 0 CA-C-O 121.09 0.471 . . . . 0.0 111.025 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 62.5 m 59.98 27.31 16.69 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.134 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.53 ' CG2' HG13 ' A' ' 6' ' ' ILE . 16.3 pt -61.39 142.92 15.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.946 0.403 . . . . 0.0 110.828 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -68.1 124.52 23.65 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.787 178.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 35.9 m -125.18 113.72 18.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.929 0.395 . . . . 0.0 111.344 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.407 ' CB ' ' HA ' ' A' ' 19' ' ' CYS . 42.1 t -136.38 111.84 9.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.96 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 17' ' ' SER . . . -69.91 129.69 21.58 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.35 -0.929 . . . . 0.0 111.125 178.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.686 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 17.2 p -68.68 -50.91 47.28 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -178.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.686 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 3.1 m -121.59 -61.29 1.53 Allowed 'General case' 0 N--CA 1.428 -1.531 0 CA-C-N 113.922 -1.49 . . . . 0.0 113.618 -172.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.473 ' HD2' ' NH1' ' A' ' 16' ' ' ARG . 66.4 t60 -62.6 -62.35 1.8 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.341 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.527 ' O ' ' N ' ' A' ' 18' ' ' LYS . 9.1 mpt_? -91.39 62.08 4.55 Favored 'General case' 0 C--O 1.218 -0.586 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.087 177.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 65.9 m -61.79 59.78 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.627 0 O-C-N 123.424 0.453 . . . . 0.0 111.414 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 16' ' ' ARG . 15.4 ptpt -149.71 135.69 18.77 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.626 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.407 ' HA ' ' CB ' ' A' ' 11' ' ' CYS . 67.5 m -99.05 135.67 40.13 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.763 178.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 176.98 144.68 5.39 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.757 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 60.9 mtm -64.48 123.42 19.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.792 0.33 . . . . 0.0 110.724 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.0 p . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.734 179.842 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.414 HD11 ' CG2' ' A' ' 8' ' ' ILE . 7.0 pt . . . . . 0 C--O 1.232 0.15 0 CA-C-O 121.093 0.473 . . . . 0.0 110.322 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.578 ' SG ' ' HB3' ' A' ' 21' ' ' MET . 34.8 t 63.62 52.75 2.18 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.834 179.349 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.414 ' CG2' HD11 ' A' ' 6' ' ' ILE . 26.9 pt -60.3 141.44 16.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.39 179.338 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -60.71 143.84 53.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.694 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 20' ' ' GLY . 26.8 p -149.91 120.98 7.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.768 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 47.6 t -135.64 120.48 18.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.939 0.399 . . . . 0.0 111.008 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.849 ' HA3' ' HG2' ' A' ' 16' ' ' ARG . . . -68.94 133.68 27.0 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.028 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.586 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 0.6 OUTLIER -58.35 -76.79 0.04 OUTLIER 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -178.831 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.586 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -119.87 -56.55 2.02 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 113.395 -1.729 . . . . 0.0 112.907 -173.16 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 42.6 m170 -56.02 -70.19 0.12 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 179.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.871 ' HB2' ' HE3' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -91.49 50.72 1.77 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 177.069 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.634 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 77.4 p -58.33 71.9 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.773 -178.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.871 ' HE3' ' HB2' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -148.82 141.0 23.98 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.977 -1.011 . . . . 0.0 111.808 179.678 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 69.6 m -102.89 136.2 43.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.86 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.454 ' O ' ' SG ' ' A' ' 10' ' ' CYS . . . -177.4 152.83 12.43 Favored Glycine 0 C--O 1.224 -0.5 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.009 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.578 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 63.5 mtm -82.12 125.11 30.49 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.984 0.392 . . . . 0.0 111.519 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 59.9 m . . . . . 0 N--CA 1.464 0.266 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.817 179.213 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.3 pt . . . . . 0 N--CA 1.454 -0.228 0 CA-C-O 120.969 0.414 . . . . 0.0 110.01 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 95.0 m 60.97 50.05 5.38 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.813 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 24.7 pt -51.06 131.02 11.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.452 179.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -61.89 146.79 48.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.151 0.501 . . . . 0.0 111.221 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.1 p -155.4 139.07 16.06 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.912 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.423 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 41.8 t -135.36 117.27 15.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.117 0.484 . . . . 0.0 111.639 -179.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.453 ' N ' ' SG ' ' A' ' 19' ' ' CYS . . . -93.69 92.82 1.64 Allowed Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 178.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.691 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 18.7 p -72.68 -50.26 26.11 Favored 'General case' 0 CA--C 1.504 -0.808 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -178.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.691 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 3.0 m -121.15 -50.39 2.14 Favored 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 113.727 -1.579 . . . . 0.0 113.087 -172.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 40.8 m170 -57.47 -83.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.671 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 0.6 OUTLIER -91.1 126.67 36.25 Favored 'General case' 0 C--O 1.22 -0.493 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 176.783 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 77.9 p -77.61 55.38 1.31 Allowed 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.291 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.671 ' HG2' ' HB3' ' A' ' 16' ' ' ARG . 13.9 ptmm? -148.29 125.54 11.51 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.453 ' SG ' ' N ' ' A' ' 12' ' ' GLY . 84.4 m -126.32 126.16 43.47 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.938 0.399 . . . . 0.0 111.387 179.037 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 176.16 -152.26 12.62 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.057 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 61.3 mtm -92.35 122.28 34.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.791 0.329 . . . . 0.0 111.212 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 35.7 m . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.814 179.232 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 13.4 pt . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.952 0.406 . . . . 0.0 110.638 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.467 ' SG ' ' HB3' ' A' ' 21' ' ' MET . 15.4 t 56.62 51.02 11.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.197 179.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.412 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 27.8 pt -53.04 149.23 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.415 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -71.21 82.4 0.73 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.031 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 21.3 m -67.09 141.58 57.41 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.807 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 26.1 t -136.01 115.45 12.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.952 0.406 . . . . 0.0 110.987 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -88.92 97.41 2.32 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.523 179.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.692 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 0.1 OUTLIER -66.11 -76.41 0.08 Allowed 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -178.808 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.692 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -104.58 -48.02 3.92 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 112.711 -2.041 . . . . 0.0 112.922 -173.332 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -55.97 -83.79 0.01 OUTLIER 'General case' 0 C--O 1.232 0.164 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.643 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 11.3 mpt_? -91.21 120.14 31.88 Favored 'General case' 0 C--O 1.221 -0.432 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 176.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.9 m -76.95 55.47 1.11 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.123 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.643 ' HG2' ' HB3' ' A' ' 16' ' ' ARG . 21.9 pttp -148.66 129.74 14.48 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.715 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 80.0 m -125.77 128.69 48.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.29 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -171.92 -150.15 7.04 Favored Glycine 0 CA--C 1.519 0.331 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.864 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.467 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 68.6 mtm -94.17 132.46 38.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.914 0.388 . . . . 0.0 111.417 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.412 ' SG ' ' O ' ' A' ' 8' ' ' ILE . 7.3 p . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.635 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.7 pt . . . . . 0 C--O 1.231 0.113 0 CA-C-O 121.023 0.44 . . . . 0.0 110.61 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.8 t 57.36 52.83 8.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.312 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 26.6 pt -57.3 149.93 4.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.545 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -52.69 129.53 29.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.329 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -165.36 133.32 3.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.281 -179.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.609 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 42.8 t -84.73 130.76 34.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.559 -179.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.516 ' HA3' ' O ' ' A' ' 16' ' ' ARG . . . -72.02 103.18 1.25 Allowed Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 178.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.688 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 16.8 p -71.38 -50.97 26.74 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 114.282 1.215 . . . . 0.0 114.282 -177.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.688 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 3.2 m -121.22 -62.56 1.42 Allowed 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 114.245 -1.343 . . . . 0.0 113.802 -171.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.537 ' HB3' ' CZ ' ' A' ' 16' ' ' ARG . 39.2 m170 -52.75 -75.78 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.537 ' CZ ' ' HB3' ' A' ' 15' ' ' HIS . 0.0 OUTLIER -91.13 106.83 18.79 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 176.737 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 46.1 t -74.25 52.91 0.49 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.713 0.292 . . . . 0.0 111.409 -179.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.519 ' HD2' ' N ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -150.69 134.53 16.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.799 179.793 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.609 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 86.5 m -75.02 132.45 41.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.648 178.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -174.54 -136.5 2.26 Favored Glycine 0 C--O 1.225 -0.417 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.933 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 84.0 mtp -114.4 120.24 39.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.662 0.231 . . . . 0.0 110.452 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 73.0 m . . . . . 0 C--N 1.33 -0.244 0 CA-C-O 120.839 0.352 . . . . 0.0 110.504 179.776 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 13.6 pt . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.654 0.264 . . . . 0.0 111.486 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 85.0 m 63.56 47.25 3.86 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.522 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.4 pt -82.24 146.25 7.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.722 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -67.47 136.97 55.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.235 179.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -168.81 148.62 4.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.853 0.358 . . . . 0.0 110.951 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 46.7 t -121.93 125.82 47.24 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.374 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.615 ' HA3' ' HG2' ' A' ' 16' ' ' ARG . . . -69.01 116.05 6.96 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.435 -0.888 . . . . 0.0 111.448 178.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.698 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -67.44 -73.93 0.13 Allowed 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 122.535 1.16 . . . . 0.0 113.379 -179.068 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.698 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -103.31 -44.2 5.23 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 112.392 -2.185 . . . . 0.0 112.339 -173.782 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 17.8 t-160 -59.98 -89.5 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.848 ' H ' ' HD2' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -91.56 101.84 14.49 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 177.532 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.7 p -68.8 66.42 0.13 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.971 0.415 . . . . 0.0 110.777 -179.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.436 ' HE3' ' HB2' ' A' ' 16' ' ' ARG . 22.2 pttp -148.34 139.74 23.48 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.943 -0.572 . . . . 0.0 112.3 -179.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 87.4 m -105.83 126.56 52.31 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.794 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 169.8 -145.34 9.18 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.459 -0.877 . . . . 0.0 113.066 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 63.8 mtm -84.11 138.49 33.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.816 0.341 . . . . 0.0 111.024 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 63.6 m . . . . . 0 C--N 1.332 -0.186 0 CA-C-O 120.997 0.427 . . . . 0.0 110.881 -179.953 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.488 HD13 ' CG2' ' A' ' 8' ' ' ILE . 10.2 pt . . . . . 0 C--O 1.232 0.148 0 CA-C-O 121.228 0.537 . . . . 0.0 110.087 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.492 ' SG ' ' HB3' ' A' ' 21' ' ' MET . 19.1 t 60.43 55.41 3.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.089 178.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.488 ' CG2' HD13 ' A' ' 6' ' ' ILE . 27.0 pt -58.88 147.04 8.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.692 179.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -59.8 110.59 1.2 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.329 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 14.9 m -114.46 158.69 21.25 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.632 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.729 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 57.8 m -125.94 128.8 48.09 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.779 0.323 . . . . 0.0 111.301 179.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.636 ' H ' ' HA ' ' A' ' 19' ' ' CYS . . . -71.3 84.41 0.42 Allowed Glycine 0 C--N 1.332 0.319 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 178.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.73 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 0.1 OUTLIER -60.51 -80.15 0.03 OUTLIER 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -178.171 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.73 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -98.45 -47.32 5.44 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 112.658 -2.064 . . . . 0.0 113.377 -172.85 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -57.01 -93.63 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 178.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.796 ' H ' ' HD2' ' A' ' 16' ' ' ARG . 0.2 OUTLIER -91.0 124.28 35.12 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 177.04 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 42.9 t -73.38 57.71 0.53 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.805 0.336 . . . . 0.0 111.305 -178.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -150.48 125.98 10.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.554 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.729 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 47.7 t -82.06 136.2 35.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.776 0.322 . . . . 0.0 110.725 179.215 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -163.68 151.96 21.68 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.716 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.492 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 3.5 mpp? -62.22 113.77 3.07 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 122.548 -0.384 . . . . 0.0 110.514 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 7.3 p . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.512 -179.835 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.477 HG13 HG21 ' A' ' 8' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.136 0 CA-C-O 120.872 0.368 . . . . 0.0 110.605 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 99.0 m 60.14 49.93 6.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.081 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.477 HG21 HG13 ' A' ' 6' ' ' ILE . 27.4 pt -53.61 132.09 16.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.881 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -72.48 135.35 45.68 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.414 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 30.0 p -150.72 116.62 5.55 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.141 0.496 . . . . 0.0 110.758 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.75 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 42.6 t -82.08 129.1 34.71 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.039 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.444 ' HA3' ' O ' ' A' ' 16' ' ' ARG . . . -62.29 101.37 0.37 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.468 -0.872 . . . . 0.0 111.27 179.31 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.721 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 0.1 OUTLIER -64.61 -79.87 0.04 OUTLIER 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 -178.484 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.721 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -100.45 -51.24 3.67 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-N 112.72 -2.037 . . . . 0.0 113.295 -172.907 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 17.7 m80 -55.69 -84.34 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.577 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 0.9 OUTLIER -91.27 114.05 26.48 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 176.748 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.4 p -75.44 54.98 0.77 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.893 0.378 . . . . 0.0 110.519 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.577 ' HG2' ' HB3' ' A' ' 16' ' ' ARG . 7.4 ptpp? -149.48 132.5 16.22 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.068 -179.053 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.75 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 75.3 m -72.82 140.09 47.42 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.706 178.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -168.33 140.93 6.47 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.107 -1.044 . . . . 0.0 113.525 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -70.69 133.91 47.04 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 122.702 -0.293 . . . . 0.0 110.408 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 2.8 p . . . . . 0 C--N 1.329 -0.295 0 CA-C-O 120.847 0.356 . . . . 0.0 111.242 179.96 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.822 HG13 HG22 ' A' ' 8' ' ' ILE . 1.6 pt . . . . . 0 CA--C 1.521 -0.154 0 CA-C-O 120.98 0.419 . . . . 0.0 110.91 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 35.8 m 54.21 27.54 7.96 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.627 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.822 HG22 HG13 ' A' ' 6' ' ' ILE . 28.0 pt -47.47 139.27 2.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.179 179.148 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -65.96 134.77 53.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.867 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -158.59 135.22 9.51 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.953 0.406 . . . . 0.0 110.753 179.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.566 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 65.8 m -80.54 132.02 35.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.112 -0.494 . . . . 0.0 112.084 -179.222 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.455 ' HA3' ' O ' ' A' ' 16' ' ' ARG . . . -76.78 74.48 1.79 Allowed Glycine 0 N--CA 1.451 -0.304 0 N-CA-C 110.996 -0.841 . . . . 0.0 110.996 178.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.674 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 23.2 p -66.01 -50.31 64.68 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -178.035 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.674 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 3.5 m -115.59 -43.99 2.99 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 113.481 -1.69 . . . . 0.0 112.854 -171.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . 0.469 ' HB2' HH11 ' A' ' 16' ' ' ARG . 42.5 m170 -65.84 -112.2 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 177.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.534 ' HD2' ' O ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -76.17 129.92 37.47 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 176.541 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 41.1 t -71.53 57.65 0.27 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.731 0.3 . . . . 0.0 111.4 -178.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.594 ' HB2' ' NZ ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -151.43 133.45 15.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.88 -179.724 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.566 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 35.0 t -95.87 131.28 42.36 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 178.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -179.56 -159.81 24.16 Favored Glycine 0 C--N 1.329 0.169 0 C-N-CA 120.533 -0.842 . . . . 0.0 112.588 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 84.9 mtp -69.19 131.35 44.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.604 0.24 . . . . 0.0 110.363 179.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.508 ' O ' ' HA ' ' A' ' 7' ' ' CYS . 25.7 m . . . . . 0 C--N 1.328 -0.355 0 CA-C-O 120.776 0.322 . . . . 0.0 110.96 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.701 HD12 HD11 ' A' ' 8' ' ' ILE . 3.7 pt . . . . . 0 N--CA 1.456 -0.173 0 CA-C-O 121.171 0.51 . . . . 0.0 109.964 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.3 t 67.84 41.52 2.14 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.946 179.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.701 HD11 HD12 ' A' ' 6' ' ' ILE . 25.0 pt -82.22 140.35 16.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.978 0.418 . . . . 0.0 111.482 179.278 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PHE . . . . . 0.712 ' HA ' ' HA ' ' A' ' 21' ' ' MET . 25.7 t80 -60.92 144.2 53.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.307 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.424 ' O ' ' O ' ' A' ' 20' ' ' GLY . 30.3 p -157.74 115.5 3.05 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.892 0.377 . . . . 0.0 111.532 -179.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.735 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 78.0 m -83.86 123.27 29.74 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 121.014 -0.274 . . . . 0.0 111.105 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.745 ' HA3' ' O ' ' A' ' 16' ' ' ARG . . . -65.88 113.68 5.96 Favored Glycine 0 N--CA 1.45 -0.367 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 178.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . 0.66 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 18.6 p -64.84 -48.33 74.73 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 115.713 1.745 . . . . 0.0 115.713 -177.03 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.66 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 4.1 m -118.83 -110.15 0.35 Allowed 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -170.03 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -47.17 -44.8 22.31 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.045 0.45 . . . . 0.0 109.93 -178.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.745 ' O ' ' HA3' ' A' ' 12' ' ' GLY . 42.8 ttt85 -90.84 46.86 1.36 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.458 178.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.619 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 79.2 p -59.55 65.84 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.243 0.617 . . . . 0.0 111.711 -178.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 16' ' ' ARG . 21.7 ptmt -151.68 129.83 11.91 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.689 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.735 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 50.1 m -73.8 133.97 43.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.797 0.332 . . . . 0.0 110.778 178.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 10' ' ' CYS . . . 178.43 141.58 4.37 Favored Glycine 0 C--O 1.226 -0.364 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.218 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.712 ' HA ' ' HA ' ' A' ' 9' ' ' PHE . 3.5 mpp? -62.39 135.46 57.45 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.93 0.365 . . . . 0.0 110.988 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 34.6 m . . . . . 0 N--CA 1.467 0.375 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.662 -179.937 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.417 ' N ' ' HB3' ' A' ' 24' ' ' LYS . 12.2 p-10 . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.775 0.321 . . . . 0.0 111.191 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.484 ' O ' ' HD3' ' A' ' 5' ' ' PRO . 71.5 m -64.07 139.24 58.75 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.768 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 79.3 t60 -63.18 -38.77 92.49 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.155 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.9 t80 -146.25 63.62 9.07 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.245 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 2' ' ' THR . 59.8 Cg_endo -73.15 -146.81 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.336 2.024 . . . . 0.0 111.872 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.457 ' H ' ' HB2' ' A' ' 5' ' ' PRO . 26.0 pt -83.46 -37.9 13.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.808 0.337 . . . . 0.0 110.853 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.776 ' HB3' ' HE2' ' A' ' 21' ' ' MET . 90.4 m 56.4 40.83 29.57 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.466 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 33.8 pt -62.18 127.23 21.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.353 179.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -55.27 138.36 45.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.89 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.6 p -158.75 109.56 2.08 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.904 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.79 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 39.0 m -75.2 124.88 27.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.828 0.347 . . . . 0.0 111.476 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.473 ' HA3' ' O ' ' A' ' 16' ' ' ARG . . . -63.77 93.89 0.13 Allowed Glycine 0 C--O 1.237 0.343 0 N-CA-C 111.066 -0.813 . . . . 0.0 111.066 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.667 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 17.8 p -70.55 -49.61 46.26 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -177.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.667 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 3.4 m -120.31 -55.49 2.04 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 114.282 -1.326 . . . . 0.0 113.938 -171.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -56.13 -84.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.662 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 1.3 mpt_? -91.48 119.9 31.84 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 176.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 59.2 m -75.16 52.81 0.6 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.662 ' HG2' ' HB3' ' A' ' 16' ' ' ARG . 20.6 pttp -150.49 139.4 20.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.992 -178.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.79 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 84.2 m -71.36 141.76 50.39 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.506 178.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -167.95 150.11 15.82 Favored Glycine 0 C--O 1.228 -0.259 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.728 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.776 ' HE2' ' HB3' ' A' ' 7' ' ' CYS . 75.9 mtp -73.69 128.25 35.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.816 0.341 . . . . 0.0 111.275 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 9.0 m -80.14 56.26 2.39 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.721 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.617 ' HA ' ' HA ' ' A' ' 7' ' ' CYS . 89.0 m -56.75 -54.78 42.35 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 121.015 -0.274 . . . . 0.0 110.911 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.417 ' HB3' ' N ' ' A' ' 1' ' ' ASP . 23.9 pttm -71.4 -147.95 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.94 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 95.1 m . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.777 -179.991 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.832 0.349 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.569 ' O ' ' HD3' ' A' ' 5' ' ' PRO . 90.8 m -76.31 140.92 41.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.066 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 45.8 m170 -66.9 -39.4 87.41 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.148 0.499 . . . . 0.0 110.474 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -136.86 64.06 48.04 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.935 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.569 ' HD3' ' O ' ' A' ' 2' ' ' THR . 28.1 Cg_endo -63.29 169.64 9.14 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.664 2.242 . . . . 0.0 113.064 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.709 HD13 HG21 ' A' ' 8' ' ' ILE . 11.4 pt -79.94 -32.29 13.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.52 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.669 ' SG ' ' HB3' ' A' ' 21' ' ' MET . 49.3 t 61.34 50.61 4.65 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.514 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.709 HG21 HD13 ' A' ' 6' ' ' ILE . 23.5 pt -56.47 139.78 15.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.953 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -58.75 138.35 57.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.592 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 24.4 p -146.85 121.94 10.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.929 0.395 . . . . 0.0 110.979 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 45.9 t -136.01 126.41 26.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.297 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.539 ' HA3' ' O ' ' A' ' 16' ' ' ARG . . . -70.95 128.6 17.11 Favored Glycine 0 C--O 1.239 0.413 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.49 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.674 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 0.8 OUTLIER -54.82 -83.45 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -178.344 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.674 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -107.12 -64.44 1.19 Allowed 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 113.044 -1.889 . . . . 0.0 113.459 -172.94 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.555 ' ND1' ' H ' ' A' ' 16' ' ' ARG . 12.0 p80 -59.01 -53.71 55.28 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.12 -0.632 . . . . 0.0 109.363 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.573 ' O ' ' N ' ' A' ' 18' ' ' LYS . 7.6 mpt_? -93.24 51.73 1.68 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.942 178.122 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 68.6 m -59.26 68.04 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.308 0.575 . . . . 0.0 111.045 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.573 ' N ' ' O ' ' A' ' 16' ' ' ARG . 55.9 mtpt -146.99 129.71 16.09 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.107 -179.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 96.9 m -102.49 137.31 40.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.889 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -174.56 147.51 9.19 Favored Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.764 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.669 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 60.9 mtm -73.78 129.57 38.18 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.624 0.25 . . . . 0.0 110.866 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 5.1 m -80.78 56.95 2.84 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.76 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 68.2 m -72.05 77.77 0.93 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.892 0.377 . . . . 0.0 110.912 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -74.31 48.94 0.35 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.496 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 80.5 p . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.243 -0.884 . . . . 0.0 111.281 179.874 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 60.8 t0 . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 121.026 0.441 . . . . 0.0 110.832 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.608 ' OG1' ' HB3' ' A' ' 5' ' ' PRO . 66.0 p -74.78 151.42 39.12 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.166 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -61.85 -41.58 98.0 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -178.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -138.83 67.82 42.63 Favored Pre-proline 0 CA--C 1.531 0.217 0 CA-C-O 120.873 0.368 . . . . 0.0 111.904 -178.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.608 ' HB3' ' OG1' ' A' ' 2' ' ' THR . 61.1 Cg_endo -76.83 -143.22 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.543 2.162 . . . . 0.0 112.32 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.454 ' H ' ' HB2' ' A' ' 5' ' ' PRO . 23.7 pt -90.38 -39.47 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.738 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 79.4 m 55.28 44.16 27.94 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.13 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.435 ' CG1' ' HB2' ' A' ' 22' ' ' CYS . 37.5 pt -54.84 130.18 16.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.929 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -69.11 85.33 0.36 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.608 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.731 ' HB3' HH22 ' A' ' 16' ' ' ARG . 83.0 m -72.49 68.36 0.79 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.749 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.702 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 22.2 t -99.86 73.56 1.78 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.063 0.458 . . . . 0.0 111.731 -178.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.721 ' HA3' ' HG3' ' A' ' 16' ' ' ARG . . . -60.34 122.25 29.27 Favored Glycine 0 C--O 1.235 0.173 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.541 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.695 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 14.9 p -69.85 -52.41 25.15 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -177.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.695 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 3.1 m -121.56 -81.67 0.64 Allowed 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -171.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 -49.52 -63.63 1.05 Allowed 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.731 HH22 ' HB3' ' A' ' 10' ' ' CYS . 6.8 ptm180 -90.96 56.55 3.24 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.27 177.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.433 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 78.6 p -59.47 65.04 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.814 0.845 . . . . 0.0 112.652 -178.247 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.688 ' NZ ' ' HB2' ' A' ' 16' ' ' ARG . 0.4 OUTLIER -149.59 140.27 22.62 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.038 178.302 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.702 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 61.2 m -125.47 131.6 52.83 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.13 0.49 . . . . 0.0 111.871 -178.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -179.71 142.49 5.2 Favored Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.275 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.451 ' HB2' ' HE2' ' A' ' 21' ' ' MET . 67.5 mtm -65.53 125.9 26.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.943 0.402 . . . . 0.0 111.451 -179.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.568 ' HB3' ' OG1' ' A' ' 25' ' ' THR . 94.1 m -95.92 61.04 2.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.787 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 96.1 m -60.24 -60.24 4.14 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.459 ' HG3' ' N ' ' A' ' 25' ' ' THR . 19.0 ptpt -60.58 -52.24 66.01 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -178.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.568 ' OG1' ' HB3' ' A' ' 22' ' ' CYS . 69.5 p . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.292 -0.861 . . . . 0.0 111.141 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.89 ' HA ' ' HA ' ' A' ' 24' ' ' LYS . 33.3 t70 . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.714 0.292 . . . . 0.0 111.127 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.59 ' HG1' ' HD3' ' A' ' 5' ' ' PRO . 74.6 p -67.77 -144.78 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.102 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 79.3 t60 -106.4 -48.55 3.53 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 120.622 0.249 . . . . 0.0 111.465 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -146.27 65.33 10.47 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.046 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.59 ' HD3' ' HG1' ' A' ' 2' ' ' THR . 95.1 Cg_endo -77.45 -137.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.579 2.186 . . . . 0.0 112.35 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.45 ' H ' ' HB2' ' A' ' 5' ' ' PRO . 12.6 pt -127.66 -34.81 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.535 179.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.63 ' SG ' ' HB3' ' A' ' 21' ' ' MET . 15.6 t 63.75 57.08 1.43 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.917 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.41 HG13 ' SG ' ' A' ' 10' ' ' CYS . 37.1 pt -54.26 131.97 17.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.092 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -72.11 89.82 1.17 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.968 0.413 . . . . 0.0 109.9 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.41 ' SG ' HG13 ' A' ' 8' ' ' ILE . 75.6 m -75.62 65.01 1.75 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.895 -179.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.755 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 34.3 t -102.65 74.21 1.34 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.116 0.484 . . . . 0.0 111.656 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.672 ' HA3' ' HG2' ' A' ' 16' ' ' ARG . . . -67.23 114.83 6.62 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.753 -0.736 . . . . 0.0 111.54 179.193 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.702 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -70.33 -74.31 0.14 Allowed 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 122.53 1.157 . . . . 0.0 113.557 -179.041 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.702 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -103.94 -44.36 5.05 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 112.489 -2.141 . . . . 0.0 112.434 -173.686 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 22.6 t-80 -58.12 -86.96 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.744 ' HB3' HH11 ' A' ' 16' ' ' ARG . 0.0 OUTLIER -91.3 114.87 27.51 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 176.961 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 64.0 m -74.99 63.32 1.21 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.931 0.396 . . . . 0.0 110.893 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.425 ' HE2' ' HB2' ' A' ' 16' ' ' ARG . 60.2 pttt -148.45 128.48 13.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.585 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.755 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 77.2 m -125.87 129.92 50.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.942 0.401 . . . . 0.0 110.99 179.178 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 176.68 146.24 5.99 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.464 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.63 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 80.4 mtp -68.25 119.66 13.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.777 0.322 . . . . 0.0 110.989 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.632 ' HB3' ' HG1' ' A' ' 25' ' ' THR . 56.6 m -89.99 53.93 2.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.036 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 7' ' ' CYS . 57.8 m -58.81 -41.87 87.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.111 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.89 ' HA ' ' HA ' ' A' ' 1' ' ' ASP . 9.4 ptpp? -58.45 -47.18 84.86 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.589 0.218 . . . . 0.0 111.589 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.632 ' HG1' ' HB3' ' A' ' 22' ' ' CYS . 77.6 p . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.171 -0.918 . . . . 0.0 111.147 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.643 ' H3 ' ' HD3' ' A' ' 24' ' ' LYS . 32.7 t70 . . . . . 0 N--CA 1.485 1.319 0 N-CA-C 110.594 -0.15 . . . . 0.0 110.594 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.478 ' H ' ' CG ' ' A' ' 1' ' ' ASP . 2.8 m -77.7 -138.19 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.472 ' H ' ' CG2' ' A' ' 2' ' ' THR . 88.8 m-70 -125.86 25.05 6.93 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.766 0.317 . . . . 0.0 110.762 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -145.28 57.29 4.18 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.69 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.411 ' HB2' ' H ' ' A' ' 6' ' ' ILE . 52.7 Cg_endo -68.79 -144.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.348 2.032 . . . . 0.0 112.689 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.475 HD12 HG22 ' A' ' 6' ' ' ILE . 14.0 pt -135.89 -33.39 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.193 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.767 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 78.0 m 62.98 47.16 4.41 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.861 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 35.3 pt -82.36 140.32 16.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.635 178.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.837 ' HA ' ' HA ' ' A' ' 21' ' ' MET . 28.1 t80 -53.01 135.94 36.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.108 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -155.63 138.97 15.74 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.254 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 47.4 t -129.88 122.33 28.43 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.749 0.309 . . . . 0.0 111.477 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.832 ' HA3' ' HG2' ' A' ' 16' ' ' ARG . . . -69.25 122.67 13.05 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.498 -0.858 . . . . 0.0 111.032 178.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.69 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 17.2 p -70.59 -51.68 26.7 Favored 'General case' 0 CA--C 1.504 -0.802 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -178.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.69 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 2.8 m -121.74 -57.05 1.83 Allowed 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 113.808 -1.542 . . . . 0.0 113.141 -172.376 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 21.5 t-80 -58.61 -79.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.832 ' HG2' ' HA3' ' A' ' 12' ' ' GLY . 0.1 OUTLIER -91.03 73.73 6.38 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.668 178.05 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.549 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 44.4 t -59.91 68.51 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.352 0.596 . . . . 0.0 110.592 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.661 ' HB3' ' NZ ' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -150.01 137.08 19.53 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.852 -178.609 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 85.2 m -102.36 131.35 49.04 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.735 0.302 . . . . 0.0 110.934 179.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 171.33 150.52 7.13 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.451 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.837 ' HA ' ' HA ' ' A' ' 9' ' ' PHE . 86.7 mtp -51.11 140.39 16.23 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.718 0.294 . . . . 0.0 110.797 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 15.0 m -131.51 129.61 41.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.201 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.767 ' HA ' ' HA ' ' A' ' 7' ' ' CYS . 59.9 m -88.8 -124.24 0.05 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.818 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.643 ' HD3' ' H3 ' ' A' ' 1' ' ' ASP . 4.1 ptpt -51.82 -44.47 63.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.659 0.266 . . . . 0.0 111.322 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 94.2 m . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.834 179.891 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.573 ' O ' ' HG3' ' A' ' 5' ' ' PRO . 53.9 m-20 . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.71 0.29 . . . . 0.0 111.154 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.431 ' OG1' ' HG2' ' A' ' 24' ' ' LYS . 15.6 m -74.91 62.04 1.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.444 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -125.69 -54.56 1.54 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.268 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.667 ' N ' ' HD3' ' A' ' 5' ' ' PRO . 22.2 t80 -147.5 51.5 1.11 Allowed Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.766 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.667 ' HD3' ' N ' ' A' ' 4' ' ' PHE . 3.5 Cg_exo -75.3 -145.75 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.554 2.169 . . . . 0.0 112.627 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.515 HD12 HG23 ' A' ' 8' ' ' ILE . 21.7 pt -96.86 -41.03 11.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.92 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.425 ' HA ' ' CB ' ' A' ' 23' ' ' CYS . 48.1 m 62.16 42.73 9.32 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.336 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.515 HG23 HD12 ' A' ' 6' ' ' ILE . 26.5 pt -80.27 147.79 6.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.045 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.586 ' HA ' ' HG2' ' A' ' 21' ' ' MET . 15.3 t80 -52.67 134.42 35.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.333 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.635 ' HB2' ' H ' ' A' ' 22' ' ' CYS . 49.8 m -163.57 120.82 1.81 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.746 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.545 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 40.0 t -91.16 131.01 36.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.81 0.338 . . . . 0.0 111.184 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.465 ' HA3' ' O ' ' A' ' 16' ' ' ARG . . . -66.97 96.78 0.32 Allowed Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 178.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.68 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 17.3 p -72.08 -50.05 31.37 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -177.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.68 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 3.3 m -121.12 -58.05 1.82 Allowed 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 114.277 -1.328 . . . . 0.0 114.157 -171.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.563 ' ND1' ' HD3' ' A' ' 16' ' ' ARG . 17.1 t-80 -56.36 -77.9 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.563 ' HD3' ' ND1' ' A' ' 15' ' ' HIS . 1.4 mpp_? -91.55 118.86 30.98 Favored 'General case' 0 C--O 1.221 -0.408 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 176.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.7 m -78.15 56.75 1.7 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -147.12 128.37 14.77 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.829 -178.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.545 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 63.7 m -75.42 135.67 40.74 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.702 0.287 . . . . 0.0 110.833 178.53 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.459 ' H ' ' HA ' ' A' ' 11' ' ' CYS . . . -166.86 -145.67 4.56 Favored Glycine 0 C--O 1.225 -0.456 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.882 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.586 ' HG2' ' HA ' ' A' ' 9' ' ' PHE . 64.0 mtm -127.6 119.29 25.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.982 0.391 . . . . 0.0 111.238 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.635 ' H ' ' HB2' ' A' ' 10' ' ' CYS . 29.7 p -74.45 126.34 30.52 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.116 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.425 ' CB ' ' HA ' ' A' ' 7' ' ' CYS . 7.6 t -126.16 -49.31 1.57 Allowed 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.144 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.431 ' HG2' ' OG1' ' A' ' 2' ' ' THR . 52.9 mttt -59.15 134.73 57.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.56 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 75.4 p . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.111 -179.97 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 51.6 p-10 . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.861 0.363 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.624 ' HA ' ' HG2' ' A' ' 24' ' ' LYS . 72.4 p -77.64 54.45 1.21 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.437 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 77.2 t60 -81.32 59.14 3.86 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.102 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.519 ' HA ' ' HB3' ' A' ' 23' ' ' CYS . 0.1 OUTLIER -46.99 101.01 0.25 Allowed Pre-proline 0 CA--C 1.531 0.241 0 CA-C-O 121.198 0.523 . . . . 0.0 112.386 -179.019 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.483 ' HB2' ' H ' ' A' ' 6' ' ' ILE . 68.1 Cg_endo -98.64 -131.23 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 123.784 2.989 . . . . 0.0 111.691 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.483 ' H ' ' HB2' ' A' ' 5' ' ' PRO . 2.8 pt -65.76 -19.54 25.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.562 178.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 64.0 m 64.58 48.74 2.53 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.94 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 29.4 pt -57.9 137.15 20.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.042 179.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.459 ' HA ' ' HA ' ' A' ' 21' ' ' MET . 23.0 t80 -63.06 135.24 57.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.539 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -148.79 141.52 24.56 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.933 0.397 . . . . 0.0 110.17 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 47.8 t -134.47 124.57 25.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.663 -178.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.518 ' O ' ' HA ' ' A' ' 17' ' ' SER . . . -75.99 119.27 5.62 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.417 -0.897 . . . . 0.0 111.053 178.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.682 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 20.0 p -72.72 -49.75 29.15 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 122.096 0.951 . . . . 0.0 112.459 -178.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.682 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 2.9 m -121.32 -48.12 2.22 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-N 113.236 -1.802 . . . . 0.0 112.247 -172.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 36.9 m170 -61.0 -87.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.81 ' HB2' ' HD3' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -91.5 86.0 5.92 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 177.257 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.518 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 57.2 m -62.68 61.3 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -177.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.81 ' HD3' ' HB2' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -150.63 140.22 21.59 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.743 178.471 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 90.1 m -100.1 132.85 45.22 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.889 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 176.7 154.77 12.23 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.986 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.459 ' HA ' ' HA ' ' A' ' 9' ' ' PHE . 86.8 mtp -56.11 136.34 52.54 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 21.8 m -122.28 132.91 54.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.153 -178.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.519 ' HB3' ' HA ' ' A' ' 4' ' ' PHE . 24.3 m -119.93 -60.42 1.71 Allowed 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.644 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.624 ' HG2' ' HA ' ' A' ' 2' ' ' THR . 28.1 mtmt -58.03 -50.06 74.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.016 -178.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 91.5 m . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.274 -0.869 . . . . 0.0 111.067 -179.889 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.508 ' H3 ' ' HB2' ' A' ' 24' ' ' LYS . 57.7 m-20 . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.516 0.198 . . . . 0.0 111.101 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 76.5 p -110.25 -153.13 0.51 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.66 0.267 . . . . 0.0 111.134 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 35.5 m170 -82.89 -42.11 18.14 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.171 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -130.63 57.24 29.98 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.982 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.405 ' HB2' ' H ' ' A' ' 6' ' ' ILE . 61.2 Cg_endo -71.24 -138.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.344 2.029 . . . . 0.0 112.208 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.497 HG22 HG23 ' A' ' 8' ' ' ILE . 41.0 mm -79.59 -37.71 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.431 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.799 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 1.7 m 64.46 47.86 2.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.118 -179.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.497 HG23 HG22 ' A' ' 6' ' ' ILE . 35.2 pt -61.12 133.2 26.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.632 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -80.8 134.98 35.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.899 179.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.9 p -145.18 140.78 28.17 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.267 0.556 . . . . 0.0 111.267 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 52.3 t -124.21 122.52 38.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.757 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.56 ' HA3' ' O ' ' A' ' 16' ' ' ARG . . . -60.42 112.55 4.64 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.319 -0.944 . . . . 0.0 111.485 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.728 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -67.67 -75.23 0.1 Allowed 'General case' 0 CA--C 1.505 -0.756 0 CA-C-O 122.539 1.162 . . . . 0.0 113.711 -178.907 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.728 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -100.44 -45.31 5.6 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 112.338 -2.21 . . . . 0.0 112.427 -173.602 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.409 ' HB2' ' HD3' ' A' ' 16' ' ' ARG . 90.5 m-70 -60.28 -91.61 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.438 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.83 ' H ' ' HD3' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -91.38 103.84 16.43 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 177.722 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.9 p -69.41 67.43 0.2 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.002 0.429 . . . . 0.0 110.692 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.415 ' HE3' ' HG3' ' A' ' 16' ' ' ARG . 22.2 pttp -147.68 138.38 23.28 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.459 -179.168 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 79.0 m -100.95 138.36 38.1 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.827 178.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -177.99 157.2 21.23 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.253 -0.975 . . . . 0.0 113.258 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.421 ' HE2' ' HB2' ' A' ' 21' ' ' MET . 3.4 mpp? -59.4 144.36 47.04 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 6.9 m -136.19 69.0 1.43 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.581 -178.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.799 ' HA ' ' HA ' ' A' ' 7' ' ' CYS . 84.2 m -64.3 -116.88 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.127 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.714 ' H ' ' HZ1' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -52.68 142.25 18.92 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.942 0.401 . . . . 0.0 111.213 -179.498 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 69.8 p . . . . . 0 C--O 1.251 1.136 0 CA-C-O 118.262 -0.875 . . . . 0.0 111.139 -179.986 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.689 ' H2 ' ' HG3' ' A' ' 24' ' ' LYS . 7.6 t70 . . . . . 0 N--CA 1.484 1.237 0 CA-C-O 120.721 0.296 . . . . 0.0 111.013 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 85.6 m -137.06 -65.73 0.54 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.618 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.459 ' O ' ' HD2' ' A' ' 24' ' ' LYS . 77.9 t60 -78.53 65.12 3.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.886 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -51.95 124.42 28.52 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-O 121.032 0.444 . . . . 0.0 110.991 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.671 ' HD3' ' HE3' ' A' ' 24' ' ' LYS . 65.3 Cg_endo -89.62 -145.98 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.912 2.408 . . . . 0.0 112.496 -179.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.449 ' H ' ' HB2' ' A' ' 5' ' ' PRO . 11.0 pt -74.37 -29.34 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 121.259 0.552 . . . . 0.0 109.605 178.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.6 ' SG ' ' HB3' ' A' ' 21' ' ' MET . 23.2 t 58.03 51.56 8.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.382 179.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 31.6 pt -50.12 141.98 3.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.267 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -62.47 147.49 48.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.804 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 17.4 p -149.23 131.13 15.19 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.21 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 47.5 t -135.71 107.47 7.03 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.89 0.376 . . . . 0.0 111.489 -179.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.474 ' HA3' ' O ' ' A' ' 16' ' ' ARG . . . -85.69 114.2 3.96 Favored Glycine 0 C--O 1.239 0.432 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.534 178.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.665 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 0.9 OUTLIER -57.33 -82.58 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -178.44 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.665 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -110.14 -63.88 1.33 Allowed 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 113.142 -1.845 . . . . 0.0 113.653 -172.743 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 52.1 t60 -51.2 -60.55 2.99 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.474 ' O ' ' HA3' ' A' ' 12' ' ' GLY . 0.0 OUTLIER -91.89 79.93 5.25 Favored 'General case' 0 C--O 1.218 -0.569 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.33 176.575 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 65.1 m -67.96 57.95 0.07 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.701 0.286 . . . . 0.0 111.158 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.632 ' HB3' ' NZ ' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -149.67 122.52 8.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.209 -179.555 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 92.1 m -126.7 130.71 50.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.142 0.496 . . . . 0.0 111.654 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 176.92 -154.84 16.94 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.96 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.6 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 80.0 mtp -96.98 126.16 41.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.743 0.306 . . . . 0.0 110.918 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 49.1 m -93.64 75.14 4.36 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.638 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.425 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 78.8 m -72.47 -124.45 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.371 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.819 ' HA ' ' HE2' ' A' ' 24' ' ' LYS . 7.9 mmpt? -68.35 136.38 53.3 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.774 0.321 . . . . 0.0 111.217 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.4 t . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.214 -0.898 . . . . 0.0 111.191 179.914 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.488 1.459 0 CA-C-O 120.825 0.345 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.532 ' O ' ' HD3' ' A' ' 5' ' ' PRO . 4.3 t -72.1 139.91 48.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.086 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 79.9 t60 -71.17 -31.49 67.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.961 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -120.25 58.81 6.11 Favored Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -178.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.532 ' HD3' ' O ' ' A' ' 2' ' ' THR . 65.1 Cg_endo -72.93 -146.88 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.313 2.009 . . . . 0.0 112.394 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.596 HD12 HG23 ' A' ' 8' ' ' ILE . 23.5 pt -92.75 -37.32 8.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.979 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.735 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 57.5 m 63.95 45.07 4.42 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.119 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.596 HG23 HD12 ' A' ' 6' ' ' ILE . 31.4 pt -75.26 133.62 31.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.18 178.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -70.93 133.59 46.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.718 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 3.3 p -162.82 144.32 10.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.817 0.341 . . . . 0.0 110.464 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.786 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 11.5 t -91.65 124.2 35.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.039 0.447 . . . . 0.0 110.985 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.591 ' HA2' ' HB3' ' A' ' 17' ' ' SER . . . 162.78 154.55 7.66 Favored Glycine 0 C--O 1.22 -0.747 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.961 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.618 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 4.8 t -141.1 -92.52 0.15 Allowed 'General case' 0 CA--C 1.51 -0.595 0 CA-C-O 123.236 1.493 . . . . 0.0 111.635 178.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.618 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.5 OUTLIER -122.13 -123.7 0.27 Allowed 'General case' 0 N--CA 1.425 -1.677 0 CA-C-N 111.185 -2.734 . . . . 0.0 108.503 -176.542 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.431 ' H ' ' HB2' ' A' ' 14' ' ' CYS . 46.8 m170 -61.17 -49.81 75.69 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 176.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.802 ' H ' ' HD2' ' A' ' 16' ' ' ARG . 0.4 OUTLIER -91.68 137.07 32.66 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.942 176.795 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.591 ' HB3' ' HA2' ' A' ' 12' ' ' GLY . 60.8 m -80.19 130.03 34.93 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.694 0.283 . . . . 0.0 111.319 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.566 ' H ' ' C ' ' A' ' 12' ' ' GLY . 13.7 mmmm -119.8 118.57 31.18 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.935 0.398 . . . . 0.0 110.86 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.786 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 85.4 m -62.57 127.75 32.77 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.417 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 174.4 -179.53 45.68 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.891 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.444 ' HB3' ' HE1' ' A' ' 21' ' ' MET . 93.9 mmm -63.32 135.27 56.91 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.724 0.297 . . . . 0.0 110.35 179.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 8' ' ' ILE . 20.6 m -116.61 53.83 0.87 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.167 -179.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.735 ' HA ' ' HA ' ' A' ' 7' ' ' CYS . 84.8 m -58.78 -74.22 0.07 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.555 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.587 ' O ' ' HD3' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -68.59 152.06 45.89 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.88 0.372 . . . . 0.0 111.53 -179.668 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.1 m . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.829 -179.774 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . 0.423 ' H1 ' ' HB3' ' A' ' 24' ' ' LYS . 1.5 m-20 . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.785 0.326 . . . . 0.0 111.081 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 82.7 p -75.37 -135.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.173 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -69.61 76.57 0.42 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.607 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -44.76 128.83 5.17 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.709 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.48 ' HB2' ' H ' ' A' ' 6' ' ' ILE . 94.4 Cg_endo -87.41 -137.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.093 2.529 . . . . 0.0 113.543 -178.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.53 HG13 ' CG2' ' A' ' 8' ' ' ILE . 0.5 OUTLIER -124.45 33.28 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.025 -179.886 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.773 ' HA ' ' HB2' ' A' ' 23' ' ' CYS . 62.5 m 59.98 27.31 16.69 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.134 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.53 ' CG2' HG13 ' A' ' 6' ' ' ILE . 16.3 pt -61.39 142.92 15.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.946 0.403 . . . . 0.0 110.828 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -68.1 124.52 23.65 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.787 178.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 35.9 m -125.18 113.72 18.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.929 0.395 . . . . 0.0 111.344 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.407 ' CB ' ' HA ' ' A' ' 19' ' ' CYS . 42.1 t -136.38 111.84 9.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.96 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 17' ' ' SER . . . -69.91 129.69 21.58 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.35 -0.929 . . . . 0.0 111.125 178.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.686 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 17.2 p -68.68 -50.91 47.28 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -178.467 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.686 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 3.1 m -121.59 -61.29 1.53 Allowed 'General case' 0 N--CA 1.428 -1.531 0 CA-C-N 113.922 -1.49 . . . . 0.0 113.618 -172.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.473 ' HD2' ' NH1' ' A' ' 16' ' ' ARG . 66.4 t60 -62.6 -62.35 1.8 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.341 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.527 ' O ' ' N ' ' A' ' 18' ' ' LYS . 9.1 mpt_? -91.39 62.08 4.55 Favored 'General case' 0 C--O 1.218 -0.586 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.087 177.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 65.9 m -61.79 59.78 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.627 0 O-C-N 123.424 0.453 . . . . 0.0 111.414 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.527 ' N ' ' O ' ' A' ' 16' ' ' ARG . 15.4 ptpt -149.71 135.69 18.77 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.626 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.407 ' HA ' ' CB ' ' A' ' 11' ' ' CYS . 67.5 m -99.05 135.67 40.13 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.763 178.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 176.98 144.68 5.39 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.757 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 60.9 mtm -64.48 123.42 19.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.792 0.33 . . . . 0.0 110.724 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 13.0 p -89.53 41.36 1.03 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.734 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.773 ' HB2' ' HA ' ' A' ' 7' ' ' CYS . 4.6 t -89.67 55.89 3.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.883 -179.059 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.423 ' HB3' ' H1 ' ' A' ' 1' ' ' ASP . 54.0 mtmt -55.81 118.42 4.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.793 0.33 . . . . 0.0 110.458 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 2.0 t . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.545 -0.74 . . . . 0.0 111.513 -179.805 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.5 p30 . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.952 0.405 . . . . 0.0 111.26 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.657 ' OG1' ' HB3' ' A' ' 5' ' ' PRO . 41.2 p -77.63 148.0 35.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.395 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 47.7 m170 -66.38 -39.11 88.89 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -179.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.41 61.43 57.17 Favored Pre-proline 0 CA--C 1.533 0.3 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -178.302 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.657 ' HB3' ' OG1' ' A' ' 2' ' ' THR . 72.9 Cg_endo -76.8 169.62 21.38 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.729 2.286 . . . . 0.0 113.162 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.414 HD11 ' CG2' ' A' ' 8' ' ' ILE . 7.0 pt -82.06 -28.58 9.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.322 178.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.6 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 34.8 t 63.62 52.75 2.18 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.834 179.349 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.414 ' CG2' HD11 ' A' ' 6' ' ' ILE . 26.9 pt -60.3 141.44 16.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.39 179.338 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -60.71 143.84 53.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.694 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 20' ' ' GLY . 26.8 p -149.91 120.98 7.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.768 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 47.6 t -135.64 120.48 18.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.939 0.399 . . . . 0.0 111.008 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.849 ' HA3' ' HG2' ' A' ' 16' ' ' ARG . . . -68.94 133.68 27.0 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.028 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.586 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 0.6 OUTLIER -58.35 -76.79 0.04 OUTLIER 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -178.831 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.586 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -119.87 -56.55 2.02 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 113.395 -1.729 . . . . 0.0 112.907 -173.16 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 42.6 m170 -56.02 -70.19 0.12 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 179.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.871 ' HB2' ' HE3' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -91.49 50.72 1.77 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 177.069 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.634 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 77.4 p -58.33 71.9 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.773 -178.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.871 ' HE3' ' HB2' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -148.82 141.0 23.98 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.977 -1.011 . . . . 0.0 111.808 179.678 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 69.6 m -102.89 136.2 43.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.86 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.454 ' O ' ' SG ' ' A' ' 10' ' ' CYS . . . -177.4 152.83 12.43 Favored Glycine 0 C--O 1.224 -0.5 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.009 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.578 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 63.5 mtm -82.12 125.11 30.49 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.984 0.392 . . . . 0.0 111.519 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 59.9 m -86.48 61.94 7.12 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.817 179.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.6 ' HA ' ' HA ' ' A' ' 7' ' ' CYS . 51.4 m -51.19 -45.88 61.96 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 48.4 mttp -48.88 -46.08 42.01 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.773 0.32 . . . . 0.0 111.282 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 65.5 p . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.403 -0.808 . . . . 0.0 110.958 -179.888 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.835 0.35 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 89.0 m -136.14 -51.23 0.71 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.049 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.465 ' HD1' ' H ' ' A' ' 3' ' ' HIS . 18.0 p-80 -81.16 54.99 2.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.069 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -51.54 107.8 0.91 Allowed Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.02 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.631 ' HD2' ' HB3' ' A' ' 23' ' ' CYS . 76.0 Cg_endo -87.4 -129.92 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.935 2.423 . . . . 0.0 112.061 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.407 ' H ' ' HB2' ' A' ' 5' ' ' PRO . 12.3 pt -70.27 -28.85 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-O 120.969 0.414 . . . . 0.0 110.01 179.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.512 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 95.0 m 60.97 50.05 5.38 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.813 179.452 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 24.7 pt -51.06 131.02 11.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.452 179.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -61.89 146.79 48.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.151 0.501 . . . . 0.0 111.221 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.1 p -155.4 139.07 16.06 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.912 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.423 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 41.8 t -135.36 117.27 15.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.117 0.484 . . . . 0.0 111.639 -179.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.453 ' N ' ' SG ' ' A' ' 19' ' ' CYS . . . -93.69 92.82 1.64 Allowed Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 178.584 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.691 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 18.7 p -72.68 -50.26 26.11 Favored 'General case' 0 CA--C 1.504 -0.808 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -178.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.691 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 3.0 m -121.15 -50.39 2.14 Favored 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 113.727 -1.579 . . . . 0.0 113.087 -172.349 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 40.8 m170 -57.47 -83.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.671 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 0.6 OUTLIER -91.1 126.67 36.25 Favored 'General case' 0 C--O 1.22 -0.493 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 176.783 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 77.9 p -77.61 55.38 1.31 Allowed 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.291 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.671 ' HG2' ' HB3' ' A' ' 16' ' ' ARG . 13.9 ptmm? -148.29 125.54 11.51 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.453 ' SG ' ' N ' ' A' ' 12' ' ' GLY . 84.4 m -126.32 126.16 43.47 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.938 0.399 . . . . 0.0 111.387 179.037 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 176.16 -152.26 12.62 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.057 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 61.3 mtm -92.35 122.28 34.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.791 0.329 . . . . 0.0 111.212 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 35.7 m -87.52 55.38 3.49 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.814 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.631 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 63.2 m -53.77 -66.77 0.33 Allowed 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.162 -179.678 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.596 ' O ' ' HD2' ' A' ' 24' ' ' LYS . 1.8 pptp? -72.84 145.36 47.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.065 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 72.2 p . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.229 -0.891 . . . . 0.0 111.071 -179.859 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.8 p30 . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.849 0.357 . . . . 0.0 111.236 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 40.1 p -61.57 121.7 13.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.067 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -76.61 -24.93 53.4 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.268 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -143.53 59.95 8.05 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.906 0.384 . . . . 0.0 111.337 -179.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.58 -144.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.394 2.063 . . . . 0.0 112.049 179.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 13.4 pt -102.99 -38.52 5.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.952 0.406 . . . . 0.0 110.638 179.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.467 ' SG ' ' HB3' ' A' ' 21' ' ' MET . 15.4 t 56.62 51.02 11.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.197 179.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.412 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 27.8 pt -53.04 149.23 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.415 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -71.21 82.4 0.73 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.031 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 21.3 m -67.09 141.58 57.41 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.807 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 26.1 t -136.01 115.45 12.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.952 0.406 . . . . 0.0 110.987 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -88.92 97.41 2.32 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.523 179.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.692 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 0.1 OUTLIER -66.11 -76.41 0.08 Allowed 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -178.808 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.692 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -104.58 -48.02 3.92 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 112.711 -2.041 . . . . 0.0 112.922 -173.332 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -55.97 -83.79 0.01 OUTLIER 'General case' 0 C--O 1.232 0.164 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.551 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.643 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 11.3 mpt_? -91.21 120.14 31.88 Favored 'General case' 0 C--O 1.221 -0.432 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 176.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.9 m -76.95 55.47 1.11 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.123 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.643 ' HG2' ' HB3' ' A' ' 16' ' ' ARG . 21.9 pttp -148.66 129.74 14.48 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.715 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 80.0 m -125.77 128.69 48.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.29 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -171.92 -150.15 7.04 Favored Glycine 0 CA--C 1.519 0.331 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.864 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.467 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 68.6 mtm -94.17 132.46 38.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.914 0.388 . . . . 0.0 111.417 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.412 ' SG ' ' O ' ' A' ' 8' ' ' ILE . 7.3 p -116.27 69.07 0.74 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.635 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.402 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 88.0 m -62.08 -118.07 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.153 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.591 ' O ' ' HD2' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -58.67 151.78 20.15 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.916 0.389 . . . . 0.0 111.499 -179.593 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 8.1 t . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.227 -0.892 . . . . 0.0 111.172 -179.661 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.425 0.155 . . . . 0.0 111.059 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.508 ' O ' ' HD3' ' A' ' 5' ' ' PRO . 75.5 m -51.4 -43.27 61.89 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.764 0.316 . . . . 0.0 111.749 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 16.8 m80 -50.5 -51.69 45.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.828 -179.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -145.98 71.56 13.55 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 120.77 0.319 . . . . 0.0 110.813 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.508 ' HD3' ' O ' ' A' ' 2' ' ' THR . 94.1 Cg_endo -80.51 -150.86 0.04 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.457 2.105 . . . . 0.0 112.528 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.42 ' H ' ' HB2' ' A' ' 5' ' ' PRO . 18.7 pt -136.2 -40.1 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.61 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.741 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 8.8 t 57.36 52.83 8.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.312 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 26.6 pt -57.3 149.93 4.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.545 179.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -52.69 129.53 29.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.329 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -165.36 133.32 3.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.281 -179.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.609 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 42.8 t -84.73 130.76 34.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.559 -179.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.516 ' HA3' ' O ' ' A' ' 16' ' ' ARG . . . -72.02 103.18 1.25 Allowed Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 178.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.688 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 16.8 p -71.38 -50.97 26.74 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 114.282 1.215 . . . . 0.0 114.282 -177.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.688 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 3.2 m -121.22 -62.56 1.42 Allowed 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 114.245 -1.343 . . . . 0.0 113.802 -171.58 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.537 ' HB3' ' CZ ' ' A' ' 16' ' ' ARG . 39.2 m170 -52.75 -75.78 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.537 ' CZ ' ' HB3' ' A' ' 15' ' ' HIS . 0.0 OUTLIER -91.13 106.83 18.79 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 176.737 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 46.1 t -74.25 52.91 0.49 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.713 0.292 . . . . 0.0 111.409 -179.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.519 ' HD2' ' N ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -150.69 134.53 16.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.799 179.793 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.609 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 86.5 m -75.02 132.45 41.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.648 178.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -174.54 -136.5 2.26 Favored Glycine 0 C--O 1.225 -0.417 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.933 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 84.0 mtp -114.4 120.24 39.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.662 0.231 . . . . 0.0 110.452 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 73.0 m -89.84 117.16 28.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.839 0.352 . . . . 0.0 110.504 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.741 ' HA ' ' HA ' ' A' ' 7' ' ' CYS . 75.9 m -84.31 -126.26 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.87 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.735 ' HD2' ' H ' ' A' ' 25' ' ' THR . 0.0 OUTLIER -56.75 -33.11 66.23 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -179.822 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.735 ' H ' ' HD2' ' A' ' 24' ' ' LYS . 9.9 t . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.193 -0.908 . . . . 0.0 111.035 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 51.7 p30 . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.417 0.151 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.564 ' HB ' ' HG3' ' A' ' 5' ' ' PRO . 90.6 m -125.56 132.97 52.46 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.852 0.358 . . . . 0.0 111.285 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -67.7 -30.1 69.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.969 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.526 ' H ' HG22 ' A' ' 2' ' ' THR . 22.0 t80 -143.63 73.62 17.1 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.506 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.564 ' HG3' ' HB ' ' A' ' 2' ' ' THR . 16.6 Cg_exo -66.07 -151.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.557 2.171 . . . . 0.0 112.74 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 13.6 pt -87.27 -34.66 7.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.486 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.511 ' HA ' ' HB2' ' A' ' 23' ' ' CYS . 85.0 m 63.56 47.25 3.86 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.522 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.4 pt -82.24 146.25 7.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.722 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -67.47 136.97 55.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.235 179.146 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -168.81 148.62 4.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.853 0.358 . . . . 0.0 110.951 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 46.7 t -121.93 125.82 47.24 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.374 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.615 ' HA3' ' HG2' ' A' ' 16' ' ' ARG . . . -69.01 116.05 6.96 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.435 -0.888 . . . . 0.0 111.448 178.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.698 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -67.44 -73.93 0.13 Allowed 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 122.535 1.16 . . . . 0.0 113.379 -179.068 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.698 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -103.31 -44.2 5.23 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 112.392 -2.185 . . . . 0.0 112.339 -173.782 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 17.8 t-160 -59.98 -89.5 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.47 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.848 ' H ' ' HD2' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -91.56 101.84 14.49 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 177.532 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.7 p -68.8 66.42 0.13 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.971 0.415 . . . . 0.0 110.777 -179.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.436 ' HE3' ' HB2' ' A' ' 16' ' ' ARG . 22.2 pttp -148.34 139.74 23.48 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.943 -0.572 . . . . 0.0 112.3 -179.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 87.4 m -105.83 126.56 52.31 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.794 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 169.8 -145.34 9.18 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.459 -0.877 . . . . 0.0 113.066 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 63.8 mtm -84.11 138.49 33.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.816 0.341 . . . . 0.0 111.024 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 63.6 m -121.84 57.21 1.05 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.997 0.427 . . . . 0.0 110.881 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.511 ' HB2' ' HA ' ' A' ' 7' ' ' CYS . 4.2 t -99.12 90.81 4.72 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.218 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -41.84 126.28 3.06 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.977 -179.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 88.5 m . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.315 -0.85 . . . . 0.0 110.992 -179.827 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 62.6 t0 . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 121.006 0.431 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.633 ' HG1' ' HB3' ' A' ' 5' ' ' PRO . 63.8 p -62.65 136.29 57.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.157 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.424 ' HD2' ' H ' ' A' ' 4' ' ' PHE . 0.4 OUTLIER -73.04 -25.91 61.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.343 -179.328 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.424 ' H ' ' HD2' ' A' ' 3' ' ' HIS . 19.9 t80 -132.45 60.81 53.24 Favored Pre-proline 0 CA--C 1.535 0.369 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.065 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.633 ' HB3' ' HG1' ' A' ' 2' ' ' THR . 73.1 Cg_endo -78.06 -149.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.412 2.075 . . . . 0.0 112.32 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.488 HD13 ' CG2' ' A' ' 8' ' ' ILE . 10.2 pt -98.88 -33.57 4.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.228 0.537 . . . . 0.0 110.087 178.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.492 ' SG ' ' HB3' ' A' ' 21' ' ' MET . 19.1 t 60.43 55.41 3.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.089 178.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.488 ' CG2' HD13 ' A' ' 6' ' ' ILE . 27.0 pt -58.88 147.04 8.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.692 179.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -59.8 110.59 1.2 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.329 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 14.9 m -114.46 158.69 21.25 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.632 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.729 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 57.8 m -125.94 128.8 48.09 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.779 0.323 . . . . 0.0 111.301 179.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.636 ' H ' ' HA ' ' A' ' 19' ' ' CYS . . . -71.3 84.41 0.42 Allowed Glycine 0 C--N 1.332 0.319 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 178.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.73 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 0.1 OUTLIER -60.51 -80.15 0.03 OUTLIER 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -178.171 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.73 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -98.45 -47.32 5.44 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 112.658 -2.064 . . . . 0.0 113.377 -172.85 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -57.01 -93.63 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 178.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.796 ' H ' ' HD2' ' A' ' 16' ' ' ARG . 0.2 OUTLIER -91.0 124.28 35.12 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 177.04 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 42.9 t -73.38 57.71 0.53 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.805 0.336 . . . . 0.0 111.305 -178.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -150.48 125.98 10.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.554 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.729 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 47.7 t -82.06 136.2 35.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.776 0.322 . . . . 0.0 110.725 179.215 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -163.68 151.96 21.68 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.716 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.492 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 3.5 mpp? -62.22 113.77 3.07 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 122.548 -0.384 . . . . 0.0 110.514 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 7.3 p -74.56 82.71 2.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.512 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.449 ' HA ' ' CB ' ' A' ' 7' ' ' CYS . 92.1 m -69.14 -117.43 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.195 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.513 ' HD2' ' N ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -52.15 -37.86 55.81 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.602 0.239 . . . . 0.0 111.372 -179.29 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.472 ' H ' ' HD2' ' A' ' 24' ' ' LYS . 77.5 p . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.132 -0.937 . . . . 0.0 111.208 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 120.815 0.341 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 68.2 p -136.18 -147.68 0.27 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.271 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 19.7 m80 -74.28 -45.56 46.85 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.16 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -145.45 63.29 9.54 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.979 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.456 ' HB2' ' H ' ' A' ' 6' ' ' ILE . 38.1 Cg_endo -65.22 -134.02 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.675 2.25 . . . . 0.0 112.094 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.477 HG13 HG21 ' A' ' 8' ' ' ILE . 0.0 OUTLIER -78.07 -34.22 18.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.872 0.368 . . . . 0.0 110.605 179.333 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.79 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 99.0 m 60.14 49.93 6.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.081 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.477 HG21 HG13 ' A' ' 6' ' ' ILE . 27.4 pt -53.61 132.09 16.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.881 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -72.48 135.35 45.68 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.414 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 30.0 p -150.72 116.62 5.55 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.141 0.496 . . . . 0.0 110.758 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.75 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 42.6 t -82.08 129.1 34.71 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.039 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.444 ' HA3' ' O ' ' A' ' 16' ' ' ARG . . . -62.29 101.37 0.37 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.468 -0.872 . . . . 0.0 111.27 179.31 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.721 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 0.1 OUTLIER -64.61 -79.87 0.04 OUTLIER 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 -178.484 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.721 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -100.45 -51.24 3.67 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-N 112.72 -2.037 . . . . 0.0 113.295 -172.907 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 17.7 m80 -55.69 -84.34 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.577 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 0.9 OUTLIER -91.27 114.05 26.48 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 176.748 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.4 p -75.44 54.98 0.77 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.893 0.378 . . . . 0.0 110.519 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.577 ' HG2' ' HB3' ' A' ' 16' ' ' ARG . 7.4 ptpp? -149.48 132.5 16.22 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.068 -179.053 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.75 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 75.3 m -72.82 140.09 47.42 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.706 178.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -168.33 140.93 6.47 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.107 -1.044 . . . . 0.0 113.525 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -70.69 133.91 47.04 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 122.702 -0.293 . . . . 0.0 110.408 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 2.8 p -120.39 123.69 43.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.847 0.356 . . . . 0.0 111.242 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.79 ' HA ' ' HA ' ' A' ' 7' ' ' CYS . 39.0 m -95.34 -63.45 1.16 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.143 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.663 ' NZ ' ' HB2' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -80.27 139.0 36.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.125 179.821 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 77.7 p . . . . . 0 C--O 1.25 1.13 0 CA-C-O 118.225 -0.893 . . . . 0.0 111.198 -179.67 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.2 p30 . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.767 0.318 . . . . 0.0 111.385 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 87.9 m -108.94 -48.14 3.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.922 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -74.17 72.14 1.7 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.719 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -51.82 109.48 1.42 Allowed Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.98 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.539 ' HD3' ' HB2' ' A' ' 24' ' ' LYS . 92.7 Cg_endo -87.7 -140.02 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.912 2.408 . . . . 0.0 112.672 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.822 HG13 HG22 ' A' ' 8' ' ' ILE . 1.6 pt -135.28 36.31 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.91 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 35.8 m 54.21 27.54 7.96 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.627 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.822 HG22 HG13 ' A' ' 6' ' ' ILE . 28.0 pt -47.47 139.27 2.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.179 179.148 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -65.96 134.77 53.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.867 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -158.59 135.22 9.51 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.953 0.406 . . . . 0.0 110.753 179.353 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.566 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 65.8 m -80.54 132.02 35.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.112 -0.494 . . . . 0.0 112.084 -179.222 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.455 ' HA3' ' O ' ' A' ' 16' ' ' ARG . . . -76.78 74.48 1.79 Allowed Glycine 0 N--CA 1.451 -0.304 0 N-CA-C 110.996 -0.841 . . . . 0.0 110.996 178.501 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.674 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 23.2 p -66.01 -50.31 64.68 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -178.035 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.674 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 3.5 m -115.59 -43.99 2.99 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 113.481 -1.69 . . . . 0.0 112.854 -171.773 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.469 ' HB2' HH11 ' A' ' 16' ' ' ARG . 42.5 m170 -65.84 -112.2 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 177.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.534 ' HD2' ' O ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -76.17 129.92 37.47 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 176.541 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 41.1 t -71.53 57.65 0.27 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.731 0.3 . . . . 0.0 111.4 -178.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.594 ' HB2' ' NZ ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -151.43 133.45 15.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.88 -179.724 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.566 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 35.0 t -95.87 131.28 42.36 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 178.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -179.56 -159.81 24.16 Favored Glycine 0 C--N 1.329 0.169 0 C-N-CA 120.533 -0.842 . . . . 0.0 112.588 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 84.9 mtp -69.19 131.35 44.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.604 0.24 . . . . 0.0 110.363 179.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.508 ' O ' ' HA ' ' A' ' 7' ' ' CYS . 25.7 m -117.57 116.69 27.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.776 0.322 . . . . 0.0 110.96 -179.299 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.2 m -126.36 107.99 10.82 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.999 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.539 ' HB2' ' HD3' ' A' ' 5' ' ' PRO . 29.2 mtpp -74.56 43.14 0.18 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.404 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 77.5 p . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.238 -0.887 . . . . 0.0 111.018 179.868 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 36.2 t70 . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.776 0.322 . . . . 0.0 111.108 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 60.8 p -135.58 52.89 1.99 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.499 0.666 . . . . 0.0 110.941 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -88.11 75.46 8.67 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.544 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . 0.412 ' HD1' ' O ' ' A' ' 4' ' ' PHE . 2.2 p90 -44.96 104.77 0.41 Allowed Pre-proline 0 CA--C 1.534 0.33 0 CA-C-O 121.35 0.595 . . . . 0.0 111.684 -179.264 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -97.56 -151.36 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 123.414 2.743 . . . . 0.0 112.856 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.701 HD12 HD11 ' A' ' 8' ' ' ILE . 3.7 pt -72.11 -13.69 16.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.964 178.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.3 t 67.84 41.52 2.14 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.946 179.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.701 HD11 HD12 ' A' ' 6' ' ' ILE . 25.0 pt -82.22 140.35 16.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.978 0.418 . . . . 0.0 111.482 179.278 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PHE . . . . . 0.712 ' HA ' ' HA ' ' A' ' 21' ' ' MET . 25.7 t80 -60.92 144.2 53.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.307 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.424 ' O ' ' O ' ' A' ' 20' ' ' GLY . 30.3 p -157.74 115.5 3.05 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.892 0.377 . . . . 0.0 111.532 -179.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.735 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 78.0 m -83.86 123.27 29.74 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 121.014 -0.274 . . . . 0.0 111.105 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.745 ' HA3' ' O ' ' A' ' 16' ' ' ARG . . . -65.88 113.68 5.96 Favored Glycine 0 N--CA 1.45 -0.367 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 178.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . 0.66 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 18.6 p -64.84 -48.33 74.73 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 115.713 1.745 . . . . 0.0 115.713 -177.03 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.66 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 4.1 m -118.83 -110.15 0.35 Allowed 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -170.03 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -47.17 -44.8 22.31 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.045 0.45 . . . . 0.0 109.93 -178.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.745 ' O ' ' HA3' ' A' ' 12' ' ' GLY . 42.8 ttt85 -90.84 46.86 1.36 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.458 178.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.619 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 79.2 p -59.55 65.84 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.243 0.617 . . . . 0.0 111.711 -178.822 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 16' ' ' ARG . 21.7 ptmt -151.68 129.83 11.91 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.689 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.735 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 50.1 m -73.8 133.97 43.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.797 0.332 . . . . 0.0 110.778 178.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 10' ' ' CYS . . . 178.43 141.58 4.37 Favored Glycine 0 C--O 1.226 -0.364 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.218 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.712 ' HA ' ' HA ' ' A' ' 9' ' ' PHE . 3.5 mpp? -62.39 135.46 57.45 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.93 0.365 . . . . 0.0 110.988 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 34.6 m -75.84 42.37 0.24 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.662 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' CYS . . . . . 0.47 ' SG ' ' HB3' ' A' ' 21' ' ' MET . 3.2 m -85.21 72.22 10.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.495 0.188 . . . . 0.0 111.17 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -50.57 108.18 0.21 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.821 0.343 . . . . 0.0 110.754 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 92.8 m . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.742 -179.794 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.408 HD12 HG23 ' A' ' 8' ' ' ILE . 26.0 pt . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.808 0.337 . . . . 0.0 110.853 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.448 ' O ' ' HE2' ' A' ' 21' ' ' MET . 90.4 m 56.4 40.83 29.57 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.466 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.408 HG23 HD12 ' A' ' 6' ' ' ILE . 33.8 pt -62.18 127.23 21.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.353 179.271 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -55.27 138.36 45.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.89 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.6 p -158.75 109.56 2.08 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.904 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.815 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 39.0 m -75.2 124.88 27.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.828 0.347 . . . . 0.0 111.476 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' A' ' 16' ' ' ARG . . . -63.77 93.89 0.13 Allowed Glycine 0 C--O 1.237 0.343 0 N-CA-C 111.066 -0.813 . . . . 0.0 111.066 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.667 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 17.8 p -70.55 -49.61 46.26 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -177.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.667 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 3.4 m -120.31 -55.49 2.04 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 114.282 -1.326 . . . . 0.0 113.938 -171.33 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -56.13 -84.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.691 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 1.3 mpt_? -91.48 119.9 31.84 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 176.214 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 59.2 m -75.16 52.81 0.6 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.691 ' HG2' ' HB3' ' A' ' 16' ' ' ARG . 20.6 pttp -150.49 139.4 20.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.992 -178.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.815 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 84.2 m -71.36 141.76 50.39 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.506 178.551 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -167.95 150.11 15.82 Favored Glycine 0 C--O 1.228 -0.259 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.728 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.448 ' HE2' ' O ' ' A' ' 7' ' ' CYS . 75.9 mtp -73.69 128.25 35.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.816 0.341 . . . . 0.0 111.275 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 9.0 m . . . . . 0 N--CA 1.464 0.249 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.721 179.672 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.434 HD12 HG23 ' A' ' 8' ' ' ILE . 11.4 pt . . . . . 0 N--CA 1.455 -0.188 0 CA-C-O 121.02 0.438 . . . . 0.0 110.52 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.688 ' SG ' ' HB3' ' A' ' 21' ' ' MET . 49.3 t 61.34 50.61 4.65 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.514 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.434 HG23 HD12 ' A' ' 6' ' ' ILE . 23.5 pt -56.47 139.78 15.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.953 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -58.75 138.35 57.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.592 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 24.4 p -146.85 121.94 10.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.929 0.395 . . . . 0.0 110.979 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 45.9 t -136.01 126.41 26.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.297 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.53 ' HA3' ' O ' ' A' ' 16' ' ' ARG . . . -70.95 128.6 17.11 Favored Glycine 0 C--O 1.239 0.413 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.49 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.674 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 0.8 OUTLIER -54.82 -83.45 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -178.344 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.674 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -107.12 -64.44 1.19 Allowed 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 113.044 -1.889 . . . . 0.0 113.459 -172.94 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.515 ' ND1' ' N ' ' A' ' 16' ' ' ARG . 12.0 p80 -59.01 -53.71 55.28 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.12 -0.632 . . . . 0.0 109.363 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.573 ' O ' ' N ' ' A' ' 18' ' ' LYS . 7.6 mpt_? -93.24 51.73 1.68 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.942 178.122 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 68.6 m -59.26 68.04 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.308 0.575 . . . . 0.0 111.045 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.573 ' N ' ' O ' ' A' ' 16' ' ' ARG . 55.9 mtpt -146.99 129.71 16.09 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.107 -179.389 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 96.9 m -102.49 137.31 40.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.889 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -174.56 147.51 9.19 Favored Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.764 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.688 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 60.9 mtm -73.78 129.57 38.18 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.624 0.25 . . . . 0.0 110.866 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 5.1 m . . . . . 0 CA--C 1.532 0.254 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.76 179.856 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.58 HD12 HG23 ' A' ' 8' ' ' ILE . 23.7 pt . . . . . 0 N--CA 1.455 -0.183 0 CA-C-O 120.874 0.369 . . . . 0.0 110.738 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 79.4 m 55.28 44.16 27.94 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.13 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.58 HG23 HD12 ' A' ' 6' ' ' ILE . 37.5 pt -54.84 130.18 16.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.929 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -69.11 85.33 0.36 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.608 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.753 ' HB3' HH22 ' A' ' 16' ' ' ARG . 83.0 m -72.49 68.36 0.79 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.749 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.686 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 22.2 t -99.86 73.56 1.78 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.063 0.458 . . . . 0.0 111.731 -178.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.757 ' HA3' ' HG3' ' A' ' 16' ' ' ARG . . . -60.34 122.25 29.27 Favored Glycine 0 C--O 1.235 0.173 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.541 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.695 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 14.9 p -69.85 -52.41 25.15 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -177.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.695 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 3.1 m -121.56 -81.67 0.64 Allowed 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -171.354 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 -49.52 -63.63 1.05 Allowed 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.757 ' HG3' ' HA3' ' A' ' 12' ' ' GLY . 6.8 ptm180 -90.96 56.55 3.24 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.27 177.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.457 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 78.6 p -59.47 65.04 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.814 0.845 . . . . 0.0 112.652 -178.247 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.708 ' NZ ' ' HB2' ' A' ' 16' ' ' ARG . 0.4 OUTLIER -149.59 140.27 22.62 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.038 178.302 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.686 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 61.2 m -125.47 131.6 52.83 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.13 0.49 . . . . 0.0 111.871 -178.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -179.71 142.49 5.2 Favored Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.275 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 67.5 mtm -65.53 125.9 26.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.943 0.402 . . . . 0.0 111.451 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.446 ' HB2' ' CG1' ' A' ' 8' ' ' ILE . 94.1 m . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.787 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.6 pt . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.935 0.398 . . . . 0.0 110.535 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.645 ' SG ' ' HB3' ' A' ' 21' ' ' MET . 15.6 t 63.75 57.08 1.43 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.917 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.41 HG13 ' SG ' ' A' ' 10' ' ' CYS . 37.1 pt -54.26 131.97 17.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.092 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -72.11 89.82 1.17 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.968 0.413 . . . . 0.0 109.9 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.41 ' SG ' HG13 ' A' ' 8' ' ' ILE . 75.6 m -75.62 65.01 1.75 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.895 -179.135 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.781 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 34.3 t -102.65 74.21 1.34 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.116 0.484 . . . . 0.0 111.656 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.672 ' HA3' ' HG2' ' A' ' 16' ' ' ARG . . . -67.23 114.83 6.62 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.753 -0.736 . . . . 0.0 111.54 179.193 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.702 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -70.33 -74.31 0.14 Allowed 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 122.53 1.157 . . . . 0.0 113.557 -179.041 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.702 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -103.94 -44.36 5.05 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 112.489 -2.141 . . . . 0.0 112.434 -173.686 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 22.6 t-80 -58.12 -86.96 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.757 HH11 ' HB3' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -91.3 114.87 27.51 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 176.961 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 64.0 m -74.99 63.32 1.21 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.931 0.396 . . . . 0.0 110.893 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.438 ' HE2' ' HB2' ' A' ' 16' ' ' ARG . 60.2 pttt -148.45 128.48 13.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.585 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.781 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 77.2 m -125.87 129.92 50.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.942 0.401 . . . . 0.0 110.99 179.178 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 176.68 146.24 5.99 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.464 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.645 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 80.4 mtp -68.25 119.66 13.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.777 0.322 . . . . 0.0 110.989 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 56.6 m . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.036 179.514 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 14.0 pt . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.742 0.306 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 78.0 m 62.98 47.16 4.41 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.861 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 35.3 pt -82.36 140.32 16.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.635 178.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.858 ' HA ' ' HA ' ' A' ' 21' ' ' MET . 28.1 t80 -53.01 135.94 36.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.108 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -155.63 138.97 15.74 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.254 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 47.4 t -129.88 122.33 28.43 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.749 0.309 . . . . 0.0 111.477 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.838 ' HA3' ' HG2' ' A' ' 16' ' ' ARG . . . -69.25 122.67 13.05 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.498 -0.858 . . . . 0.0 111.032 178.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.69 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 17.2 p -70.59 -51.68 26.7 Favored 'General case' 0 CA--C 1.504 -0.802 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -178.384 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.69 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 2.8 m -121.74 -57.05 1.83 Allowed 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 113.808 -1.542 . . . . 0.0 113.141 -172.376 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.404 ' HB3' ' HD2' ' A' ' 16' ' ' ARG . 21.5 t-80 -58.61 -79.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.838 ' HG2' ' HA3' ' A' ' 12' ' ' GLY . 0.1 OUTLIER -91.03 73.73 6.38 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.668 178.05 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.558 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 44.4 t -59.91 68.51 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.352 0.596 . . . . 0.0 110.592 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.666 ' NZ ' ' HB3' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -150.01 137.08 19.53 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.852 -178.609 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 85.2 m -102.36 131.35 49.04 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.735 0.302 . . . . 0.0 110.934 179.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 171.33 150.52 7.13 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.451 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.858 ' HA ' ' HA ' ' A' ' 9' ' ' PHE . 86.7 mtp -51.11 140.39 16.23 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.718 0.294 . . . . 0.0 110.797 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 15.0 m . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.201 -179.477 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.443 ' HB ' HG23 ' A' ' 8' ' ' ILE . 21.7 pt . . . . . 0 C--O 1.231 0.129 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 48.1 m 62.16 42.73 9.32 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.336 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.492 HG13 ' SG ' ' A' ' 22' ' ' CYS . 26.5 pt -80.27 147.79 6.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.045 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.589 ' HA ' ' HG2' ' A' ' 21' ' ' MET . 15.3 t80 -52.67 134.42 35.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.333 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.673 ' HB2' ' H ' ' A' ' 22' ' ' CYS . 49.8 m -163.57 120.82 1.81 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.746 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.552 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 40.0 t -91.16 131.01 36.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.81 0.338 . . . . 0.0 111.184 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.463 ' HA3' ' O ' ' A' ' 16' ' ' ARG . . . -66.97 96.78 0.32 Allowed Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 178.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.68 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 17.3 p -72.08 -50.05 31.37 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -177.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.68 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 3.3 m -121.12 -58.05 1.82 Allowed 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 114.277 -1.328 . . . . 0.0 114.157 -171.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.585 ' ND1' ' HD3' ' A' ' 16' ' ' ARG . 17.1 t-80 -56.36 -77.9 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.585 ' HD3' ' ND1' ' A' ' 15' ' ' HIS . 1.4 mpp_? -91.55 118.86 30.98 Favored 'General case' 0 C--O 1.221 -0.408 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 176.558 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.7 m -78.15 56.75 1.7 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -147.12 128.37 14.77 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.829 -178.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.552 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 63.7 m -75.42 135.67 40.74 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.702 0.287 . . . . 0.0 110.833 178.53 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.458 ' H ' ' HA ' ' A' ' 11' ' ' CYS . . . -166.86 -145.67 4.56 Favored Glycine 0 C--O 1.225 -0.456 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.882 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.589 ' HG2' ' HA ' ' A' ' 9' ' ' PHE . 64.0 mtm -127.6 119.29 25.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.982 0.391 . . . . 0.0 111.238 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.673 ' H ' ' HB2' ' A' ' 10' ' ' CYS . 29.7 p . . . . . 0 C--O 1.232 0.157 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.116 179.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.557 HG13 HG23 ' A' ' 8' ' ' ILE . 2.8 pt . . . . . 0 N--CA 1.456 -0.139 0 CA-C-O 120.98 0.419 . . . . 0.0 110.562 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 64.0 m 64.58 48.74 2.53 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.94 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.557 HG23 HG13 ' A' ' 6' ' ' ILE . 29.4 pt -57.9 137.15 20.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.042 179.283 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.476 ' HA ' ' HA ' ' A' ' 21' ' ' MET . 23.0 t80 -63.06 135.24 57.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.539 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -148.79 141.52 24.56 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.933 0.397 . . . . 0.0 110.17 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 47.8 t -134.47 124.57 25.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.663 -178.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.554 ' O ' ' HA ' ' A' ' 17' ' ' SER . . . -75.99 119.27 5.62 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.417 -0.897 . . . . 0.0 111.053 178.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.682 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 20.0 p -72.72 -49.75 29.15 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 122.096 0.951 . . . . 0.0 112.459 -178.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.682 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 2.9 m -121.32 -48.12 2.22 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-N 113.236 -1.802 . . . . 0.0 112.247 -172.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 36.9 m170 -61.0 -87.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.827 ' H ' ' HD3' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -91.5 86.0 5.92 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 177.257 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.554 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 57.2 m -62.68 61.3 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -177.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.827 ' HD3' ' HB2' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -150.63 140.22 21.59 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.743 178.471 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 90.1 m -100.1 132.85 45.22 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.889 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 176.7 154.77 12.23 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.986 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.476 ' HA ' ' HA ' ' A' ' 9' ' ' PHE . 86.8 mtp -56.11 136.34 52.54 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 21.8 m . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.153 -178.793 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 41.0 mm . . . . . 0 N--CA 1.446 -0.643 0 CA-C-O 120.695 0.283 . . . . 0.0 111.431 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.7 m 64.46 47.86 2.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.118 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 35.2 pt -61.12 133.2 26.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.632 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -80.8 134.98 35.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.899 179.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.9 p -145.18 140.78 28.17 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.267 0.556 . . . . 0.0 111.267 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 52.3 t -124.21 122.52 38.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.757 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.552 ' HA3' ' O ' ' A' ' 16' ' ' ARG . . . -60.42 112.55 4.64 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.319 -0.944 . . . . 0.0 111.485 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.728 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -67.67 -75.23 0.1 Allowed 'General case' 0 CA--C 1.505 -0.756 0 CA-C-O 122.539 1.162 . . . . 0.0 113.711 -178.907 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.728 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -100.44 -45.31 5.6 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 112.338 -2.21 . . . . 0.0 112.427 -173.602 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.445 ' HB2' ' HD3' ' A' ' 16' ' ' ARG . 90.5 m-70 -60.28 -91.61 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.438 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.894 ' H ' ' HD3' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -91.38 103.84 16.43 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 177.722 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.9 p -69.41 67.43 0.2 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.002 0.429 . . . . 0.0 110.692 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.407 ' HE3' ' HG3' ' A' ' 16' ' ' ARG . 22.2 pttp -147.68 138.38 23.28 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.459 -179.168 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 79.0 m -100.95 138.36 38.1 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.827 178.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -177.99 157.2 21.23 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.253 -0.975 . . . . 0.0 113.258 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -59.4 144.36 47.04 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 6.9 m . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.581 -178.582 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.0 pt . . . . . 0 N--CA 1.452 -0.331 0 CA-C-O 121.259 0.552 . . . . 0.0 109.605 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.621 ' SG ' ' HB3' ' A' ' 21' ' ' MET . 23.2 t 58.03 51.56 8.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.382 179.058 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 31.6 pt -50.12 141.98 3.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.267 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -62.47 147.49 48.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.804 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 17.4 p -149.23 131.13 15.19 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.21 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 47.5 t -135.71 107.47 7.03 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.89 0.376 . . . . 0.0 111.489 -179.252 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.47 ' HA3' ' O ' ' A' ' 16' ' ' ARG . . . -85.69 114.2 3.96 Favored Glycine 0 C--O 1.239 0.432 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.534 178.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.665 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 0.9 OUTLIER -57.33 -82.58 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -178.44 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.665 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -110.14 -63.88 1.33 Allowed 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 113.142 -1.845 . . . . 0.0 113.653 -172.743 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -51.2 -60.55 2.99 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.47 ' O ' ' HA3' ' A' ' 12' ' ' GLY . 0.0 OUTLIER -91.89 79.93 5.25 Favored 'General case' 0 C--O 1.218 -0.569 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.33 176.575 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 65.1 m -67.96 57.95 0.07 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.701 0.286 . . . . 0.0 111.158 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.635 ' NZ ' ' HB3' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -149.67 122.52 8.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.209 -179.555 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 92.1 m -126.7 130.71 50.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.142 0.496 . . . . 0.0 111.654 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 176.92 -154.84 16.94 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.96 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.621 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 80.0 mtp -96.98 126.16 41.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.743 0.306 . . . . 0.0 110.918 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 49.1 m . . . . . 0 N--CA 1.463 0.176 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.638 -179.989 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 23.5 pt . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.816 0.341 . . . . 0.0 110.979 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 57.5 m 63.95 45.07 4.42 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.119 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.441 ' O ' ' HB2' ' A' ' 22' ' ' CYS . 31.4 pt -75.26 133.62 31.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.18 178.692 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -70.93 133.59 46.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.718 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 3.3 p -162.82 144.32 10.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.817 0.341 . . . . 0.0 110.464 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.817 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 11.5 t -91.65 124.2 35.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.039 0.447 . . . . 0.0 110.985 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.593 ' C ' ' H ' ' A' ' 18' ' ' LYS . . . 162.78 154.55 7.66 Favored Glycine 0 C--O 1.22 -0.747 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.961 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.618 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 4.8 t -141.1 -92.52 0.15 Allowed 'General case' 0 CA--C 1.51 -0.595 0 CA-C-O 123.236 1.493 . . . . 0.0 111.635 178.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.618 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.5 OUTLIER -122.13 -123.7 0.27 Allowed 'General case' 0 N--CA 1.425 -1.677 0 CA-C-N 111.185 -2.734 . . . . 0.0 108.503 -176.542 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.436 ' H ' ' HB2' ' A' ' 14' ' ' CYS . 46.8 m170 -61.17 -49.81 75.69 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 176.505 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.878 ' H ' ' HD2' ' A' ' 16' ' ' ARG . 0.4 OUTLIER -91.68 137.07 32.66 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.942 176.795 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.578 ' HB3' ' HA2' ' A' ' 12' ' ' GLY . 60.8 m -80.19 130.03 34.93 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.694 0.283 . . . . 0.0 111.319 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.593 ' H ' ' C ' ' A' ' 12' ' ' GLY . 13.7 mmmm -119.8 118.57 31.18 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.935 0.398 . . . . 0.0 110.86 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.817 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 85.4 m -62.57 127.75 32.77 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.417 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 174.4 -179.53 45.68 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.891 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 93.9 mmm -63.32 135.27 56.91 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.724 0.297 . . . . 0.0 110.35 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 8' ' ' ILE . 20.6 m . . . . . 0 C--N 1.327 -0.377 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.167 -179.095 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.683 HG13 HG23 ' A' ' 8' ' ' ILE . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.143 0 CA-C-O 121.09 0.471 . . . . 0.0 111.025 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 62.5 m 59.98 27.31 16.69 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.134 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.683 HG23 HG13 ' A' ' 6' ' ' ILE . 16.3 pt -61.39 142.92 15.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.946 0.403 . . . . 0.0 110.828 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -68.1 124.52 23.65 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.787 178.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 35.9 m -125.18 113.72 18.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.929 0.395 . . . . 0.0 111.344 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.419 ' CB ' ' HA ' ' A' ' 19' ' ' CYS . 42.1 t -136.38 111.84 9.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.96 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 17' ' ' SER . . . -69.91 129.69 21.58 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.35 -0.929 . . . . 0.0 111.125 178.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.686 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 17.2 p -68.68 -50.91 47.28 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -178.467 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.686 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 3.1 m -121.59 -61.29 1.53 Allowed 'General case' 0 N--CA 1.428 -1.531 0 CA-C-N 113.922 -1.49 . . . . 0.0 113.618 -172.176 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 -62.6 -62.35 1.8 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.541 ' O ' ' N ' ' A' ' 18' ' ' LYS . 9.1 mpt_? -91.39 62.08 4.55 Favored 'General case' 0 C--O 1.218 -0.586 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.087 177.364 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.436 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 65.9 m -61.79 59.78 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.627 0 O-C-N 123.424 0.453 . . . . 0.0 111.414 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.541 ' N ' ' O ' ' A' ' 16' ' ' ARG . 15.4 ptpt -149.71 135.69 18.77 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.626 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.419 ' HA ' ' CB ' ' A' ' 11' ' ' CYS . 67.5 m -99.05 135.67 40.13 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.763 178.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 176.98 144.68 5.39 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.757 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 60.9 mtm -64.48 123.42 19.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.792 0.33 . . . . 0.0 110.724 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.416 ' SG ' HG13 ' A' ' 8' ' ' ILE . 13.0 p . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.734 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.0 pt . . . . . 0 C--O 1.232 0.15 0 CA-C-O 121.093 0.473 . . . . 0.0 110.322 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.597 ' SG ' ' HB3' ' A' ' 21' ' ' MET . 34.8 t 63.62 52.75 2.18 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.834 179.349 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 26.9 pt -60.3 141.44 16.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.39 179.338 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -60.71 143.84 53.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.694 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 20' ' ' GLY . 26.8 p -149.91 120.98 7.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.768 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 47.6 t -135.64 120.48 18.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.939 0.399 . . . . 0.0 111.008 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.888 ' HA3' ' HG2' ' A' ' 16' ' ' ARG . . . -68.94 133.68 27.0 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.028 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.586 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 0.6 OUTLIER -58.35 -76.79 0.04 OUTLIER 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -178.831 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.586 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -119.87 -56.55 2.02 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 113.395 -1.729 . . . . 0.0 112.907 -173.16 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 42.6 m170 -56.02 -70.19 0.12 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 179.105 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.895 ' H ' ' HD3' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -91.49 50.72 1.77 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 177.069 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.651 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 77.4 p -58.33 71.9 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.773 -178.365 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.886 ' HE3' ' HB2' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -148.82 141.0 23.98 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.977 -1.011 . . . . 0.0 111.808 179.678 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 69.6 m -102.89 136.2 43.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.86 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.454 ' O ' ' SG ' ' A' ' 10' ' ' CYS . . . -177.4 152.83 12.43 Favored Glycine 0 C--O 1.224 -0.5 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.009 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.597 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 63.5 mtm -82.12 125.11 30.49 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.984 0.392 . . . . 0.0 111.519 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 59.9 m . . . . . 0 N--CA 1.464 0.266 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.817 179.213 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.411 ' CD1' HG23 ' A' ' 8' ' ' ILE . 12.3 pt . . . . . 0 N--CA 1.454 -0.228 0 CA-C-O 120.969 0.414 . . . . 0.0 110.01 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 95.0 m 60.97 50.05 5.38 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.813 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.411 HG23 ' CD1' ' A' ' 6' ' ' ILE . 24.7 pt -51.06 131.02 11.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.452 179.257 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -61.89 146.79 48.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.151 0.501 . . . . 0.0 111.221 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.1 p -155.4 139.07 16.06 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.912 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 41.8 t -135.36 117.27 15.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.117 0.484 . . . . 0.0 111.639 -179.357 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.453 ' N ' ' SG ' ' A' ' 19' ' ' CYS . . . -93.69 92.82 1.64 Allowed Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 178.584 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.691 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 18.7 p -72.68 -50.26 26.11 Favored 'General case' 0 CA--C 1.504 -0.808 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -178.427 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.691 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 3.0 m -121.15 -50.39 2.14 Favored 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 113.727 -1.579 . . . . 0.0 113.087 -172.349 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 40.8 m170 -57.47 -83.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.701 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 0.6 OUTLIER -91.1 126.67 36.25 Favored 'General case' 0 C--O 1.22 -0.493 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 176.783 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 77.9 p -77.61 55.38 1.31 Allowed 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.291 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.701 ' HG2' ' HB3' ' A' ' 16' ' ' ARG . 13.9 ptmm? -148.29 125.54 11.51 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.248 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.453 ' SG ' ' N ' ' A' ' 12' ' ' GLY . 84.4 m -126.32 126.16 43.47 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.938 0.399 . . . . 0.0 111.387 179.037 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 176.16 -152.26 12.62 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.057 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 61.3 mtm -92.35 122.28 34.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.791 0.329 . . . . 0.0 111.212 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 35.7 m . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.814 179.232 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 13.4 pt . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.952 0.406 . . . . 0.0 110.638 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.477 ' SG ' ' HB3' ' A' ' 21' ' ' MET . 15.4 t 56.62 51.02 11.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.197 179.461 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.412 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 27.8 pt -53.04 149.23 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.415 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -71.21 82.4 0.73 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.031 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 21.3 m -67.09 141.58 57.41 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.807 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 26.1 t -136.01 115.45 12.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.952 0.406 . . . . 0.0 110.987 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -88.92 97.41 2.32 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.523 179.205 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.692 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 0.1 OUTLIER -66.11 -76.41 0.08 Allowed 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -178.808 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.692 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -104.58 -48.02 3.92 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 112.711 -2.041 . . . . 0.0 112.922 -173.332 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -55.97 -83.79 0.01 OUTLIER 'General case' 0 C--O 1.232 0.164 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.551 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.674 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 11.3 mpt_? -91.21 120.14 31.88 Favored 'General case' 0 C--O 1.221 -0.432 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 176.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.9 m -76.95 55.47 1.11 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.123 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.674 ' HG2' ' HB3' ' A' ' 16' ' ' ARG . 21.9 pttp -148.66 129.74 14.48 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.715 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 80.0 m -125.77 128.69 48.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.29 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -171.92 -150.15 7.04 Favored Glycine 0 CA--C 1.519 0.331 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.864 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.477 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 68.6 mtm -94.17 132.46 38.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.914 0.388 . . . . 0.0 111.417 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.412 ' SG ' ' O ' ' A' ' 8' ' ' ILE . 7.3 p . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.635 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.499 HD12 HG23 ' A' ' 8' ' ' ILE . 18.7 pt . . . . . 0 C--O 1.231 0.113 0 CA-C-O 121.023 0.44 . . . . 0.0 110.61 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.8 t 57.36 52.83 8.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.312 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.499 HG23 HD12 ' A' ' 6' ' ' ILE . 26.6 pt -57.3 149.93 4.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.545 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -52.69 129.53 29.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.329 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -165.36 133.32 3.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.281 -179.146 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.617 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 42.8 t -84.73 130.76 34.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.559 -179.477 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.511 ' HA3' ' O ' ' A' ' 16' ' ' ARG . . . -72.02 103.18 1.25 Allowed Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 178.603 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.688 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 16.8 p -71.38 -50.97 26.74 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 114.282 1.215 . . . . 0.0 114.282 -177.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.688 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 3.2 m -121.22 -62.56 1.42 Allowed 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 114.245 -1.343 . . . . 0.0 113.802 -171.58 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.552 ' HB3' ' CZ ' ' A' ' 16' ' ' ARG . 39.2 m170 -52.75 -75.78 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.552 ' CZ ' ' HB3' ' A' ' 15' ' ' HIS . 0.0 OUTLIER -91.13 106.83 18.79 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 176.737 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 46.1 t -74.25 52.91 0.49 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.713 0.292 . . . . 0.0 111.409 -179.041 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.509 ' HD2' ' N ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -150.69 134.53 16.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.799 179.793 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.617 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 86.5 m -75.02 132.45 41.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.648 178.81 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -174.54 -136.5 2.26 Favored Glycine 0 C--O 1.225 -0.417 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.933 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 84.0 mtp -114.4 120.24 39.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.662 0.231 . . . . 0.0 110.452 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 73.0 m . . . . . 0 C--N 1.33 -0.244 0 CA-C-O 120.839 0.352 . . . . 0.0 110.504 179.776 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 13.6 pt . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.654 0.264 . . . . 0.0 111.486 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 85.0 m 63.56 47.25 3.86 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.522 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.4 pt -82.24 146.25 7.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.722 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -67.47 136.97 55.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.235 179.146 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -168.81 148.62 4.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.853 0.358 . . . . 0.0 110.951 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 46.7 t -121.93 125.82 47.24 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.374 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.623 ' HA3' ' HG2' ' A' ' 16' ' ' ARG . . . -69.01 116.05 6.96 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.435 -0.888 . . . . 0.0 111.448 178.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.698 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -67.44 -73.93 0.13 Allowed 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 122.535 1.16 . . . . 0.0 113.379 -179.068 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.698 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -103.31 -44.2 5.23 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 112.392 -2.185 . . . . 0.0 112.339 -173.782 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.4 ' HB3' ' HD2' ' A' ' 16' ' ' ARG . 17.8 t-160 -59.98 -89.5 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.47 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.914 ' H ' ' HD2' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -91.56 101.84 14.49 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 177.532 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.7 p -68.8 66.42 0.13 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.971 0.415 . . . . 0.0 110.777 -179.323 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.437 ' HE3' ' HB2' ' A' ' 16' ' ' ARG . 22.2 pttp -148.34 139.74 23.48 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.943 -0.572 . . . . 0.0 112.3 -179.234 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 87.4 m -105.83 126.56 52.31 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.794 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 169.8 -145.34 9.18 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.459 -0.877 . . . . 0.0 113.066 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 63.8 mtm -84.11 138.49 33.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.816 0.341 . . . . 0.0 111.024 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 63.6 m . . . . . 0 C--N 1.332 -0.186 0 CA-C-O 120.997 0.427 . . . . 0.0 110.881 -179.953 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.2 pt . . . . . 0 C--O 1.232 0.148 0 CA-C-O 121.228 0.537 . . . . 0.0 110.087 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.513 ' SG ' ' HB3' ' A' ' 21' ' ' MET . 19.1 t 60.43 55.41 3.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.089 178.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 27.0 pt -58.88 147.04 8.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.692 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -59.8 110.59 1.2 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.329 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 14.9 m -114.46 158.69 21.25 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.632 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.745 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 57.8 m -125.94 128.8 48.09 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.779 0.323 . . . . 0.0 111.301 179.69 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.609 ' H ' ' HA ' ' A' ' 19' ' ' CYS . . . -71.3 84.41 0.42 Allowed Glycine 0 C--N 1.332 0.319 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 178.792 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.73 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 0.1 OUTLIER -60.51 -80.15 0.03 OUTLIER 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -178.171 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.73 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -98.45 -47.32 5.44 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 112.658 -2.064 . . . . 0.0 113.377 -172.85 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -57.01 -93.63 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 178.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.882 ' H ' ' HD2' ' A' ' 16' ' ' ARG . 0.2 OUTLIER -91.0 124.28 35.12 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 177.04 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 42.9 t -73.38 57.71 0.53 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.805 0.336 . . . . 0.0 111.305 -178.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -150.48 125.98 10.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.554 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.745 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 47.7 t -82.06 136.2 35.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.776 0.322 . . . . 0.0 110.725 179.215 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -163.68 151.96 21.68 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.716 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.513 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 3.5 mpp? -62.22 113.77 3.07 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 122.548 -0.384 . . . . 0.0 110.514 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 7.3 p . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.512 -179.835 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.529 HG13 HG23 ' A' ' 8' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.136 0 CA-C-O 120.872 0.368 . . . . 0.0 110.605 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 99.0 m 60.14 49.93 6.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.081 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.529 HG23 HG13 ' A' ' 6' ' ' ILE . 27.4 pt -53.61 132.09 16.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.881 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -72.48 135.35 45.68 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.414 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 30.0 p -150.72 116.62 5.55 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.141 0.496 . . . . 0.0 110.758 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.765 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 42.6 t -82.08 129.1 34.71 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.039 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.446 ' HA3' ' O ' ' A' ' 16' ' ' ARG . . . -62.29 101.37 0.37 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.468 -0.872 . . . . 0.0 111.27 179.31 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.721 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 0.1 OUTLIER -64.61 -79.87 0.04 OUTLIER 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 -178.484 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.721 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -100.45 -51.24 3.67 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-N 112.72 -2.037 . . . . 0.0 113.295 -172.907 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 17.7 m80 -55.69 -84.34 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.605 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 0.9 OUTLIER -91.27 114.05 26.48 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 176.748 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.4 p -75.44 54.98 0.77 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.893 0.378 . . . . 0.0 110.519 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.605 ' HG2' ' HB3' ' A' ' 16' ' ' ARG . 7.4 ptpp? -149.48 132.5 16.22 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.068 -179.053 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.765 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 75.3 m -72.82 140.09 47.42 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.706 178.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -168.33 140.93 6.47 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.107 -1.044 . . . . 0.0 113.525 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -70.69 133.91 47.04 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 122.702 -0.293 . . . . 0.0 110.408 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 2.8 p . . . . . 0 C--N 1.329 -0.295 0 CA-C-O 120.847 0.356 . . . . 0.0 111.242 179.96 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.87 HG13 HG23 ' A' ' 8' ' ' ILE . 1.6 pt . . . . . 0 CA--C 1.521 -0.154 0 CA-C-O 120.98 0.419 . . . . 0.0 110.91 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' CYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 35.8 m 54.21 27.54 7.96 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.627 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.87 HG23 HG13 ' A' ' 6' ' ' ILE . 28.0 pt -47.47 139.27 2.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.179 179.148 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -65.96 134.77 53.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.867 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -158.59 135.22 9.51 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.953 0.406 . . . . 0.0 110.753 179.353 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.592 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 65.8 m -80.54 132.02 35.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.112 -0.494 . . . . 0.0 112.084 -179.222 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' A' ' 16' ' ' ARG . . . -76.78 74.48 1.79 Allowed Glycine 0 N--CA 1.451 -0.304 0 N-CA-C 110.996 -0.841 . . . . 0.0 110.996 178.501 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.674 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 23.2 p -66.01 -50.31 64.68 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -178.035 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.674 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 3.5 m -115.59 -43.99 2.99 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 113.481 -1.69 . . . . 0.0 112.854 -171.773 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.5 ' HB2' HH11 ' A' ' 16' ' ' ARG . 42.5 m170 -65.84 -112.2 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 177.305 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.554 ' HD2' ' O ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -76.17 129.92 37.47 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 176.541 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 41.1 t -71.53 57.65 0.27 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.731 0.3 . . . . 0.0 111.4 -178.438 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.599 ' NZ ' ' HB2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -151.43 133.45 15.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.88 -179.724 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.592 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 35.0 t -95.87 131.28 42.36 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 178.637 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -179.56 -159.81 24.16 Favored Glycine 0 C--N 1.329 0.169 0 C-N-CA 120.533 -0.842 . . . . 0.0 112.588 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 84.9 mtp -69.19 131.35 44.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.604 0.24 . . . . 0.0 110.363 179.608 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.523 ' O ' ' HA ' ' A' ' 7' ' ' CYS . 25.7 m . . . . . 0 C--N 1.328 -0.355 0 CA-C-O 120.776 0.322 . . . . 0.0 110.96 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.459 HD11 HD13 ' A' ' 8' ' ' ILE . 3.7 pt . . . . . 0 N--CA 1.456 -0.173 0 CA-C-O 121.171 0.51 . . . . 0.0 109.964 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.3 t 67.84 41.52 2.14 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.946 179.085 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.459 HD13 HD11 ' A' ' 6' ' ' ILE . 25.0 pt -82.22 140.35 16.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.978 0.418 . . . . 0.0 111.482 179.278 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PHE . . . . . 0.738 ' HA ' ' HA ' ' A' ' 21' ' ' MET . 25.7 t80 -60.92 144.2 53.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.307 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.424 ' O ' ' O ' ' A' ' 20' ' ' GLY . 30.3 p -157.74 115.5 3.05 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.892 0.377 . . . . 0.0 111.532 -179.639 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.752 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 78.0 m -83.86 123.27 29.74 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 121.014 -0.274 . . . . 0.0 111.105 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.75 ' HA3' ' O ' ' A' ' 16' ' ' ARG . . . -65.88 113.68 5.96 Favored Glycine 0 N--CA 1.45 -0.367 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 178.833 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' CYS . . . . . 0.66 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 18.6 p -64.84 -48.33 74.73 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 115.713 1.745 . . . . 0.0 115.713 -177.03 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.66 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 4.1 m -118.83 -110.15 0.35 Allowed 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -170.03 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -47.17 -44.8 22.31 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.045 0.45 . . . . 0.0 109.93 -178.256 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.75 ' O ' ' HA3' ' A' ' 12' ' ' GLY . 42.8 ttt85 -90.84 46.86 1.36 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.458 178.334 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.638 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 79.2 p -59.55 65.84 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.243 0.617 . . . . 0.0 111.711 -178.822 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 16' ' ' ARG . 21.7 ptmt -151.68 129.83 11.91 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.689 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.752 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 50.1 m -73.8 133.97 43.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.797 0.332 . . . . 0.0 110.778 178.728 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 10' ' ' CYS . . . 178.43 141.58 4.37 Favored Glycine 0 C--O 1.226 -0.364 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.218 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.738 ' HA ' ' HA ' ' A' ' 9' ' ' PHE . 3.5 mpp? -62.39 135.46 57.45 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.93 0.365 . . . . 0.0 110.988 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 34.6 m . . . . . 0 N--CA 1.467 0.375 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.662 -179.937 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.437 ' N ' ' HB3' ' A' ' 24' ' ' LYS . 12.2 p-10 . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.775 0.321 . . . . 0.0 111.191 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.542 HG22 ' H ' ' A' ' 4' ' ' PHE . 71.5 m -64.07 139.24 58.75 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.768 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 79.3 t60 -63.18 -38.77 92.49 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.155 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.542 ' H ' HG22 ' A' ' 2' ' ' THR . 16.9 t80 -146.25 63.62 9.07 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.245 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.503 ' HD3' ' O ' ' A' ' 2' ' ' THR . 59.8 Cg_endo -73.15 -146.81 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.336 2.024 . . . . 0.0 111.872 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.414 ' H ' ' HB2' ' A' ' 5' ' ' PRO . 26.0 pt -83.46 -37.9 13.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.808 0.337 . . . . 0.0 110.853 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.626 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 90.4 m 56.4 40.83 29.57 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.466 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.408 HG23 HD12 ' A' ' 6' ' ' ILE . 33.8 pt -62.18 127.23 21.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.353 179.271 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -55.27 138.36 45.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.89 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.6 p -158.75 109.56 2.08 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.904 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.815 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 39.0 m -75.2 124.88 27.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.828 0.347 . . . . 0.0 111.476 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' A' ' 16' ' ' ARG . . . -63.77 93.89 0.13 Allowed Glycine 0 C--O 1.237 0.343 0 N-CA-C 111.066 -0.813 . . . . 0.0 111.066 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.667 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 17.8 p -70.55 -49.61 46.26 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -177.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.667 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 3.4 m -120.31 -55.49 2.04 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 114.282 -1.326 . . . . 0.0 113.938 -171.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -56.13 -84.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.691 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 1.3 mpt_? -91.48 119.9 31.84 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 176.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 59.2 m -75.16 52.81 0.6 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.691 ' HG2' ' HB3' ' A' ' 16' ' ' ARG . 20.6 pttp -150.49 139.4 20.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.992 -178.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.815 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 84.2 m -71.36 141.76 50.39 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.506 178.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -167.95 150.11 15.82 Favored Glycine 0 C--O 1.228 -0.259 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.728 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.448 ' HE2' ' O ' ' A' ' 7' ' ' CYS . 75.9 mtp -73.69 128.25 35.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.816 0.341 . . . . 0.0 111.275 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 9.0 m -80.14 56.26 2.39 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.721 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.626 ' HA ' ' HA ' ' A' ' 7' ' ' CYS . 89.0 m -56.75 -54.78 42.35 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 121.015 -0.274 . . . . 0.0 110.911 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.437 ' HB3' ' N ' ' A' ' 1' ' ' ASP . 23.9 pttm -71.4 -147.95 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.94 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 95.1 m . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.777 -179.991 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.832 0.349 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.584 ' O ' ' HD3' ' A' ' 5' ' ' PRO . 90.8 m -76.31 140.92 41.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.066 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 45.8 m170 -66.9 -39.4 87.41 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.148 0.499 . . . . 0.0 110.474 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.556 ' H ' HG22 ' A' ' 2' ' ' THR . 27.8 m-85 -136.86 64.06 48.04 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.935 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.584 ' HD3' ' O ' ' A' ' 2' ' ' THR . 28.1 Cg_endo -63.29 169.64 9.14 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.664 2.242 . . . . 0.0 113.064 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.436 ' H ' HG12 ' A' ' 6' ' ' ILE . 11.4 pt -79.94 -32.29 13.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.52 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.688 ' SG ' ' HB3' ' A' ' 21' ' ' MET . 49.3 t 61.34 50.61 4.65 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.514 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.434 HG23 HD12 ' A' ' 6' ' ' ILE . 23.5 pt -56.47 139.78 15.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.953 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -58.75 138.35 57.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.592 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 24.4 p -146.85 121.94 10.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.929 0.395 . . . . 0.0 110.979 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 45.9 t -136.01 126.41 26.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.297 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.53 ' HA3' ' O ' ' A' ' 16' ' ' ARG . . . -70.95 128.6 17.11 Favored Glycine 0 C--O 1.239 0.413 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.49 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.674 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 0.8 OUTLIER -54.82 -83.45 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -178.344 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.674 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -107.12 -64.44 1.19 Allowed 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 113.044 -1.889 . . . . 0.0 113.459 -172.94 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.515 ' ND1' ' N ' ' A' ' 16' ' ' ARG . 12.0 p80 -59.01 -53.71 55.28 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.12 -0.632 . . . . 0.0 109.363 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.573 ' O ' ' N ' ' A' ' 18' ' ' LYS . 7.6 mpt_? -93.24 51.73 1.68 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.942 178.122 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 68.6 m -59.26 68.04 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.308 0.575 . . . . 0.0 111.045 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.573 ' N ' ' O ' ' A' ' 16' ' ' ARG . 55.9 mtpt -146.99 129.71 16.09 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.107 -179.389 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 96.9 m -102.49 137.31 40.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.889 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -174.56 147.51 9.19 Favored Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.764 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.688 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 60.9 mtm -73.78 129.57 38.18 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.624 0.25 . . . . 0.0 110.866 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 5.1 m -80.78 56.95 2.84 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.76 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 68.2 m -72.05 77.77 0.93 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.892 0.377 . . . . 0.0 110.912 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -74.31 48.94 0.35 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.496 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 80.5 p . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.243 -0.884 . . . . 0.0 111.281 179.874 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 60.8 t0 . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 121.026 0.441 . . . . 0.0 110.832 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.602 ' OG1' ' HB3' ' A' ' 5' ' ' PRO . 66.0 p -74.78 151.42 39.12 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.166 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -61.85 -41.58 98.0 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -178.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -138.83 67.82 42.63 Favored Pre-proline 0 CA--C 1.531 0.217 0 CA-C-O 120.873 0.368 . . . . 0.0 111.904 -178.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.602 ' HB3' ' OG1' ' A' ' 2' ' ' THR . 61.1 Cg_endo -76.83 -143.22 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.543 2.162 . . . . 0.0 112.32 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.58 HD12 HG23 ' A' ' 8' ' ' ILE . 23.7 pt -90.38 -39.47 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.738 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 79.4 m 55.28 44.16 27.94 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.13 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.58 HG23 HD12 ' A' ' 6' ' ' ILE . 37.5 pt -54.84 130.18 16.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.929 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -69.11 85.33 0.36 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.608 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.753 ' HB3' HH22 ' A' ' 16' ' ' ARG . 83.0 m -72.49 68.36 0.79 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.749 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.686 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 22.2 t -99.86 73.56 1.78 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.063 0.458 . . . . 0.0 111.731 -178.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.757 ' HA3' ' HG3' ' A' ' 16' ' ' ARG . . . -60.34 122.25 29.27 Favored Glycine 0 C--O 1.235 0.173 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.541 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.695 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 14.9 p -69.85 -52.41 25.15 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -177.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.695 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 3.1 m -121.56 -81.67 0.64 Allowed 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -171.354 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 -49.52 -63.63 1.05 Allowed 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.757 ' HG3' ' HA3' ' A' ' 12' ' ' GLY . 6.8 ptm180 -90.96 56.55 3.24 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.27 177.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.457 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 78.6 p -59.47 65.04 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.814 0.845 . . . . 0.0 112.652 -178.247 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.708 ' NZ ' ' HB2' ' A' ' 16' ' ' ARG . 0.4 OUTLIER -149.59 140.27 22.62 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.038 178.302 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.686 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 61.2 m -125.47 131.6 52.83 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.13 0.49 . . . . 0.0 111.871 -178.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -179.71 142.49 5.2 Favored Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.275 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 67.5 mtm -65.53 125.9 26.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.943 0.402 . . . . 0.0 111.451 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.568 ' HB3' ' OG1' ' A' ' 25' ' ' THR . 94.1 m -95.92 61.04 2.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.787 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 96.1 m -60.24 -60.24 4.14 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.465 ' HG3' ' N ' ' A' ' 25' ' ' THR . 19.0 ptpt -60.58 -52.24 66.01 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -178.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.568 ' OG1' ' HB3' ' A' ' 22' ' ' CYS . 69.5 p . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.292 -0.861 . . . . 0.0 111.141 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.9 ' HA ' ' HA ' ' A' ' 24' ' ' LYS . 33.3 t70 . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.714 0.292 . . . . 0.0 111.127 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 74.6 p -67.77 -144.78 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.102 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 79.3 t60 -106.4 -48.55 3.53 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 120.622 0.249 . . . . 0.0 111.465 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -146.27 65.33 10.47 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.046 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -77.45 -137.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.579 2.186 . . . . 0.0 112.35 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.6 pt -127.66 -34.81 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.535 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.645 ' SG ' ' HB3' ' A' ' 21' ' ' MET . 15.6 t 63.75 57.08 1.43 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.917 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.41 HG13 ' SG ' ' A' ' 10' ' ' CYS . 37.1 pt -54.26 131.97 17.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.092 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -72.11 89.82 1.17 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.968 0.413 . . . . 0.0 109.9 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.41 ' SG ' HG13 ' A' ' 8' ' ' ILE . 75.6 m -75.62 65.01 1.75 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.895 -179.135 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.781 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 34.3 t -102.65 74.21 1.34 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.116 0.484 . . . . 0.0 111.656 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.672 ' HA3' ' HG2' ' A' ' 16' ' ' ARG . . . -67.23 114.83 6.62 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.753 -0.736 . . . . 0.0 111.54 179.193 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.702 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -70.33 -74.31 0.14 Allowed 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 122.53 1.157 . . . . 0.0 113.557 -179.041 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.702 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -103.94 -44.36 5.05 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 112.489 -2.141 . . . . 0.0 112.434 -173.686 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 22.6 t-80 -58.12 -86.96 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.757 HH11 ' HB3' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -91.3 114.87 27.51 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 176.961 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 64.0 m -74.99 63.32 1.21 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.931 0.396 . . . . 0.0 110.893 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.438 ' HE2' ' HB2' ' A' ' 16' ' ' ARG . 60.2 pttt -148.45 128.48 13.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.585 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.781 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 77.2 m -125.87 129.92 50.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.942 0.401 . . . . 0.0 110.99 179.178 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 176.68 146.24 5.99 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.464 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.645 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 80.4 mtp -68.25 119.66 13.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.777 0.322 . . . . 0.0 110.989 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.576 ' HB3' ' OG1' ' A' ' 25' ' ' THR . 56.6 m -89.99 53.93 2.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.036 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 7' ' ' CYS . 57.8 m -58.81 -41.87 87.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.111 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.9 ' HA ' ' HA ' ' A' ' 1' ' ' ASP . 9.4 ptpp? -58.45 -47.18 84.86 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.589 0.218 . . . . 0.0 111.589 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.576 ' OG1' ' HB3' ' A' ' 22' ' ' CYS . 77.6 p . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.171 -0.918 . . . . 0.0 111.147 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.68 ' H3 ' ' HD3' ' A' ' 24' ' ' LYS . 32.7 t70 . . . . . 0 N--CA 1.485 1.319 0 N-CA-C 110.594 -0.15 . . . . 0.0 110.594 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.593 HG22 ' H ' ' A' ' 3' ' ' HIS . 2.8 m -77.7 -138.19 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.593 ' H ' HG22 ' A' ' 2' ' ' THR . 88.8 m-70 -125.86 25.05 6.93 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.766 0.317 . . . . 0.0 110.762 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -145.28 57.29 4.18 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.69 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.42 ' HB2' ' H ' ' A' ' 6' ' ' ILE . 52.7 Cg_endo -68.79 -144.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.348 2.032 . . . . 0.0 112.689 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.42 ' H ' ' HB2' ' A' ' 5' ' ' PRO . 14.0 pt -135.89 -33.39 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.193 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.751 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 78.0 m 62.98 47.16 4.41 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.861 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 35.3 pt -82.36 140.32 16.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.635 178.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.858 ' HA ' ' HA ' ' A' ' 21' ' ' MET . 28.1 t80 -53.01 135.94 36.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.108 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -155.63 138.97 15.74 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.254 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 47.4 t -129.88 122.33 28.43 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.749 0.309 . . . . 0.0 111.477 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.838 ' HA3' ' HG2' ' A' ' 16' ' ' ARG . . . -69.25 122.67 13.05 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.498 -0.858 . . . . 0.0 111.032 178.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.69 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 17.2 p -70.59 -51.68 26.7 Favored 'General case' 0 CA--C 1.504 -0.802 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -178.384 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.69 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 2.8 m -121.74 -57.05 1.83 Allowed 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 113.808 -1.542 . . . . 0.0 113.141 -172.376 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.404 ' HB3' ' HD2' ' A' ' 16' ' ' ARG . 21.5 t-80 -58.61 -79.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.838 ' HG2' ' HA3' ' A' ' 12' ' ' GLY . 0.1 OUTLIER -91.03 73.73 6.38 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.668 178.05 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.558 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 44.4 t -59.91 68.51 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.352 0.596 . . . . 0.0 110.592 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.666 ' NZ ' ' HB3' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -150.01 137.08 19.53 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.852 -178.609 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 85.2 m -102.36 131.35 49.04 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.735 0.302 . . . . 0.0 110.934 179.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 171.33 150.52 7.13 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.451 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.858 ' HA ' ' HA ' ' A' ' 9' ' ' PHE . 86.7 mtp -51.11 140.39 16.23 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.718 0.294 . . . . 0.0 110.797 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 15.0 m -131.51 129.61 41.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.201 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.751 ' HA ' ' HA ' ' A' ' 7' ' ' CYS . 59.9 m -88.8 -124.24 0.05 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.818 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.68 ' HD3' ' H3 ' ' A' ' 1' ' ' ASP . 4.1 ptpt -51.82 -44.47 63.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.659 0.266 . . . . 0.0 111.322 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 94.2 m . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.834 179.891 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.583 ' O ' ' HG3' ' A' ' 5' ' ' PRO . 53.9 m-20 . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.71 0.29 . . . . 0.0 111.154 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.416 ' OG1' ' HG2' ' A' ' 24' ' ' LYS . 15.6 m -74.91 62.04 1.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.444 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -125.69 -54.56 1.54 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.268 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.664 ' N ' ' HD3' ' A' ' 5' ' ' PRO . 22.2 t80 -147.5 51.5 1.11 Allowed Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.766 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.664 ' HD3' ' N ' ' A' ' 4' ' ' PHE . 3.5 Cg_exo -75.3 -145.75 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.554 2.169 . . . . 0.0 112.627 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.443 ' HB ' HG23 ' A' ' 8' ' ' ILE . 21.7 pt -96.86 -41.03 11.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.92 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.432 ' HA ' ' CB ' ' A' ' 23' ' ' CYS . 48.1 m 62.16 42.73 9.32 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.336 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.492 HG13 ' SG ' ' A' ' 22' ' ' CYS . 26.5 pt -80.27 147.79 6.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.045 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.589 ' HA ' ' HG2' ' A' ' 21' ' ' MET . 15.3 t80 -52.67 134.42 35.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.333 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.673 ' HB2' ' H ' ' A' ' 22' ' ' CYS . 49.8 m -163.57 120.82 1.81 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.746 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.552 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 40.0 t -91.16 131.01 36.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.81 0.338 . . . . 0.0 111.184 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.463 ' HA3' ' O ' ' A' ' 16' ' ' ARG . . . -66.97 96.78 0.32 Allowed Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 178.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.68 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 17.3 p -72.08 -50.05 31.37 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -177.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.68 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 3.3 m -121.12 -58.05 1.82 Allowed 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 114.277 -1.328 . . . . 0.0 114.157 -171.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.585 ' ND1' ' HD3' ' A' ' 16' ' ' ARG . 17.1 t-80 -56.36 -77.9 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.585 ' HD3' ' ND1' ' A' ' 15' ' ' HIS . 1.4 mpp_? -91.55 118.86 30.98 Favored 'General case' 0 C--O 1.221 -0.408 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 176.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.7 m -78.15 56.75 1.7 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -147.12 128.37 14.77 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.829 -178.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.552 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 63.7 m -75.42 135.67 40.74 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.702 0.287 . . . . 0.0 110.833 178.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.458 ' H ' ' HA ' ' A' ' 11' ' ' CYS . . . -166.86 -145.67 4.56 Favored Glycine 0 C--O 1.225 -0.456 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.882 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.589 ' HG2' ' HA ' ' A' ' 9' ' ' PHE . 64.0 mtm -127.6 119.29 25.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.982 0.391 . . . . 0.0 111.238 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.673 ' H ' ' HB2' ' A' ' 10' ' ' CYS . 29.7 p -74.45 126.34 30.52 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.116 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.432 ' CB ' ' HA ' ' A' ' 7' ' ' CYS . 7.6 t -126.16 -49.31 1.57 Allowed 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.144 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.416 ' HG2' ' OG1' ' A' ' 2' ' ' THR . 52.9 mttt -59.15 134.73 57.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.56 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 75.4 p . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.111 -179.97 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 51.6 p-10 . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.861 0.363 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.675 HG22 ' HD2' ' A' ' 24' ' ' LYS . 72.4 p -77.64 54.45 1.21 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.437 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 77.2 t60 -81.32 59.14 3.86 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.102 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.548 ' HA ' ' HB3' ' A' ' 23' ' ' CYS . 0.1 OUTLIER -46.99 101.01 0.25 Allowed Pre-proline 0 CA--C 1.531 0.241 0 CA-C-O 121.198 0.523 . . . . 0.0 112.386 -179.019 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.461 ' HB2' ' H ' ' A' ' 6' ' ' ILE . 68.1 Cg_endo -98.64 -131.23 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 123.784 2.989 . . . . 0.0 111.691 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.557 HG13 HG23 ' A' ' 8' ' ' ILE . 2.8 pt -65.76 -19.54 25.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.562 178.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 64.0 m 64.58 48.74 2.53 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.94 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.557 HG23 HG13 ' A' ' 6' ' ' ILE . 29.4 pt -57.9 137.15 20.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.042 179.283 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.476 ' HA ' ' HA ' ' A' ' 21' ' ' MET . 23.0 t80 -63.06 135.24 57.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.539 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -148.79 141.52 24.56 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.933 0.397 . . . . 0.0 110.17 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 47.8 t -134.47 124.57 25.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.663 -178.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.554 ' O ' ' HA ' ' A' ' 17' ' ' SER . . . -75.99 119.27 5.62 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.417 -0.897 . . . . 0.0 111.053 178.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.682 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 20.0 p -72.72 -49.75 29.15 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 122.096 0.951 . . . . 0.0 112.459 -178.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.682 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 2.9 m -121.32 -48.12 2.22 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-N 113.236 -1.802 . . . . 0.0 112.247 -172.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 36.9 m170 -61.0 -87.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.827 ' H ' ' HD3' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -91.5 86.0 5.92 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 177.257 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.554 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 57.2 m -62.68 61.3 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -177.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.827 ' HD3' ' HB2' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -150.63 140.22 21.59 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.743 178.471 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 90.1 m -100.1 132.85 45.22 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.889 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 176.7 154.77 12.23 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.986 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.476 ' HA ' ' HA ' ' A' ' 9' ' ' PHE . 86.8 mtp -56.11 136.34 52.54 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 21.8 m -122.28 132.91 54.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.153 -178.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.548 ' HB3' ' HA ' ' A' ' 4' ' ' PHE . 24.3 m -119.93 -60.42 1.71 Allowed 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.644 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.675 ' HD2' HG22 ' A' ' 2' ' ' THR . 28.1 mtmt -58.03 -50.06 74.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.016 -178.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 91.5 m . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.274 -0.869 . . . . 0.0 111.067 -179.889 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.443 ' HB2' ' HA ' ' A' ' 24' ' ' LYS . 57.7 m-20 . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.516 0.198 . . . . 0.0 111.101 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 76.5 p -110.25 -153.13 0.51 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.66 0.267 . . . . 0.0 111.134 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 35.5 m170 -82.89 -42.11 18.14 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.171 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -130.63 57.24 29.98 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.982 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.526 ' HB2' ' H ' ' A' ' 6' ' ' ILE . 61.2 Cg_endo -71.24 -138.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.344 2.029 . . . . 0.0 112.208 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.526 ' H ' ' HB2' ' A' ' 5' ' ' PRO . 41.0 mm -79.59 -37.71 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.431 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.814 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 1.7 m 64.46 47.86 2.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.118 -179.175 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 35.2 pt -61.12 133.2 26.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.632 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -80.8 134.98 35.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.899 179.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.9 p -145.18 140.78 28.17 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.267 0.556 . . . . 0.0 111.267 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 52.3 t -124.21 122.52 38.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.757 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.552 ' HA3' ' O ' ' A' ' 16' ' ' ARG . . . -60.42 112.55 4.64 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.319 -0.944 . . . . 0.0 111.485 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.728 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -67.67 -75.23 0.1 Allowed 'General case' 0 CA--C 1.505 -0.756 0 CA-C-O 122.539 1.162 . . . . 0.0 113.711 -178.907 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.728 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -100.44 -45.31 5.6 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 112.338 -2.21 . . . . 0.0 112.427 -173.602 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.445 ' HB2' ' HD3' ' A' ' 16' ' ' ARG . 90.5 m-70 -60.28 -91.61 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.438 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.894 ' H ' ' HD3' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -91.38 103.84 16.43 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 177.722 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.9 p -69.41 67.43 0.2 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.002 0.429 . . . . 0.0 110.692 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.407 ' HE3' ' HG3' ' A' ' 16' ' ' ARG . 22.2 pttp -147.68 138.38 23.28 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.459 -179.168 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 79.0 m -100.95 138.36 38.1 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.827 178.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -177.99 157.2 21.23 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.253 -0.975 . . . . 0.0 113.258 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -59.4 144.36 47.04 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 6.9 m -136.19 69.0 1.43 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.581 -178.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.814 ' HA ' ' HA ' ' A' ' 7' ' ' CYS . 84.2 m -64.3 -116.88 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.127 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.815 ' HZ3' ' H ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -52.68 142.25 18.92 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.942 0.401 . . . . 0.0 111.213 -179.498 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 69.8 p . . . . . 0 C--O 1.251 1.136 0 CA-C-O 118.262 -0.875 . . . . 0.0 111.139 -179.986 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.42 ' N ' ' HG3' ' A' ' 24' ' ' LYS . 7.6 t70 . . . . . 0 N--CA 1.484 1.237 0 CA-C-O 120.721 0.296 . . . . 0.0 111.013 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 85.6 m -137.06 -65.73 0.54 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.618 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.457 ' O ' ' HD2' ' A' ' 24' ' ' LYS . 77.9 t60 -78.53 65.12 3.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.886 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -51.95 124.42 28.52 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-O 121.032 0.444 . . . . 0.0 110.991 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.652 ' HD3' ' HE3' ' A' ' 24' ' ' LYS . 65.3 Cg_endo -89.62 -145.98 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.912 2.408 . . . . 0.0 112.496 -179.177 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.408 ' H ' HG12 ' A' ' 6' ' ' ILE . 11.0 pt -74.37 -29.34 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 121.259 0.552 . . . . 0.0 109.605 178.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.621 ' SG ' ' HB3' ' A' ' 21' ' ' MET . 23.2 t 58.03 51.56 8.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.382 179.058 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 31.6 pt -50.12 141.98 3.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.267 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -62.47 147.49 48.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.804 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 17.4 p -149.23 131.13 15.19 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.21 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 47.5 t -135.71 107.47 7.03 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.89 0.376 . . . . 0.0 111.489 -179.252 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.47 ' HA3' ' O ' ' A' ' 16' ' ' ARG . . . -85.69 114.2 3.96 Favored Glycine 0 C--O 1.239 0.432 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.534 178.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.665 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 0.9 OUTLIER -57.33 -82.58 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -178.44 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.665 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -110.14 -63.88 1.33 Allowed 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 113.142 -1.845 . . . . 0.0 113.653 -172.743 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -51.2 -60.55 2.99 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.47 ' O ' ' HA3' ' A' ' 12' ' ' GLY . 0.0 OUTLIER -91.89 79.93 5.25 Favored 'General case' 0 C--O 1.218 -0.569 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.33 176.575 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 65.1 m -67.96 57.95 0.07 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.701 0.286 . . . . 0.0 111.158 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.635 ' NZ ' ' HB3' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -149.67 122.52 8.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.209 -179.555 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 92.1 m -126.7 130.71 50.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.142 0.496 . . . . 0.0 111.654 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 176.92 -154.84 16.94 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.96 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.621 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 80.0 mtp -96.98 126.16 41.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.743 0.306 . . . . 0.0 110.918 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 49.1 m -93.64 75.14 4.36 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.638 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.425 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 78.8 m -72.47 -124.45 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.371 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.841 ' HA ' ' HE2' ' A' ' 24' ' ' LYS . 7.9 mmpt? -68.35 136.38 53.3 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.774 0.321 . . . . 0.0 111.217 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.4 t . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.214 -0.898 . . . . 0.0 111.191 179.914 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.488 1.459 0 CA-C-O 120.825 0.345 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.537 ' O ' ' HD3' ' A' ' 5' ' ' PRO . 4.3 t -72.1 139.91 48.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.086 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 79.9 t60 -71.17 -31.49 67.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.961 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -120.25 58.81 6.11 Favored Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -178.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.537 ' HD3' ' O ' ' A' ' 2' ' ' THR . 65.1 Cg_endo -72.93 -146.88 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.313 2.009 . . . . 0.0 112.394 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.477 ' H ' ' HB2' ' A' ' 5' ' ' PRO . 23.5 pt -92.75 -37.32 8.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.979 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.749 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 57.5 m 63.95 45.07 4.42 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.119 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.441 ' O ' ' HB2' ' A' ' 22' ' ' CYS . 31.4 pt -75.26 133.62 31.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.18 178.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -70.93 133.59 46.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.718 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 3.3 p -162.82 144.32 10.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.817 0.341 . . . . 0.0 110.464 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.817 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 11.5 t -91.65 124.2 35.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.039 0.447 . . . . 0.0 110.985 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.593 ' C ' ' H ' ' A' ' 18' ' ' LYS . . . 162.78 154.55 7.66 Favored Glycine 0 C--O 1.22 -0.747 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.961 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.618 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 4.8 t -141.1 -92.52 0.15 Allowed 'General case' 0 CA--C 1.51 -0.595 0 CA-C-O 123.236 1.493 . . . . 0.0 111.635 178.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.618 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.5 OUTLIER -122.13 -123.7 0.27 Allowed 'General case' 0 N--CA 1.425 -1.677 0 CA-C-N 111.185 -2.734 . . . . 0.0 108.503 -176.542 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.436 ' H ' ' HB2' ' A' ' 14' ' ' CYS . 46.8 m170 -61.17 -49.81 75.69 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 176.505 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.878 ' H ' ' HD2' ' A' ' 16' ' ' ARG . 0.4 OUTLIER -91.68 137.07 32.66 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.942 176.795 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.578 ' HB3' ' HA2' ' A' ' 12' ' ' GLY . 60.8 m -80.19 130.03 34.93 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.694 0.283 . . . . 0.0 111.319 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.593 ' H ' ' C ' ' A' ' 12' ' ' GLY . 13.7 mmmm -119.8 118.57 31.18 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.935 0.398 . . . . 0.0 110.86 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.817 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 85.4 m -62.57 127.75 32.77 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.417 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 174.4 -179.53 45.68 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.891 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 93.9 mmm -63.32 135.27 56.91 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.724 0.297 . . . . 0.0 110.35 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 8' ' ' ILE . 20.6 m -116.61 53.83 0.87 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.167 -179.095 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.749 ' HA ' ' HA ' ' A' ' 7' ' ' CYS . 84.8 m -58.78 -74.22 0.07 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.555 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.587 ' HD3' ' O ' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -68.59 152.06 45.89 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.88 0.372 . . . . 0.0 111.53 -179.668 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.1 m . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.829 -179.774 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ASP . . . . . 0.427 ' H3 ' ' HB3' ' A' ' 24' ' ' LYS . 1.5 m-20 . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.785 0.326 . . . . 0.0 111.081 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 82.7 p -75.37 -135.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.173 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -69.61 76.57 0.42 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.607 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -44.76 128.83 5.17 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.709 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.501 ' HB2' ' H ' ' A' ' 6' ' ' ILE . 94.4 Cg_endo -87.41 -137.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.093 2.529 . . . . 0.0 113.543 -178.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.683 HG13 HG23 ' A' ' 8' ' ' ILE . 0.5 OUTLIER -124.45 33.28 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.025 -179.886 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.758 ' HA ' ' HB2' ' A' ' 23' ' ' CYS . 62.5 m 59.98 27.31 16.69 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.134 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.683 HG23 HG13 ' A' ' 6' ' ' ILE . 16.3 pt -61.39 142.92 15.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.946 0.403 . . . . 0.0 110.828 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -68.1 124.52 23.65 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.787 178.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 35.9 m -125.18 113.72 18.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.929 0.395 . . . . 0.0 111.344 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.419 ' CB ' ' HA ' ' A' ' 19' ' ' CYS . 42.1 t -136.38 111.84 9.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.96 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 17' ' ' SER . . . -69.91 129.69 21.58 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.35 -0.929 . . . . 0.0 111.125 178.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.686 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 17.2 p -68.68 -50.91 47.28 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -178.467 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.686 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 3.1 m -121.59 -61.29 1.53 Allowed 'General case' 0 N--CA 1.428 -1.531 0 CA-C-N 113.922 -1.49 . . . . 0.0 113.618 -172.176 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 -62.6 -62.35 1.8 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.541 ' O ' ' N ' ' A' ' 18' ' ' LYS . 9.1 mpt_? -91.39 62.08 4.55 Favored 'General case' 0 C--O 1.218 -0.586 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.087 177.364 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.436 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 65.9 m -61.79 59.78 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.627 0 O-C-N 123.424 0.453 . . . . 0.0 111.414 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.541 ' N ' ' O ' ' A' ' 16' ' ' ARG . 15.4 ptpt -149.71 135.69 18.77 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.626 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.419 ' HA ' ' CB ' ' A' ' 11' ' ' CYS . 67.5 m -99.05 135.67 40.13 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.763 178.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 176.98 144.68 5.39 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.757 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 60.9 mtm -64.48 123.42 19.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.792 0.33 . . . . 0.0 110.724 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.416 ' SG ' HG13 ' A' ' 8' ' ' ILE . 13.0 p -89.53 41.36 1.03 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.734 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.758 ' HB2' ' HA ' ' A' ' 7' ' ' CYS . 4.6 t -89.67 55.89 3.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.883 -179.059 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.427 ' HB3' ' H3 ' ' A' ' 1' ' ' ASP . 54.0 mtmt -55.81 118.42 4.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.793 0.33 . . . . 0.0 110.458 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.412 ' O ' HG23 ' A' ' 25' ' ' THR . 2.0 t . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.545 -0.74 . . . . 0.0 111.513 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.5 p30 . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.952 0.405 . . . . 0.0 111.26 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.657 ' OG1' ' HB3' ' A' ' 5' ' ' PRO . 41.2 p -77.63 148.0 35.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.395 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 47.7 m170 -66.38 -39.11 88.89 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -179.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.41 61.43 57.17 Favored Pre-proline 0 CA--C 1.533 0.3 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -178.302 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.657 ' HB3' ' OG1' ' A' ' 2' ' ' THR . 72.9 Cg_endo -76.8 169.62 21.38 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.729 2.286 . . . . 0.0 113.162 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.412 ' H ' HG12 ' A' ' 6' ' ' ILE . 7.0 pt -82.06 -28.58 9.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.322 178.591 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.612 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 34.8 t 63.62 52.75 2.18 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.834 179.349 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 26.9 pt -60.3 141.44 16.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.39 179.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -60.71 143.84 53.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.694 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 20' ' ' GLY . 26.8 p -149.91 120.98 7.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.768 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 47.6 t -135.64 120.48 18.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.939 0.399 . . . . 0.0 111.008 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.888 ' HA3' ' HG2' ' A' ' 16' ' ' ARG . . . -68.94 133.68 27.0 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.028 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.586 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 0.6 OUTLIER -58.35 -76.79 0.04 OUTLIER 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -178.831 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.586 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -119.87 -56.55 2.02 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 113.395 -1.729 . . . . 0.0 112.907 -173.16 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 42.6 m170 -56.02 -70.19 0.12 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 179.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.895 ' H ' ' HD3' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -91.49 50.72 1.77 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 177.069 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.651 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 77.4 p -58.33 71.9 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.773 -178.365 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.886 ' HE3' ' HB2' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -148.82 141.0 23.98 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.977 -1.011 . . . . 0.0 111.808 179.678 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 69.6 m -102.89 136.2 43.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.86 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.454 ' O ' ' SG ' ' A' ' 10' ' ' CYS . . . -177.4 152.83 12.43 Favored Glycine 0 C--O 1.224 -0.5 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.009 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.597 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 63.5 mtm -82.12 125.11 30.49 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.984 0.392 . . . . 0.0 111.519 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 59.9 m -86.48 61.94 7.12 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.817 179.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.612 ' HA ' ' HA ' ' A' ' 7' ' ' CYS . 51.4 m -51.19 -45.88 61.96 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 48.4 mttp -48.88 -46.08 42.01 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.773 0.32 . . . . 0.0 111.282 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 65.5 p . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.403 -0.808 . . . . 0.0 110.958 -179.888 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.835 0.35 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 89.0 m -136.14 -51.23 0.71 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.049 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 18.0 p-80 -81.16 54.99 2.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.069 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -51.54 107.8 0.91 Allowed Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.02 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.661 ' HD2' ' HB3' ' A' ' 23' ' ' CYS . 76.0 Cg_endo -87.4 -129.92 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.935 2.423 . . . . 0.0 112.061 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.457 ' H ' ' HB2' ' A' ' 5' ' ' PRO . 12.3 pt -70.27 -28.85 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-O 120.969 0.414 . . . . 0.0 110.01 179.197 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.523 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 95.0 m 60.97 50.05 5.38 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.813 179.452 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.411 HG23 ' CD1' ' A' ' 6' ' ' ILE . 24.7 pt -51.06 131.02 11.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.452 179.257 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -61.89 146.79 48.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.151 0.501 . . . . 0.0 111.221 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.1 p -155.4 139.07 16.06 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.912 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 41.8 t -135.36 117.27 15.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.117 0.484 . . . . 0.0 111.639 -179.357 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.453 ' N ' ' SG ' ' A' ' 19' ' ' CYS . . . -93.69 92.82 1.64 Allowed Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 178.584 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.691 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 18.7 p -72.68 -50.26 26.11 Favored 'General case' 0 CA--C 1.504 -0.808 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -178.427 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.691 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 3.0 m -121.15 -50.39 2.14 Favored 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 113.727 -1.579 . . . . 0.0 113.087 -172.349 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 40.8 m170 -57.47 -83.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.701 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 0.6 OUTLIER -91.1 126.67 36.25 Favored 'General case' 0 C--O 1.22 -0.493 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 176.783 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 77.9 p -77.61 55.38 1.31 Allowed 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.291 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.701 ' HG2' ' HB3' ' A' ' 16' ' ' ARG . 13.9 ptmm? -148.29 125.54 11.51 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.248 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.453 ' SG ' ' N ' ' A' ' 12' ' ' GLY . 84.4 m -126.32 126.16 43.47 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.938 0.399 . . . . 0.0 111.387 179.037 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 176.16 -152.26 12.62 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.057 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 61.3 mtm -92.35 122.28 34.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.791 0.329 . . . . 0.0 111.212 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 35.7 m -87.52 55.38 3.49 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.814 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.661 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 63.2 m -53.77 -66.77 0.33 Allowed 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.162 -179.678 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.6 ' O ' ' HD2' ' A' ' 24' ' ' LYS . 1.8 pptp? -72.84 145.36 47.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.065 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 72.2 p . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.229 -0.891 . . . . 0.0 111.071 -179.859 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.8 p30 . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.849 0.357 . . . . 0.0 111.236 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 40.1 p -61.57 121.7 13.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.067 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -76.61 -24.93 53.4 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.268 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -143.53 59.95 8.05 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.906 0.384 . . . . 0.0 111.337 -179.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.486 ' HB2' ' H ' ' A' ' 6' ' ' ILE . 56.5 Cg_endo -71.58 -144.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.394 2.063 . . . . 0.0 112.049 179.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.486 ' H ' ' HB2' ' A' ' 5' ' ' PRO . 13.4 pt -102.99 -38.52 5.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.952 0.406 . . . . 0.0 110.638 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.477 ' SG ' ' HB3' ' A' ' 21' ' ' MET . 15.4 t 56.62 51.02 11.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.197 179.461 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.412 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 27.8 pt -53.04 149.23 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.415 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -71.21 82.4 0.73 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.031 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 21.3 m -67.09 141.58 57.41 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.807 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 26.1 t -136.01 115.45 12.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.952 0.406 . . . . 0.0 110.987 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -88.92 97.41 2.32 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.523 179.205 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.692 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 0.1 OUTLIER -66.11 -76.41 0.08 Allowed 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -178.808 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.692 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -104.58 -48.02 3.92 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 112.711 -2.041 . . . . 0.0 112.922 -173.332 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -55.97 -83.79 0.01 OUTLIER 'General case' 0 C--O 1.232 0.164 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.551 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.674 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 11.3 mpt_? -91.21 120.14 31.88 Favored 'General case' 0 C--O 1.221 -0.432 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 176.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.9 m -76.95 55.47 1.11 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.123 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.674 ' HG2' ' HB3' ' A' ' 16' ' ' ARG . 21.9 pttp -148.66 129.74 14.48 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.715 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 80.0 m -125.77 128.69 48.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.29 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -171.92 -150.15 7.04 Favored Glycine 0 CA--C 1.519 0.331 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.864 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.477 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 68.6 mtm -94.17 132.46 38.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.914 0.388 . . . . 0.0 111.417 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.412 ' SG ' ' O ' ' A' ' 8' ' ' ILE . 7.3 p -116.27 69.07 0.74 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.635 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.402 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 88.0 m -62.08 -118.07 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.153 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.609 ' O ' ' HD2' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -58.67 151.78 20.15 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.916 0.389 . . . . 0.0 111.499 -179.593 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 8.1 t . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.227 -0.892 . . . . 0.0 111.172 -179.661 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.425 0.155 . . . . 0.0 111.059 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.525 ' O ' ' HD3' ' A' ' 5' ' ' PRO . 75.5 m -51.4 -43.27 61.89 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.764 0.316 . . . . 0.0 111.749 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 16.8 m80 -50.5 -51.69 45.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.828 -179.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -145.98 71.56 13.55 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 120.77 0.319 . . . . 0.0 110.813 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.525 ' HD3' ' O ' ' A' ' 2' ' ' THR . 94.1 Cg_endo -80.51 -150.86 0.04 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.457 2.105 . . . . 0.0 112.528 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.499 HD12 HG23 ' A' ' 8' ' ' ILE . 18.7 pt -136.2 -40.1 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.61 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.748 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 8.8 t 57.36 52.83 8.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.312 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.499 HG23 HD12 ' A' ' 6' ' ' ILE . 26.6 pt -57.3 149.93 4.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.545 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -52.69 129.53 29.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.329 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -165.36 133.32 3.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.281 -179.146 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.617 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 42.8 t -84.73 130.76 34.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.559 -179.477 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.511 ' HA3' ' O ' ' A' ' 16' ' ' ARG . . . -72.02 103.18 1.25 Allowed Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 178.603 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.688 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 16.8 p -71.38 -50.97 26.74 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 114.282 1.215 . . . . 0.0 114.282 -177.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.688 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 3.2 m -121.22 -62.56 1.42 Allowed 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 114.245 -1.343 . . . . 0.0 113.802 -171.58 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.552 ' HB3' ' CZ ' ' A' ' 16' ' ' ARG . 39.2 m170 -52.75 -75.78 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.552 ' CZ ' ' HB3' ' A' ' 15' ' ' HIS . 0.0 OUTLIER -91.13 106.83 18.79 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 176.737 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 46.1 t -74.25 52.91 0.49 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.713 0.292 . . . . 0.0 111.409 -179.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.509 ' HD2' ' N ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -150.69 134.53 16.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.799 179.793 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.617 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 86.5 m -75.02 132.45 41.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.648 178.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -174.54 -136.5 2.26 Favored Glycine 0 C--O 1.225 -0.417 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.933 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 84.0 mtp -114.4 120.24 39.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.662 0.231 . . . . 0.0 110.452 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 73.0 m -89.84 117.16 28.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.839 0.352 . . . . 0.0 110.504 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.748 ' HA ' ' HA ' ' A' ' 7' ' ' CYS . 75.9 m -84.31 -126.26 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.87 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.742 ' HD2' ' H ' ' A' ' 25' ' ' THR . 0.0 OUTLIER -56.75 -33.11 66.23 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -179.822 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.742 ' H ' ' HD2' ' A' ' 24' ' ' LYS . 9.9 t . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.193 -0.908 . . . . 0.0 111.035 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 51.7 p30 . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.417 0.151 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.636 HG22 ' H ' ' A' ' 4' ' ' PHE . 90.6 m -125.56 132.97 52.46 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.852 0.358 . . . . 0.0 111.285 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -67.7 -30.1 69.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.969 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.636 ' H ' HG22 ' A' ' 2' ' ' THR . 22.0 t80 -143.63 73.62 17.1 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.506 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.564 ' HG3' ' HB ' ' A' ' 2' ' ' THR . 16.6 Cg_exo -66.07 -151.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.557 2.171 . . . . 0.0 112.74 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 13.6 pt -87.27 -34.66 7.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.486 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.499 ' HA ' ' HB2' ' A' ' 23' ' ' CYS . 85.0 m 63.56 47.25 3.86 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.522 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.4 pt -82.24 146.25 7.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.722 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -67.47 136.97 55.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.235 179.146 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -168.81 148.62 4.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.853 0.358 . . . . 0.0 110.951 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 46.7 t -121.93 125.82 47.24 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.374 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.623 ' HA3' ' HG2' ' A' ' 16' ' ' ARG . . . -69.01 116.05 6.96 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.435 -0.888 . . . . 0.0 111.448 178.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.698 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -67.44 -73.93 0.13 Allowed 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 122.535 1.16 . . . . 0.0 113.379 -179.068 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.698 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -103.31 -44.2 5.23 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 112.392 -2.185 . . . . 0.0 112.339 -173.782 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.4 ' HB3' ' HD2' ' A' ' 16' ' ' ARG . 17.8 t-160 -59.98 -89.5 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.47 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.914 ' H ' ' HD2' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -91.56 101.84 14.49 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 177.532 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.7 p -68.8 66.42 0.13 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.971 0.415 . . . . 0.0 110.777 -179.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.437 ' HE3' ' HB2' ' A' ' 16' ' ' ARG . 22.2 pttp -148.34 139.74 23.48 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.943 -0.572 . . . . 0.0 112.3 -179.234 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 87.4 m -105.83 126.56 52.31 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.794 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 169.8 -145.34 9.18 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.459 -0.877 . . . . 0.0 113.066 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 63.8 mtm -84.11 138.49 33.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.816 0.341 . . . . 0.0 111.024 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 63.6 m -121.84 57.21 1.05 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.997 0.427 . . . . 0.0 110.881 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.499 ' HB2' ' HA ' ' A' ' 7' ' ' CYS . 4.2 t -99.12 90.81 4.72 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.218 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -41.84 126.28 3.06 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.977 -179.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 88.5 m . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.315 -0.85 . . . . 0.0 110.992 -179.827 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 62.6 t0 . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 121.006 0.431 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.57 ' OG1' ' HB3' ' A' ' 5' ' ' PRO . 63.8 p -62.65 136.29 57.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.157 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -73.04 -25.91 61.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.343 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -132.45 60.81 53.24 Favored Pre-proline 0 CA--C 1.535 0.369 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.57 ' HB3' ' OG1' ' A' ' 2' ' ' THR . 73.1 Cg_endo -78.06 -149.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.412 2.075 . . . . 0.0 112.32 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.2 pt -98.88 -33.57 4.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.228 0.537 . . . . 0.0 110.087 178.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.513 ' SG ' ' HB3' ' A' ' 21' ' ' MET . 19.1 t 60.43 55.41 3.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.089 178.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 27.0 pt -58.88 147.04 8.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.692 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -59.8 110.59 1.2 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.329 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 14.9 m -114.46 158.69 21.25 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.632 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.745 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 57.8 m -125.94 128.8 48.09 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.779 0.323 . . . . 0.0 111.301 179.69 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.609 ' H ' ' HA ' ' A' ' 19' ' ' CYS . . . -71.3 84.41 0.42 Allowed Glycine 0 C--N 1.332 0.319 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 178.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.73 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 0.1 OUTLIER -60.51 -80.15 0.03 OUTLIER 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -178.171 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.73 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -98.45 -47.32 5.44 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 112.658 -2.064 . . . . 0.0 113.377 -172.85 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -57.01 -93.63 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 178.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.882 ' H ' ' HD2' ' A' ' 16' ' ' ARG . 0.2 OUTLIER -91.0 124.28 35.12 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 177.04 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 42.9 t -73.38 57.71 0.53 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.805 0.336 . . . . 0.0 111.305 -178.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -150.48 125.98 10.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.554 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.745 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 47.7 t -82.06 136.2 35.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.776 0.322 . . . . 0.0 110.725 179.215 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -163.68 151.96 21.68 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.716 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.513 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 3.5 mpp? -62.22 113.77 3.07 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 122.548 -0.384 . . . . 0.0 110.514 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 7.3 p -74.56 82.71 2.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.512 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.452 ' HA ' ' CB ' ' A' ' 7' ' ' CYS . 92.1 m -69.14 -117.43 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.195 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.497 ' HD2' ' N ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -52.15 -37.86 55.81 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.602 0.239 . . . . 0.0 111.372 -179.29 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.465 ' H ' ' HD2' ' A' ' 24' ' ' LYS . 77.5 p . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.132 -0.937 . . . . 0.0 111.208 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 120.815 0.341 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 68.2 p -136.18 -147.68 0.27 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.271 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 19.7 m80 -74.28 -45.56 46.85 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.16 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -145.45 63.29 9.54 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.979 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.496 ' HB2' ' H ' ' A' ' 6' ' ' ILE . 38.1 Cg_endo -65.22 -134.02 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.675 2.25 . . . . 0.0 112.094 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.669 HD13 ' H ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -78.07 -34.22 18.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.872 0.368 . . . . 0.0 110.605 179.333 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.811 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 99.0 m 60.14 49.93 6.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.081 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.529 HG23 HG13 ' A' ' 6' ' ' ILE . 27.4 pt -53.61 132.09 16.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.881 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -72.48 135.35 45.68 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.414 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 30.0 p -150.72 116.62 5.55 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.141 0.496 . . . . 0.0 110.758 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.765 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 42.6 t -82.08 129.1 34.71 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.039 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.446 ' HA3' ' O ' ' A' ' 16' ' ' ARG . . . -62.29 101.37 0.37 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.468 -0.872 . . . . 0.0 111.27 179.31 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.721 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 0.1 OUTLIER -64.61 -79.87 0.04 OUTLIER 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 -178.484 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.721 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -100.45 -51.24 3.67 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-N 112.72 -2.037 . . . . 0.0 113.295 -172.907 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 17.7 m80 -55.69 -84.34 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.605 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 0.9 OUTLIER -91.27 114.05 26.48 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 176.748 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.4 p -75.44 54.98 0.77 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.893 0.378 . . . . 0.0 110.519 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.605 ' HG2' ' HB3' ' A' ' 16' ' ' ARG . 7.4 ptpp? -149.48 132.5 16.22 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.068 -179.053 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.765 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 75.3 m -72.82 140.09 47.42 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.706 178.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -168.33 140.93 6.47 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.107 -1.044 . . . . 0.0 113.525 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -70.69 133.91 47.04 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 122.702 -0.293 . . . . 0.0 110.408 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 2.8 p -120.39 123.69 43.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.847 0.356 . . . . 0.0 111.242 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.811 ' HA ' ' HA ' ' A' ' 7' ' ' CYS . 39.0 m -95.34 -63.45 1.16 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.143 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.66 ' NZ ' ' HB2' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -80.27 139.0 36.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.125 179.821 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 77.7 p . . . . . 0 C--O 1.25 1.13 0 CA-C-O 118.225 -0.893 . . . . 0.0 111.198 -179.67 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.2 p30 . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.767 0.318 . . . . 0.0 111.385 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 87.9 m -108.94 -48.14 3.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.922 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -74.17 72.14 1.7 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.719 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -51.82 109.48 1.42 Allowed Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.98 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.546 ' HD3' ' HB2' ' A' ' 24' ' ' LYS . 92.7 Cg_endo -87.7 -140.02 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.912 2.408 . . . . 0.0 112.672 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.87 HG13 HG23 ' A' ' 8' ' ' ILE . 1.6 pt -135.28 36.31 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.91 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 35.8 m 54.21 27.54 7.96 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.627 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.87 HG23 HG13 ' A' ' 6' ' ' ILE . 28.0 pt -47.47 139.27 2.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.179 179.148 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -65.96 134.77 53.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.867 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -158.59 135.22 9.51 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.953 0.406 . . . . 0.0 110.753 179.353 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.592 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 65.8 m -80.54 132.02 35.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.112 -0.494 . . . . 0.0 112.084 -179.222 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' A' ' 16' ' ' ARG . . . -76.78 74.48 1.79 Allowed Glycine 0 N--CA 1.451 -0.304 0 N-CA-C 110.996 -0.841 . . . . 0.0 110.996 178.501 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.674 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 23.2 p -66.01 -50.31 64.68 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -178.035 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.674 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 3.5 m -115.59 -43.99 2.99 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 113.481 -1.69 . . . . 0.0 112.854 -171.773 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.5 ' HB2' HH11 ' A' ' 16' ' ' ARG . 42.5 m170 -65.84 -112.2 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 177.305 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.554 ' HD2' ' O ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -76.17 129.92 37.47 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 176.541 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 41.1 t -71.53 57.65 0.27 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.731 0.3 . . . . 0.0 111.4 -178.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.599 ' NZ ' ' HB2' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -151.43 133.45 15.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.88 -179.724 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.592 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 35.0 t -95.87 131.28 42.36 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 178.637 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -179.56 -159.81 24.16 Favored Glycine 0 C--N 1.329 0.169 0 C-N-CA 120.533 -0.842 . . . . 0.0 112.588 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 84.9 mtp -69.19 131.35 44.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.604 0.24 . . . . 0.0 110.363 179.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.523 ' O ' ' HA ' ' A' ' 7' ' ' CYS . 25.7 m -117.57 116.69 27.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.776 0.322 . . . . 0.0 110.96 -179.299 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.2 m -126.36 107.99 10.82 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.999 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.546 ' HB2' ' HD3' ' A' ' 5' ' ' PRO . 29.2 mtpp -74.56 43.14 0.18 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.404 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 77.5 p . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.238 -0.887 . . . . 0.0 111.018 179.868 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 36.2 t70 . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.776 0.322 . . . . 0.0 111.108 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 60.8 p -135.58 52.89 1.99 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.499 0.666 . . . . 0.0 110.941 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -88.11 75.46 8.67 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.544 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PHE . . . . . 0.409 ' HD1' ' O ' ' A' ' 4' ' ' PHE . 2.2 p90 -44.96 104.77 0.41 Allowed Pre-proline 0 CA--C 1.534 0.33 0 CA-C-O 121.35 0.595 . . . . 0.0 111.684 -179.264 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -97.56 -151.36 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 123.414 2.743 . . . . 0.0 112.856 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.459 HD11 HD13 ' A' ' 8' ' ' ILE . 3.7 pt -72.11 -13.69 16.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.964 178.506 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.3 t 67.84 41.52 2.14 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.946 179.085 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.459 HD13 HD11 ' A' ' 6' ' ' ILE . 25.0 pt -82.22 140.35 16.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.978 0.418 . . . . 0.0 111.482 179.278 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PHE . . . . . 0.738 ' HA ' ' HA ' ' A' ' 21' ' ' MET . 25.7 t80 -60.92 144.2 53.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.307 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.424 ' O ' ' O ' ' A' ' 20' ' ' GLY . 30.3 p -157.74 115.5 3.05 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.892 0.377 . . . . 0.0 111.532 -179.639 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.752 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 78.0 m -83.86 123.27 29.74 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 121.014 -0.274 . . . . 0.0 111.105 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.75 ' HA3' ' O ' ' A' ' 16' ' ' ARG . . . -65.88 113.68 5.96 Favored Glycine 0 N--CA 1.45 -0.367 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 178.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' CYS . . . . . 0.66 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 18.6 p -64.84 -48.33 74.73 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 115.713 1.745 . . . . 0.0 115.713 -177.03 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.66 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 4.1 m -118.83 -110.15 0.35 Allowed 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -170.03 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -47.17 -44.8 22.31 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.045 0.45 . . . . 0.0 109.93 -178.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.75 ' O ' ' HA3' ' A' ' 12' ' ' GLY . 42.8 ttt85 -90.84 46.86 1.36 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.458 178.334 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.638 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 79.2 p -59.55 65.84 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.243 0.617 . . . . 0.0 111.711 -178.822 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 16' ' ' ARG . 21.7 ptmt -151.68 129.83 11.91 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.689 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.752 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 50.1 m -73.8 133.97 43.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.797 0.332 . . . . 0.0 110.778 178.728 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 10' ' ' CYS . . . 178.43 141.58 4.37 Favored Glycine 0 C--O 1.226 -0.364 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.218 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.738 ' HA ' ' HA ' ' A' ' 9' ' ' PHE . 3.5 mpp? -62.39 135.46 57.45 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.93 0.365 . . . . 0.0 110.988 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 34.6 m -75.84 42.37 0.24 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.662 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' CYS . . . . . 0.49 ' SG ' ' HB3' ' A' ' 21' ' ' MET . 3.2 m -85.21 72.22 10.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.495 0.188 . . . . 0.0 111.17 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -50.57 108.18 0.21 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.821 0.343 . . . . 0.0 110.754 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 92.8 m . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.742 -179.794 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.408 HD12 HG23 ' A' ' 8' ' ' ILE . 26.0 pt . . . . . 0 C--O 1.232 0.17 0 CA-C-O 120.808 0.337 . . . . 0.0 110.853 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.448 ' O ' ' HE2' ' A' ' 21' ' ' MET . 90.4 m 56.4 40.83 29.57 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.466 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.408 HG23 HD12 ' A' ' 6' ' ' ILE . 33.8 pt -62.18 127.23 21.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.353 179.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -55.27 138.36 45.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.89 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.6 p -158.75 109.56 2.08 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.904 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.815 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 39.0 m -75.2 124.88 27.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.828 0.347 . . . . 0.0 111.476 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' A' ' 16' ' ' ARG . . . -63.77 93.89 0.13 Allowed Glycine 0 C--O 1.237 0.343 0 N-CA-C 111.066 -0.813 . . . . 0.0 111.066 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.667 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 17.8 p -70.55 -49.61 46.26 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -177.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.667 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 3.4 m -120.31 -55.49 2.04 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 114.282 -1.326 . . . . 0.0 113.938 -171.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -56.13 -84.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.691 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 1.3 mpt_? -91.48 119.9 31.84 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 176.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 59.2 m -75.16 52.81 0.6 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.691 ' HG2' ' HB3' ' A' ' 16' ' ' ARG . 20.6 pttp -150.49 139.4 20.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.992 -178.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.815 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 84.2 m -71.36 141.76 50.39 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.506 178.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -167.95 150.11 15.82 Favored Glycine 0 C--O 1.228 -0.259 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.728 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.448 ' HE2' ' O ' ' A' ' 7' ' ' CYS . 75.9 mtp -73.69 128.25 35.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.816 0.341 . . . . 0.0 111.275 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 9.0 m . . . . . 0 N--CA 1.464 0.249 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.721 179.672 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.434 HD12 HG23 ' A' ' 8' ' ' ILE . 11.4 pt . . . . . 0 N--CA 1.455 -0.188 0 CA-C-O 121.02 0.438 . . . . 0.0 110.52 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.688 ' SG ' ' HB3' ' A' ' 21' ' ' MET . 49.3 t 61.34 50.61 4.65 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.514 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.434 HG23 HD12 ' A' ' 6' ' ' ILE . 23.5 pt -56.47 139.78 15.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.953 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -58.75 138.35 57.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.592 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 24.4 p -146.85 121.94 10.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.929 0.395 . . . . 0.0 110.979 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 45.9 t -136.01 126.41 26.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.297 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.53 ' HA3' ' O ' ' A' ' 16' ' ' ARG . . . -70.95 128.6 17.11 Favored Glycine 0 C--O 1.239 0.413 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.49 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.674 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 0.8 OUTLIER -54.82 -83.45 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -178.344 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.674 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -107.12 -64.44 1.19 Allowed 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 113.044 -1.889 . . . . 0.0 113.459 -172.94 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.515 ' ND1' ' N ' ' A' ' 16' ' ' ARG . 12.0 p80 -59.01 -53.71 55.28 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.12 -0.632 . . . . 0.0 109.363 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.573 ' O ' ' N ' ' A' ' 18' ' ' LYS . 7.6 mpt_? -93.24 51.73 1.68 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.942 178.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 68.6 m -59.26 68.04 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.308 0.575 . . . . 0.0 111.045 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.573 ' N ' ' O ' ' A' ' 16' ' ' ARG . 55.9 mtpt -146.99 129.71 16.09 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.107 -179.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 96.9 m -102.49 137.31 40.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.889 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -174.56 147.51 9.19 Favored Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.764 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.688 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 60.9 mtm -73.78 129.57 38.18 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.624 0.25 . . . . 0.0 110.866 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 5.1 m . . . . . 0 CA--C 1.532 0.254 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.76 179.856 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.58 HD12 HG23 ' A' ' 8' ' ' ILE . 23.7 pt . . . . . 0 N--CA 1.455 -0.183 0 CA-C-O 120.874 0.369 . . . . 0.0 110.738 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 79.4 m 55.28 44.16 27.94 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.13 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.58 HG23 HD12 ' A' ' 6' ' ' ILE . 37.5 pt -54.84 130.18 16.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.929 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -69.11 85.33 0.36 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.608 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.753 ' HB3' HH22 ' A' ' 16' ' ' ARG . 83.0 m -72.49 68.36 0.79 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.749 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.686 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 22.2 t -99.86 73.56 1.78 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.063 0.458 . . . . 0.0 111.731 -178.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.757 ' HA3' ' HG3' ' A' ' 16' ' ' ARG . . . -60.34 122.25 29.27 Favored Glycine 0 C--O 1.235 0.173 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.541 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.695 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 14.9 p -69.85 -52.41 25.15 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -177.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.695 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 3.1 m -121.56 -81.67 0.64 Allowed 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -171.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 -49.52 -63.63 1.05 Allowed 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.757 ' HG3' ' HA3' ' A' ' 12' ' ' GLY . 6.8 ptm180 -90.96 56.55 3.24 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.27 177.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.457 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 78.6 p -59.47 65.04 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.814 0.845 . . . . 0.0 112.652 -178.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.708 ' NZ ' ' HB2' ' A' ' 16' ' ' ARG . 0.4 OUTLIER -149.59 140.27 22.62 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.038 178.302 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.686 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 61.2 m -125.47 131.6 52.83 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.13 0.49 . . . . 0.0 111.871 -178.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -179.71 142.49 5.2 Favored Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.275 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 67.5 mtm -65.53 125.9 26.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.943 0.402 . . . . 0.0 111.451 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.446 ' HB2' ' CG1' ' A' ' 8' ' ' ILE . 94.1 m . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.787 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.6 pt . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.935 0.398 . . . . 0.0 110.535 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.645 ' SG ' ' HB3' ' A' ' 21' ' ' MET . 15.6 t 63.75 57.08 1.43 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.917 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.41 HG13 ' SG ' ' A' ' 10' ' ' CYS . 37.1 pt -54.26 131.97 17.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.092 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -72.11 89.82 1.17 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.968 0.413 . . . . 0.0 109.9 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.41 ' SG ' HG13 ' A' ' 8' ' ' ILE . 75.6 m -75.62 65.01 1.75 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.895 -179.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.781 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 34.3 t -102.65 74.21 1.34 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.116 0.484 . . . . 0.0 111.656 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.672 ' HA3' ' HG2' ' A' ' 16' ' ' ARG . . . -67.23 114.83 6.62 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.753 -0.736 . . . . 0.0 111.54 179.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.702 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -70.33 -74.31 0.14 Allowed 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 122.53 1.157 . . . . 0.0 113.557 -179.041 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.702 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -103.94 -44.36 5.05 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 112.489 -2.141 . . . . 0.0 112.434 -173.686 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 22.6 t-80 -58.12 -86.96 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.757 ' HB3' HH11 ' A' ' 16' ' ' ARG . 0.0 OUTLIER -91.3 114.87 27.51 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 176.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 64.0 m -74.99 63.32 1.21 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.931 0.396 . . . . 0.0 110.893 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.438 ' HE2' ' HB2' ' A' ' 16' ' ' ARG . 60.2 pttt -148.45 128.48 13.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.585 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.781 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 77.2 m -125.87 129.92 50.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.942 0.401 . . . . 0.0 110.99 179.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 176.68 146.24 5.99 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.464 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.645 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 80.4 mtp -68.25 119.66 13.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.777 0.322 . . . . 0.0 110.989 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 56.6 m . . . . . 0 C--N 1.329 -0.323 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.036 179.514 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 14.0 pt . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.742 0.306 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 78.0 m 62.98 47.16 4.41 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.861 179.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 35.3 pt -82.36 140.32 16.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.635 178.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.858 ' HA ' ' HA ' ' A' ' 21' ' ' MET . 28.1 t80 -53.01 135.94 36.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.108 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -155.63 138.97 15.74 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.254 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 47.4 t -129.88 122.33 28.43 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.749 0.309 . . . . 0.0 111.477 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.838 ' HA3' ' HG2' ' A' ' 16' ' ' ARG . . . -69.25 122.67 13.05 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.498 -0.858 . . . . 0.0 111.032 178.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.69 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 17.2 p -70.59 -51.68 26.7 Favored 'General case' 0 CA--C 1.504 -0.802 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -178.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.69 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 2.8 m -121.74 -57.05 1.83 Allowed 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 113.808 -1.542 . . . . 0.0 113.141 -172.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.404 ' HB3' ' HD2' ' A' ' 16' ' ' ARG . 21.5 t-80 -58.61 -79.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.838 ' HG2' ' HA3' ' A' ' 12' ' ' GLY . 0.1 OUTLIER -91.03 73.73 6.38 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.668 178.05 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.558 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 44.4 t -59.91 68.51 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.352 0.596 . . . . 0.0 110.592 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.666 ' HB3' ' NZ ' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -150.01 137.08 19.53 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.852 -178.609 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 85.2 m -102.36 131.35 49.04 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.735 0.302 . . . . 0.0 110.934 179.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 171.33 150.52 7.13 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.451 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.858 ' HA ' ' HA ' ' A' ' 9' ' ' PHE . 86.7 mtp -51.11 140.39 16.23 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.718 0.294 . . . . 0.0 110.797 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 15.0 m . . . . . 0 C--N 1.33 -0.282 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.201 -179.477 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.443 ' HB ' HG23 ' A' ' 8' ' ' ILE . 21.7 pt . . . . . 0 C--O 1.231 0.129 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 48.1 m 62.16 42.73 9.32 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.336 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.492 HG13 ' SG ' ' A' ' 22' ' ' CYS . 26.5 pt -80.27 147.79 6.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.045 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.589 ' HA ' ' HG2' ' A' ' 21' ' ' MET . 15.3 t80 -52.67 134.42 35.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.333 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.673 ' HB2' ' H ' ' A' ' 22' ' ' CYS . 49.8 m -163.57 120.82 1.81 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.746 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.552 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 40.0 t -91.16 131.01 36.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.81 0.338 . . . . 0.0 111.184 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.463 ' HA3' ' O ' ' A' ' 16' ' ' ARG . . . -66.97 96.78 0.32 Allowed Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 178.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.68 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 17.3 p -72.08 -50.05 31.37 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -177.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.68 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 3.3 m -121.12 -58.05 1.82 Allowed 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 114.277 -1.328 . . . . 0.0 114.157 -171.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.585 ' ND1' ' HD3' ' A' ' 16' ' ' ARG . 17.1 t-80 -56.36 -77.9 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.585 ' HD3' ' ND1' ' A' ' 15' ' ' HIS . 1.4 mpp_? -91.55 118.86 30.98 Favored 'General case' 0 C--O 1.221 -0.408 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 176.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.7 m -78.15 56.75 1.7 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -147.12 128.37 14.77 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.829 -178.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.552 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 63.7 m -75.42 135.67 40.74 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.702 0.287 . . . . 0.0 110.833 178.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.458 ' H ' ' HA ' ' A' ' 11' ' ' CYS . . . -166.86 -145.67 4.56 Favored Glycine 0 C--O 1.225 -0.456 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.882 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.589 ' HG2' ' HA ' ' A' ' 9' ' ' PHE . 64.0 mtm -127.6 119.29 25.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.982 0.391 . . . . 0.0 111.238 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.673 ' H ' ' HB2' ' A' ' 10' ' ' CYS . 29.7 p . . . . . 0 C--O 1.232 0.157 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.116 179.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.557 HG13 HG23 ' A' ' 8' ' ' ILE . 2.8 pt . . . . . 0 N--CA 1.456 -0.139 0 CA-C-O 120.98 0.419 . . . . 0.0 110.562 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 64.0 m 64.58 48.74 2.53 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.94 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.557 HG23 HG13 ' A' ' 6' ' ' ILE . 29.4 pt -57.9 137.15 20.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.042 179.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.476 ' HA ' ' HA ' ' A' ' 21' ' ' MET . 23.0 t80 -63.06 135.24 57.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.539 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -148.79 141.52 24.56 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.933 0.397 . . . . 0.0 110.17 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 47.8 t -134.47 124.57 25.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.663 -178.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.554 ' O ' ' HA ' ' A' ' 17' ' ' SER . . . -75.99 119.27 5.62 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.417 -0.897 . . . . 0.0 111.053 178.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.682 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 20.0 p -72.72 -49.75 29.15 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 122.096 0.951 . . . . 0.0 112.459 -178.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.682 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 2.9 m -121.32 -48.12 2.22 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-N 113.236 -1.802 . . . . 0.0 112.247 -172.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 36.9 m170 -61.0 -87.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.827 ' H ' ' HD3' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -91.5 86.0 5.92 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 177.257 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.554 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 57.2 m -62.68 61.3 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -177.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.827 ' HD3' ' HB2' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -150.63 140.22 21.59 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.743 178.471 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 90.1 m -100.1 132.85 45.22 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.889 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 176.7 154.77 12.23 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.986 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.476 ' HA ' ' HA ' ' A' ' 9' ' ' PHE . 86.8 mtp -56.11 136.34 52.54 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 21.8 m . . . . . 0 C--N 1.33 -0.272 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.153 -178.793 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 41.0 mm . . . . . 0 N--CA 1.446 -0.643 0 CA-C-O 120.695 0.283 . . . . 0.0 111.431 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.7 m 64.46 47.86 2.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.118 -179.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 35.2 pt -61.12 133.2 26.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.632 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -80.8 134.98 35.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.899 179.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.9 p -145.18 140.78 28.17 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.267 0.556 . . . . 0.0 111.267 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 52.3 t -124.21 122.52 38.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.757 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.552 ' HA3' ' O ' ' A' ' 16' ' ' ARG . . . -60.42 112.55 4.64 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.319 -0.944 . . . . 0.0 111.485 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.728 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -67.67 -75.23 0.1 Allowed 'General case' 0 CA--C 1.505 -0.756 0 CA-C-O 122.539 1.162 . . . . 0.0 113.711 -178.907 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.728 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -100.44 -45.31 5.6 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 112.338 -2.21 . . . . 0.0 112.427 -173.602 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.445 ' HB2' ' HD3' ' A' ' 16' ' ' ARG . 90.5 m-70 -60.28 -91.61 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.894 ' H ' ' HD3' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -91.38 103.84 16.43 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 177.722 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.9 p -69.41 67.43 0.2 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.002 0.429 . . . . 0.0 110.692 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.407 ' HE3' ' HG3' ' A' ' 16' ' ' ARG . 22.2 pttp -147.68 138.38 23.28 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.459 -179.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 79.0 m -100.95 138.36 38.1 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.827 178.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -177.99 157.2 21.23 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.253 -0.975 . . . . 0.0 113.258 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -59.4 144.36 47.04 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 6.9 m . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.581 -178.582 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 11.0 pt . . . . . 0 N--CA 1.452 -0.331 0 CA-C-O 121.259 0.552 . . . . 0.0 109.605 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.621 ' SG ' ' HB3' ' A' ' 21' ' ' MET . 23.2 t 58.03 51.56 8.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.382 179.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 31.6 pt -50.12 141.98 3.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.267 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -62.47 147.49 48.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.804 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 17.4 p -149.23 131.13 15.19 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.21 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 47.5 t -135.71 107.47 7.03 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.89 0.376 . . . . 0.0 111.489 -179.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.47 ' HA3' ' O ' ' A' ' 16' ' ' ARG . . . -85.69 114.2 3.96 Favored Glycine 0 C--O 1.239 0.432 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.534 178.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.665 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 0.9 OUTLIER -57.33 -82.58 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -178.44 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.665 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -110.14 -63.88 1.33 Allowed 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 113.142 -1.845 . . . . 0.0 113.653 -172.743 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 52.1 t60 -51.2 -60.55 2.99 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.47 ' O ' ' HA3' ' A' ' 12' ' ' GLY . 0.0 OUTLIER -91.89 79.93 5.25 Favored 'General case' 0 C--O 1.218 -0.569 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.33 176.575 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 65.1 m -67.96 57.95 0.07 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.701 0.286 . . . . 0.0 111.158 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.635 ' HB3' ' NZ ' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -149.67 122.52 8.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.209 -179.555 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 92.1 m -126.7 130.71 50.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.142 0.496 . . . . 0.0 111.654 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 176.92 -154.84 16.94 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.96 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.621 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 80.0 mtp -96.98 126.16 41.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.743 0.306 . . . . 0.0 110.918 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 49.1 m . . . . . 0 N--CA 1.463 0.176 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.638 -179.989 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 23.5 pt . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.816 0.341 . . . . 0.0 110.979 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 57.5 m 63.95 45.07 4.42 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.119 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.441 ' O ' ' HB2' ' A' ' 22' ' ' CYS . 31.4 pt -75.26 133.62 31.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.18 178.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -70.93 133.59 46.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.718 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 3.3 p -162.82 144.32 10.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.817 0.341 . . . . 0.0 110.464 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.817 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 11.5 t -91.65 124.2 35.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.039 0.447 . . . . 0.0 110.985 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.593 ' C ' ' H ' ' A' ' 18' ' ' LYS . . . 162.78 154.55 7.66 Favored Glycine 0 C--O 1.22 -0.747 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.961 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.618 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 4.8 t -141.1 -92.52 0.15 Allowed 'General case' 0 CA--C 1.51 -0.595 0 CA-C-O 123.236 1.493 . . . . 0.0 111.635 178.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.618 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.5 OUTLIER -122.13 -123.7 0.27 Allowed 'General case' 0 N--CA 1.425 -1.677 0 CA-C-N 111.185 -2.734 . . . . 0.0 108.503 -176.542 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.436 ' H ' ' HB2' ' A' ' 14' ' ' CYS . 46.8 m170 -61.17 -49.81 75.69 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 176.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.878 ' H ' ' HD2' ' A' ' 16' ' ' ARG . 0.4 OUTLIER -91.68 137.07 32.66 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.942 176.795 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.578 ' HB3' ' HA2' ' A' ' 12' ' ' GLY . 60.8 m -80.19 130.03 34.93 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.694 0.283 . . . . 0.0 111.319 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.593 ' H ' ' C ' ' A' ' 12' ' ' GLY . 13.7 mmmm -119.8 118.57 31.18 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.935 0.398 . . . . 0.0 110.86 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.817 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 85.4 m -62.57 127.75 32.77 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.417 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 174.4 -179.53 45.68 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.891 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 93.9 mmm -63.32 135.27 56.91 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.724 0.297 . . . . 0.0 110.35 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 8' ' ' ILE . 20.6 m . . . . . 0 C--N 1.327 -0.377 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.167 -179.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.683 HG13 HG23 ' A' ' 8' ' ' ILE . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.143 0 CA-C-O 121.09 0.471 . . . . 0.0 111.025 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 62.5 m 59.98 27.31 16.69 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.134 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.683 HG23 HG13 ' A' ' 6' ' ' ILE . 16.3 pt -61.39 142.92 15.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.946 0.403 . . . . 0.0 110.828 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -68.1 124.52 23.65 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.787 178.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 35.9 m -125.18 113.72 18.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.929 0.395 . . . . 0.0 111.344 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.419 ' CB ' ' HA ' ' A' ' 19' ' ' CYS . 42.1 t -136.38 111.84 9.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.96 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 17' ' ' SER . . . -69.91 129.69 21.58 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.35 -0.929 . . . . 0.0 111.125 178.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.686 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 17.2 p -68.68 -50.91 47.28 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -178.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.686 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 3.1 m -121.59 -61.29 1.53 Allowed 'General case' 0 N--CA 1.428 -1.531 0 CA-C-N 113.922 -1.49 . . . . 0.0 113.618 -172.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.472 ' HD2' ' NH1' ' A' ' 16' ' ' ARG . 66.4 t60 -62.6 -62.35 1.8 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.541 ' O ' ' N ' ' A' ' 18' ' ' LYS . 9.1 mpt_? -91.39 62.08 4.55 Favored 'General case' 0 C--O 1.218 -0.586 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.087 177.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.436 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 65.9 m -61.79 59.78 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.627 0 O-C-N 123.424 0.453 . . . . 0.0 111.414 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.541 ' N ' ' O ' ' A' ' 16' ' ' ARG . 15.4 ptpt -149.71 135.69 18.77 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.626 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.419 ' HA ' ' CB ' ' A' ' 11' ' ' CYS . 67.5 m -99.05 135.67 40.13 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.763 178.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 176.98 144.68 5.39 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.757 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 60.9 mtm -64.48 123.42 19.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.792 0.33 . . . . 0.0 110.724 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.416 ' SG ' HG13 ' A' ' 8' ' ' ILE . 13.0 p . . . . . 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.734 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 7.0 pt . . . . . 0 C--O 1.232 0.15 0 CA-C-O 121.093 0.473 . . . . 0.0 110.322 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.597 ' SG ' ' HB3' ' A' ' 21' ' ' MET . 34.8 t 63.62 52.75 2.18 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.834 179.349 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 26.9 pt -60.3 141.44 16.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.39 179.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -60.71 143.84 53.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.694 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 20' ' ' GLY . 26.8 p -149.91 120.98 7.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.768 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 47.6 t -135.64 120.48 18.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.939 0.399 . . . . 0.0 111.008 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.888 ' HA3' ' HG2' ' A' ' 16' ' ' ARG . . . -68.94 133.68 27.0 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.028 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.586 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 0.6 OUTLIER -58.35 -76.79 0.04 OUTLIER 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -178.831 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.586 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -119.87 -56.55 2.02 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 113.395 -1.729 . . . . 0.0 112.907 -173.16 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 42.6 m170 -56.02 -70.19 0.12 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 179.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.895 ' H ' ' HD3' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -91.49 50.72 1.77 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 177.069 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.651 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 77.4 p -58.33 71.9 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.773 -178.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.886 ' HE3' ' HB2' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -148.82 141.0 23.98 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.977 -1.011 . . . . 0.0 111.808 179.678 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 69.6 m -102.89 136.2 43.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.86 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.454 ' O ' ' SG ' ' A' ' 10' ' ' CYS . . . -177.4 152.83 12.43 Favored Glycine 0 C--O 1.224 -0.5 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.009 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.597 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 63.5 mtm -82.12 125.11 30.49 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.984 0.392 . . . . 0.0 111.519 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 59.9 m . . . . . 0 N--CA 1.464 0.266 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.817 179.213 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.411 ' CD1' HG23 ' A' ' 8' ' ' ILE . 12.3 pt . . . . . 0 N--CA 1.454 -0.228 0 CA-C-O 120.969 0.414 . . . . 0.0 110.01 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 95.0 m 60.97 50.05 5.38 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.813 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.411 HG23 ' CD1' ' A' ' 6' ' ' ILE . 24.7 pt -51.06 131.02 11.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.452 179.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -61.89 146.79 48.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.151 0.501 . . . . 0.0 111.221 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.1 p -155.4 139.07 16.06 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.912 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 41.8 t -135.36 117.27 15.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.117 0.484 . . . . 0.0 111.639 -179.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.453 ' N ' ' SG ' ' A' ' 19' ' ' CYS . . . -93.69 92.82 1.64 Allowed Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 178.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.691 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 18.7 p -72.68 -50.26 26.11 Favored 'General case' 0 CA--C 1.504 -0.808 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -178.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.691 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 3.0 m -121.15 -50.39 2.14 Favored 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 113.727 -1.579 . . . . 0.0 113.087 -172.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 40.8 m170 -57.47 -83.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.701 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 0.6 OUTLIER -91.1 126.67 36.25 Favored 'General case' 0 C--O 1.22 -0.493 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 176.783 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 77.9 p -77.61 55.38 1.31 Allowed 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.291 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.701 ' HG2' ' HB3' ' A' ' 16' ' ' ARG . 13.9 ptmm? -148.29 125.54 11.51 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.453 ' SG ' ' N ' ' A' ' 12' ' ' GLY . 84.4 m -126.32 126.16 43.47 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.938 0.399 . . . . 0.0 111.387 179.037 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 176.16 -152.26 12.62 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.057 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 61.3 mtm -92.35 122.28 34.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.791 0.329 . . . . 0.0 111.212 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 35.7 m . . . . . 0 C--N 1.331 -0.227 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.814 179.232 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 13.4 pt . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.952 0.406 . . . . 0.0 110.638 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.477 ' SG ' ' HB3' ' A' ' 21' ' ' MET . 15.4 t 56.62 51.02 11.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.197 179.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.412 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 27.8 pt -53.04 149.23 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.415 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -71.21 82.4 0.73 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.031 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 21.3 m -67.09 141.58 57.41 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.807 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 26.1 t -136.01 115.45 12.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.952 0.406 . . . . 0.0 110.987 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -88.92 97.41 2.32 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.523 179.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.692 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 0.1 OUTLIER -66.11 -76.41 0.08 Allowed 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -178.808 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.692 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -104.58 -48.02 3.92 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 112.711 -2.041 . . . . 0.0 112.922 -173.332 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -55.97 -83.79 0.01 OUTLIER 'General case' 0 C--O 1.232 0.164 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.674 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 11.3 mpt_? -91.21 120.14 31.88 Favored 'General case' 0 C--O 1.221 -0.432 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 176.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.9 m -76.95 55.47 1.11 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.123 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.674 ' HG2' ' HB3' ' A' ' 16' ' ' ARG . 21.9 pttp -148.66 129.74 14.48 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.715 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 80.0 m -125.77 128.69 48.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.29 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -171.92 -150.15 7.04 Favored Glycine 0 CA--C 1.519 0.331 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.864 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.477 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 68.6 mtm -94.17 132.46 38.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.914 0.388 . . . . 0.0 111.417 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.412 ' SG ' ' O ' ' A' ' 8' ' ' ILE . 7.3 p . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.635 179.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.499 HD12 HG23 ' A' ' 8' ' ' ILE . 18.7 pt . . . . . 0 C--O 1.231 0.113 0 CA-C-O 121.023 0.44 . . . . 0.0 110.61 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 8.8 t 57.36 52.83 8.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.312 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.499 HG23 HD12 ' A' ' 6' ' ' ILE . 26.6 pt -57.3 149.93 4.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.545 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -52.69 129.53 29.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.329 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -165.36 133.32 3.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.281 -179.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.617 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 42.8 t -84.73 130.76 34.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.559 -179.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.511 ' HA3' ' O ' ' A' ' 16' ' ' ARG . . . -72.02 103.18 1.25 Allowed Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 178.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.688 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 16.8 p -71.38 -50.97 26.74 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 114.282 1.215 . . . . 0.0 114.282 -177.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.688 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 3.2 m -121.22 -62.56 1.42 Allowed 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 114.245 -1.343 . . . . 0.0 113.802 -171.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.552 ' HB3' ' CZ ' ' A' ' 16' ' ' ARG . 39.2 m170 -52.75 -75.78 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.552 ' CZ ' ' HB3' ' A' ' 15' ' ' HIS . 0.0 OUTLIER -91.13 106.83 18.79 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 176.737 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 46.1 t -74.25 52.91 0.49 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.713 0.292 . . . . 0.0 111.409 -179.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.509 ' HD2' ' N ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -150.69 134.53 16.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.799 179.793 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.617 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 86.5 m -75.02 132.45 41.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.648 178.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -174.54 -136.5 2.26 Favored Glycine 0 C--O 1.225 -0.417 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.933 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 84.0 mtp -114.4 120.24 39.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.662 0.231 . . . . 0.0 110.452 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 73.0 m . . . . . 0 C--N 1.33 -0.244 0 CA-C-O 120.839 0.352 . . . . 0.0 110.504 179.776 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 13.6 pt . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.654 0.264 . . . . 0.0 111.486 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 85.0 m 63.56 47.25 3.86 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.522 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.4 pt -82.24 146.25 7.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.722 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -67.47 136.97 55.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.235 179.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -168.81 148.62 4.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.853 0.358 . . . . 0.0 110.951 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 46.7 t -121.93 125.82 47.24 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.374 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.623 ' HA3' ' HG2' ' A' ' 16' ' ' ARG . . . -69.01 116.05 6.96 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.435 -0.888 . . . . 0.0 111.448 178.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.698 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -67.44 -73.93 0.13 Allowed 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 122.535 1.16 . . . . 0.0 113.379 -179.068 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.698 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -103.31 -44.2 5.23 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 112.392 -2.185 . . . . 0.0 112.339 -173.782 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.4 ' HB3' ' HD2' ' A' ' 16' ' ' ARG . 17.8 t-160 -59.98 -89.5 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.914 ' H ' ' HD2' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -91.56 101.84 14.49 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 177.532 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.7 p -68.8 66.42 0.13 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.971 0.415 . . . . 0.0 110.777 -179.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.437 ' HE3' ' HB2' ' A' ' 16' ' ' ARG . 22.2 pttp -148.34 139.74 23.48 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.943 -0.572 . . . . 0.0 112.3 -179.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 87.4 m -105.83 126.56 52.31 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.794 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 169.8 -145.34 9.18 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.459 -0.877 . . . . 0.0 113.066 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 63.8 mtm -84.11 138.49 33.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.816 0.341 . . . . 0.0 111.024 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 63.6 m . . . . . 0 C--N 1.332 -0.186 0 CA-C-O 120.997 0.427 . . . . 0.0 110.881 -179.953 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.2 pt . . . . . 0 C--O 1.232 0.148 0 CA-C-O 121.228 0.537 . . . . 0.0 110.087 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.513 ' SG ' ' HB3' ' A' ' 21' ' ' MET . 19.1 t 60.43 55.41 3.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.089 178.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 27.0 pt -58.88 147.04 8.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.692 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -59.8 110.59 1.2 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.329 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 14.9 m -114.46 158.69 21.25 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.632 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.745 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 57.8 m -125.94 128.8 48.09 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.779 0.323 . . . . 0.0 111.301 179.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.609 ' H ' ' HA ' ' A' ' 19' ' ' CYS . . . -71.3 84.41 0.42 Allowed Glycine 0 C--N 1.332 0.319 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 178.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.73 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 0.1 OUTLIER -60.51 -80.15 0.03 OUTLIER 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -178.171 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.73 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -98.45 -47.32 5.44 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 112.658 -2.064 . . . . 0.0 113.377 -172.85 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -57.01 -93.63 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 178.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.882 ' H ' ' HD2' ' A' ' 16' ' ' ARG . 0.2 OUTLIER -91.0 124.28 35.12 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 177.04 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 42.9 t -73.38 57.71 0.53 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.805 0.336 . . . . 0.0 111.305 -178.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -150.48 125.98 10.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.554 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.745 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 47.7 t -82.06 136.2 35.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.776 0.322 . . . . 0.0 110.725 179.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -163.68 151.96 21.68 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.716 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.513 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 3.5 mpp? -62.22 113.77 3.07 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 122.548 -0.384 . . . . 0.0 110.514 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 7.3 p . . . . . 0 C--N 1.33 -0.26 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.512 -179.835 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.529 HG13 HG23 ' A' ' 8' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.136 0 CA-C-O 120.872 0.368 . . . . 0.0 110.605 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 99.0 m 60.14 49.93 6.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.081 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.529 HG23 HG13 ' A' ' 6' ' ' ILE . 27.4 pt -53.61 132.09 16.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.881 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -72.48 135.35 45.68 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.414 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 30.0 p -150.72 116.62 5.55 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.141 0.496 . . . . 0.0 110.758 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.765 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 42.6 t -82.08 129.1 34.71 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.039 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.446 ' HA3' ' O ' ' A' ' 16' ' ' ARG . . . -62.29 101.37 0.37 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.468 -0.872 . . . . 0.0 111.27 179.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.721 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 0.1 OUTLIER -64.61 -79.87 0.04 OUTLIER 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 -178.484 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.721 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -100.45 -51.24 3.67 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-N 112.72 -2.037 . . . . 0.0 113.295 -172.907 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 17.7 m80 -55.69 -84.34 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.605 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 0.9 OUTLIER -91.27 114.05 26.48 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 176.748 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.4 p -75.44 54.98 0.77 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.893 0.378 . . . . 0.0 110.519 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.605 ' HG2' ' HB3' ' A' ' 16' ' ' ARG . 7.4 ptpp? -149.48 132.5 16.22 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.068 -179.053 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.765 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 75.3 m -72.82 140.09 47.42 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.706 178.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -168.33 140.93 6.47 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.107 -1.044 . . . . 0.0 113.525 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -70.69 133.91 47.04 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 122.702 -0.293 . . . . 0.0 110.408 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 2.8 p . . . . . 0 C--N 1.329 -0.295 0 CA-C-O 120.847 0.356 . . . . 0.0 111.242 179.96 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.87 HG13 HG23 ' A' ' 8' ' ' ILE . 1.6 pt . . . . . 0 CA--C 1.521 -0.154 0 CA-C-O 120.98 0.419 . . . . 0.0 110.91 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 35.8 m 54.21 27.54 7.96 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.627 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.87 HG23 HG13 ' A' ' 6' ' ' ILE . 28.0 pt -47.47 139.27 2.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.179 179.148 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -65.96 134.77 53.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.867 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -158.59 135.22 9.51 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.953 0.406 . . . . 0.0 110.753 179.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.592 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 65.8 m -80.54 132.02 35.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.112 -0.494 . . . . 0.0 112.084 -179.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' A' ' 16' ' ' ARG . . . -76.78 74.48 1.79 Allowed Glycine 0 N--CA 1.451 -0.304 0 N-CA-C 110.996 -0.841 . . . . 0.0 110.996 178.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.674 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 23.2 p -66.01 -50.31 64.68 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -178.035 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.674 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 3.5 m -115.59 -43.99 2.99 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 113.481 -1.69 . . . . 0.0 112.854 -171.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.5 ' HB2' HH11 ' A' ' 16' ' ' ARG . 42.5 m170 -65.84 -112.2 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 177.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.554 ' HD2' ' O ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -76.17 129.92 37.47 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 176.541 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 41.1 t -71.53 57.65 0.27 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.731 0.3 . . . . 0.0 111.4 -178.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.599 ' HB2' ' NZ ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -151.43 133.45 15.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.88 -179.724 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.592 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 35.0 t -95.87 131.28 42.36 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 178.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -179.56 -159.81 24.16 Favored Glycine 0 C--N 1.329 0.169 0 C-N-CA 120.533 -0.842 . . . . 0.0 112.588 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 84.9 mtp -69.19 131.35 44.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.604 0.24 . . . . 0.0 110.363 179.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.523 ' O ' ' HA ' ' A' ' 7' ' ' CYS . 25.7 m . . . . . 0 C--N 1.328 -0.355 0 CA-C-O 120.776 0.322 . . . . 0.0 110.96 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.459 HD11 HD13 ' A' ' 8' ' ' ILE . 3.7 pt . . . . . 0 N--CA 1.456 -0.173 0 CA-C-O 121.171 0.51 . . . . 0.0 109.964 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.3 t 67.84 41.52 2.14 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.946 179.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.459 HD13 HD11 ' A' ' 6' ' ' ILE . 25.0 pt -82.22 140.35 16.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.978 0.418 . . . . 0.0 111.482 179.278 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PHE . . . . . 0.738 ' HA ' ' HA ' ' A' ' 21' ' ' MET . 25.7 t80 -60.92 144.2 53.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.307 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.424 ' O ' ' O ' ' A' ' 20' ' ' GLY . 30.3 p -157.74 115.5 3.05 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.892 0.377 . . . . 0.0 111.532 -179.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.752 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 78.0 m -83.86 123.27 29.74 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 121.014 -0.274 . . . . 0.0 111.105 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.75 ' HA3' ' O ' ' A' ' 16' ' ' ARG . . . -65.88 113.68 5.96 Favored Glycine 0 N--CA 1.45 -0.367 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 178.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . 0.66 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 18.6 p -64.84 -48.33 74.73 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 115.713 1.745 . . . . 0.0 115.713 -177.03 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.66 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 4.1 m -118.83 -110.15 0.35 Allowed 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -170.03 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -47.17 -44.8 22.31 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.045 0.45 . . . . 0.0 109.93 -178.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.75 ' O ' ' HA3' ' A' ' 12' ' ' GLY . 42.8 ttt85 -90.84 46.86 1.36 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.458 178.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.638 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 79.2 p -59.55 65.84 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.243 0.617 . . . . 0.0 111.711 -178.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 16' ' ' ARG . 21.7 ptmt -151.68 129.83 11.91 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.689 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.752 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 50.1 m -73.8 133.97 43.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.797 0.332 . . . . 0.0 110.778 178.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 10' ' ' CYS . . . 178.43 141.58 4.37 Favored Glycine 0 C--O 1.226 -0.364 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.218 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.738 ' HA ' ' HA ' ' A' ' 9' ' ' PHE . 3.5 mpp? -62.39 135.46 57.45 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.93 0.365 . . . . 0.0 110.988 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 34.6 m . . . . . 0 N--CA 1.467 0.375 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.662 -179.937 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.437 ' N ' ' HB3' ' A' ' 24' ' ' LYS . 12.2 p-10 . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.775 0.321 . . . . 0.0 111.191 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.542 HG22 ' H ' ' A' ' 4' ' ' PHE . 71.5 m -64.07 139.24 58.75 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.768 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 79.3 t60 -63.18 -38.77 92.49 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.155 -179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.542 ' H ' HG22 ' A' ' 2' ' ' THR . 16.9 t80 -146.25 63.62 9.07 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.245 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.503 ' HD3' ' O ' ' A' ' 2' ' ' THR . 59.8 Cg_endo -73.15 -146.81 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.364 0 C-N-CA 122.336 2.024 . . . . 0.0 111.872 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.414 ' H ' ' HB2' ' A' ' 5' ' ' PRO . 26.0 pt -83.46 -37.9 13.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.808 0.337 . . . . 0.0 110.853 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.626 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 90.4 m 56.4 40.83 29.57 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.466 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.408 HG23 HD12 ' A' ' 6' ' ' ILE . 33.8 pt -62.18 127.23 21.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.353 179.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -55.27 138.36 45.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.89 -179.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 28.6 p -158.75 109.56 2.08 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.904 -179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.815 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 39.0 m -75.2 124.88 27.83 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.828 0.347 . . . . 0.0 111.476 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' A' ' 16' ' ' ARG . . . -63.77 93.89 0.13 Allowed Glycine 0 C--O 1.237 0.343 0 N-CA-C 111.066 -0.813 . . . . 0.0 111.066 179.034 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.667 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 17.8 p -70.55 -49.61 46.26 Favored 'General case' 0 CA--C 1.505 -0.775 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -177.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.667 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 3.4 m -120.31 -55.49 2.04 Favored 'General case' 0 N--CA 1.43 -1.427 0 CA-C-N 114.282 -1.326 . . . . 0.0 113.938 -171.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -56.13 -84.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 178.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.691 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 1.3 mpt_? -91.48 119.9 31.84 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 176.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 59.2 m -75.16 52.81 0.6 Allowed 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.691 ' HG2' ' HB3' ' A' ' 16' ' ' ARG . 20.6 pttp -150.49 139.4 20.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.992 -178.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.815 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 84.2 m -71.36 141.76 50.39 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.506 178.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -167.95 150.11 15.82 Favored Glycine 0 C--O 1.228 -0.259 0 C-N-CA 120.605 -0.807 . . . . 0.0 112.728 -179.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.448 ' HE2' ' O ' ' A' ' 7' ' ' CYS . 75.9 mtp -73.69 128.25 35.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.816 0.341 . . . . 0.0 111.275 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 9.0 m -80.14 56.26 2.39 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.721 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.626 ' HA ' ' HA ' ' A' ' 7' ' ' CYS . 89.0 m -56.75 -54.78 42.35 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 121.015 -0.274 . . . . 0.0 110.911 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.437 ' HB3' ' N ' ' A' ' 1' ' ' ASP . 23.9 pttm -71.4 -147.95 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.94 179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 95.1 m . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.184 -0.912 . . . . 0.0 110.777 -179.991 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 53.4 m-20 . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.832 0.349 . . . . 0.0 111.154 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.584 ' O ' ' HD3' ' A' ' 5' ' ' PRO . 90.8 m -76.31 140.92 41.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.066 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 45.8 m170 -66.9 -39.4 87.41 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.148 0.499 . . . . 0.0 110.474 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.556 ' H ' HG22 ' A' ' 2' ' ' THR . 27.8 m-85 -136.86 64.06 48.04 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.935 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.584 ' HD3' ' O ' ' A' ' 2' ' ' THR . 28.1 Cg_endo -63.29 169.64 9.14 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.664 2.242 . . . . 0.0 113.064 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.436 ' H ' HG12 ' A' ' 6' ' ' ILE . 11.4 pt -79.94 -32.29 13.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.52 179.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.688 ' SG ' ' HB3' ' A' ' 21' ' ' MET . 49.3 t 61.34 50.61 4.65 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.514 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.434 HG23 HD12 ' A' ' 6' ' ' ILE . 23.5 pt -56.47 139.78 15.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.953 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 27.0 t80 -58.75 138.35 57.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.592 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 24.4 p -146.85 121.94 10.11 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.929 0.395 . . . . 0.0 110.979 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 45.9 t -136.01 126.41 26.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.297 -179.787 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.53 ' HA3' ' O ' ' A' ' 16' ' ' ARG . . . -70.95 128.6 17.11 Favored Glycine 0 C--O 1.239 0.413 0 C-N-CA 120.618 -0.801 . . . . 0.0 111.49 179.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.674 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 0.8 OUTLIER -54.82 -83.45 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.536 0 N-CA-C 114.803 1.408 . . . . 0.0 114.803 -178.344 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.674 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -107.12 -64.44 1.19 Allowed 'General case' 0 N--CA 1.434 -1.26 0 CA-C-N 113.044 -1.889 . . . . 0.0 113.459 -172.94 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.515 ' ND1' ' N ' ' A' ' 16' ' ' ARG . 12.0 p80 -59.01 -53.71 55.28 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 120.12 -0.632 . . . . 0.0 109.363 179.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.573 ' O ' ' N ' ' A' ' 18' ' ' LYS . 7.6 mpt_? -93.24 51.73 1.68 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.942 178.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 68.6 m -59.26 68.04 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.392 0 CA-C-O 121.308 0.575 . . . . 0.0 111.045 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.573 ' N ' ' O ' ' A' ' 16' ' ' ARG . 55.9 mtpt -146.99 129.71 16.09 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.107 -179.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 96.9 m -102.49 137.31 40.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.889 179.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -174.56 147.51 9.19 Favored Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.764 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.688 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 60.9 mtm -73.78 129.57 38.18 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.624 0.25 . . . . 0.0 110.866 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 5.1 m -80.78 56.95 2.84 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.76 179.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 68.2 m -72.05 77.77 0.93 Allowed 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.892 0.377 . . . . 0.0 110.912 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -74.31 48.94 0.35 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.496 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 80.5 p . . . . . 0 C--O 1.249 1.076 0 CA-C-O 118.243 -0.884 . . . . 0.0 111.281 179.874 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 60.8 t0 . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 121.026 0.441 . . . . 0.0 110.832 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.602 ' OG1' ' HB3' ' A' ' 5' ' ' PRO . 66.0 p -74.78 151.42 39.12 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.166 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 89.0 m-70 -61.85 -41.58 98.0 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.822 0.675 . . . . 0.0 112.822 -178.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.8 t80 -138.83 67.82 42.63 Favored Pre-proline 0 CA--C 1.531 0.217 0 CA-C-O 120.873 0.368 . . . . 0.0 111.904 -178.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.602 ' HB3' ' OG1' ' A' ' 2' ' ' THR . 61.1 Cg_endo -76.83 -143.22 0.02 OUTLIER 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.543 2.162 . . . . 0.0 112.32 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.58 HD12 HG23 ' A' ' 8' ' ' ILE . 23.7 pt -90.38 -39.47 12.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.738 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 79.4 m 55.28 44.16 27.94 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.13 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.58 HG23 HD12 ' A' ' 6' ' ' ILE . 37.5 pt -54.84 130.18 16.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.929 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -69.11 85.33 0.36 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.608 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.753 ' HB3' HH22 ' A' ' 16' ' ' ARG . 83.0 m -72.49 68.36 0.79 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.749 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.686 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 22.2 t -99.86 73.56 1.78 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.063 0.458 . . . . 0.0 111.731 -178.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.757 ' HA3' ' HG3' ' A' ' 16' ' ' ARG . . . -60.34 122.25 29.27 Favored Glycine 0 C--O 1.235 0.173 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.541 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.695 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 14.9 p -69.85 -52.41 25.15 Favored 'General case' 0 CA--C 1.508 -0.666 0 N-CA-C 114.796 1.406 . . . . 0.0 114.796 -177.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.695 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 3.1 m -121.56 -81.67 0.64 Allowed 'General case' 0 N--CA 1.433 -1.311 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 -171.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 22.9 t-80 -49.52 -63.63 1.05 Allowed 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 -179.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.757 ' HG3' ' HA3' ' A' ' 12' ' ' GLY . 6.8 ptm180 -90.96 56.55 3.24 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.499 -0.773 . . . . 0.0 109.27 177.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.457 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 78.6 p -59.47 65.04 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 123.814 0.845 . . . . 0.0 112.652 -178.247 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.708 ' NZ ' ' HB2' ' A' ' 16' ' ' ARG . 0.4 OUTLIER -149.59 140.27 22.62 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.038 178.302 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.686 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 61.2 m -125.47 131.6 52.83 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.13 0.49 . . . . 0.0 111.871 -178.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -179.71 142.49 5.2 Favored Glycine 0 N--CA 1.452 -0.294 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.275 -179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 67.5 mtm -65.53 125.9 26.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.943 0.402 . . . . 0.0 111.451 -179.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.568 ' HB3' ' OG1' ' A' ' 25' ' ' THR . 94.1 m -95.92 61.04 2.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.787 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 96.1 m -60.24 -60.24 4.14 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.169 0.433 . . . . 0.0 112.169 -178.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.465 ' HG3' ' N ' ' A' ' 25' ' ' THR . 19.0 ptpt -60.58 -52.24 66.01 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -178.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.568 ' OG1' ' HB3' ' A' ' 22' ' ' CYS . 69.5 p . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.292 -0.861 . . . . 0.0 111.141 -179.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.9 ' HA ' ' HA ' ' A' ' 24' ' ' LYS . 33.3 t70 . . . . . 0 N--CA 1.486 1.353 0 CA-C-O 120.714 0.292 . . . . 0.0 111.127 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 74.6 p -67.77 -144.78 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.102 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 79.3 t60 -106.4 -48.55 3.53 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-O 120.622 0.249 . . . . 0.0 111.465 -179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -146.27 65.33 10.47 Favored Pre-proline 0 C--N 1.33 -0.25 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.046 -179.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -77.45 -137.29 0.02 OUTLIER 'Trans proline' 0 C--N 1.343 0.286 0 C-N-CA 122.579 2.186 . . . . 0.0 112.35 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 12.6 pt -127.66 -34.81 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.535 179.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.645 ' SG ' ' HB3' ' A' ' 21' ' ' MET . 15.6 t 63.75 57.08 1.43 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.917 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.41 HG13 ' SG ' ' A' ' 10' ' ' CYS . 37.1 pt -54.26 131.97 17.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.092 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 9.7 t80 -72.11 89.82 1.17 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.968 0.413 . . . . 0.0 109.9 179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.41 ' SG ' HG13 ' A' ' 8' ' ' ILE . 75.6 m -75.62 65.01 1.75 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.769 -0.65 . . . . 0.0 111.895 -179.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.781 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 34.3 t -102.65 74.21 1.34 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.116 0.484 . . . . 0.0 111.656 -179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.672 ' HA3' ' HG2' ' A' ' 16' ' ' ARG . . . -67.23 114.83 6.62 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.753 -0.736 . . . . 0.0 111.54 179.193 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.702 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -70.33 -74.31 0.14 Allowed 'General case' 0 CA--C 1.507 -0.704 0 CA-C-O 122.53 1.157 . . . . 0.0 113.557 -179.041 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.702 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -103.94 -44.36 5.05 Favored 'General case' 0 N--CA 1.431 -1.413 0 CA-C-N 112.489 -2.141 . . . . 0.0 112.434 -173.686 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 22.6 t-80 -58.12 -86.96 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 108.415 -0.957 . . . . 0.0 108.415 178.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.757 ' HB3' HH11 ' A' ' 16' ' ' ARG . 0.0 OUTLIER -91.3 114.87 27.51 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 176.961 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 64.0 m -74.99 63.32 1.21 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.931 0.396 . . . . 0.0 110.893 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.438 ' HE2' ' HB2' ' A' ' 16' ' ' ARG . 60.2 pttt -148.45 128.48 13.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.585 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.781 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 77.2 m -125.87 129.92 50.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.942 0.401 . . . . 0.0 110.99 179.178 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 176.68 146.24 5.99 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.816 -0.706 . . . . 0.0 112.464 -179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.645 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 80.4 mtp -68.25 119.66 13.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.777 0.322 . . . . 0.0 110.989 -179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.576 ' HB3' ' OG1' ' A' ' 25' ' ' THR . 56.6 m -89.99 53.93 2.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.036 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 7' ' ' CYS . 57.8 m -58.81 -41.87 87.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.111 -179.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.9 ' HA ' ' HA ' ' A' ' 1' ' ' ASP . 9.4 ptpp? -58.45 -47.18 84.86 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 111.589 0.218 . . . . 0.0 111.589 -179.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.576 ' OG1' ' HB3' ' A' ' 22' ' ' CYS . 77.6 p . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.171 -0.918 . . . . 0.0 111.147 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.68 ' H3 ' ' HD3' ' A' ' 24' ' ' LYS . 32.7 t70 . . . . . 0 N--CA 1.485 1.319 0 N-CA-C 110.594 -0.15 . . . . 0.0 110.594 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.593 HG22 ' H ' ' A' ' 3' ' ' HIS . 2.8 m -77.7 -138.19 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.593 ' H ' HG22 ' A' ' 2' ' ' THR . 88.8 m-70 -125.86 25.05 6.93 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.766 0.317 . . . . 0.0 110.762 179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 48.5 m-85 -145.28 57.29 4.18 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.69 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.42 ' HB2' ' H ' ' A' ' 6' ' ' ILE . 52.7 Cg_endo -68.79 -144.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.55 0 C-N-CA 122.348 2.032 . . . . 0.0 112.689 -179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.42 ' H ' ' HB2' ' A' ' 5' ' ' PRO . 14.0 pt -135.89 -33.39 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.193 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.751 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 78.0 m 62.98 47.16 4.41 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.861 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 35.3 pt -82.36 140.32 16.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.635 178.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.858 ' HA ' ' HA ' ' A' ' 21' ' ' MET . 28.1 t80 -53.01 135.94 36.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.385 -0.371 . . . . 0.0 111.108 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -155.63 138.97 15.74 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.254 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 47.4 t -129.88 122.33 28.43 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.749 0.309 . . . . 0.0 111.477 -179.285 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.838 ' HA3' ' HG2' ' A' ' 16' ' ' ARG . . . -69.25 122.67 13.05 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.498 -0.858 . . . . 0.0 111.032 178.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.69 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 17.2 p -70.59 -51.68 26.7 Favored 'General case' 0 CA--C 1.504 -0.802 0 N-CA-C 113.224 0.824 . . . . 0.0 113.224 -178.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.69 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 2.8 m -121.74 -57.05 1.83 Allowed 'General case' 0 N--CA 1.429 -1.52 0 CA-C-N 113.808 -1.542 . . . . 0.0 113.141 -172.376 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.404 ' HB3' ' HD2' ' A' ' 16' ' ' ARG . 21.5 t-80 -58.61 -79.83 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.838 ' HG2' ' HA3' ' A' ' 12' ' ' GLY . 0.1 OUTLIER -91.03 73.73 6.38 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.932 -0.576 . . . . 0.0 109.668 178.05 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.558 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 44.4 t -59.91 68.51 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 121.352 0.596 . . . . 0.0 110.592 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.666 ' HB3' ' NZ ' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -150.01 137.08 19.53 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.208 -0.905 . . . . 0.0 111.852 -178.609 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 85.2 m -102.36 131.35 49.04 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.735 0.302 . . . . 0.0 110.934 179.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 171.33 150.52 7.13 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.451 -179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.858 ' HA ' ' HA ' ' A' ' 9' ' ' PHE . 86.7 mtp -51.11 140.39 16.23 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.718 0.294 . . . . 0.0 110.797 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 15.0 m -131.51 129.61 41.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.201 -179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.751 ' HA ' ' HA ' ' A' ' 7' ' ' CYS . 59.9 m -88.8 -124.24 0.05 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.818 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.68 ' HD3' ' H3 ' ' A' ' 1' ' ' ASP . 4.1 ptpt -51.82 -44.47 63.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.659 0.266 . . . . 0.0 111.322 -179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 94.2 m . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.235 -0.888 . . . . 0.0 110.834 179.891 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.583 ' O ' ' HG3' ' A' ' 5' ' ' PRO . 53.9 m-20 . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 120.71 0.29 . . . . 0.0 111.154 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.416 ' OG1' ' HG2' ' A' ' 24' ' ' LYS . 15.6 m -74.91 62.04 1.08 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.444 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -125.69 -54.56 1.54 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.268 179.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.664 ' N ' ' HD3' ' A' ' 5' ' ' PRO . 22.2 t80 -147.5 51.5 1.11 Allowed Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.766 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.664 ' HD3' ' N ' ' A' ' 4' ' ' PHE . 3.5 Cg_exo -75.3 -145.75 0.03 OUTLIER 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.554 2.169 . . . . 0.0 112.627 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.443 ' HB ' HG23 ' A' ' 8' ' ' ILE . 21.7 pt -96.86 -41.03 11.07 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.92 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.432 ' HA ' ' CB ' ' A' ' 23' ' ' CYS . 48.1 m 62.16 42.73 9.32 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.336 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.492 HG13 ' SG ' ' A' ' 22' ' ' CYS . 26.5 pt -80.27 147.79 6.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.045 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.589 ' HA ' ' HG2' ' A' ' 21' ' ' MET . 15.3 t80 -52.67 134.42 35.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.333 -179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.673 ' HB2' ' H ' ' A' ' 22' ' ' CYS . 49.8 m -163.57 120.82 1.81 Allowed 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.746 -179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.552 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 40.0 t -91.16 131.01 36.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.81 0.338 . . . . 0.0 111.184 179.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.463 ' HA3' ' O ' ' A' ' 16' ' ' ARG . . . -66.97 96.78 0.32 Allowed Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 110.967 -0.853 . . . . 0.0 110.967 178.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.68 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 17.3 p -72.08 -50.05 31.37 Favored 'General case' 0 CA--C 1.505 -0.767 0 N-CA-C 114.102 1.149 . . . . 0.0 114.102 -177.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.68 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 3.3 m -121.12 -58.05 1.82 Allowed 'General case' 0 N--CA 1.429 -1.488 0 CA-C-N 114.277 -1.328 . . . . 0.0 114.157 -171.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.585 ' ND1' ' HD3' ' A' ' 16' ' ' ARG . 17.1 t-80 -56.36 -77.9 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 179.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.585 ' HD3' ' ND1' ' A' ' 15' ' ' HIS . 1.4 mpp_? -91.55 118.86 30.98 Favored 'General case' 0 C--O 1.221 -0.408 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 176.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.7 m -78.15 56.75 1.7 Allowed 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 179.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -147.12 128.37 14.77 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.829 -178.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.552 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 63.7 m -75.42 135.67 40.74 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.702 0.287 . . . . 0.0 110.833 178.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.458 ' H ' ' HA ' ' A' ' 11' ' ' CYS . . . -166.86 -145.67 4.56 Favored Glycine 0 C--O 1.225 -0.456 0 C-N-CA 120.948 -0.644 . . . . 0.0 111.882 179.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.589 ' HG2' ' HA ' ' A' ' 9' ' ' PHE . 64.0 mtm -127.6 119.29 25.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.982 0.391 . . . . 0.0 111.238 179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.673 ' H ' ' HB2' ' A' ' 10' ' ' CYS . 29.7 p -74.45 126.34 30.52 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.116 179.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.432 ' CB ' ' HA ' ' A' ' 7' ' ' CYS . 7.6 t -126.16 -49.31 1.57 Allowed 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.85 -0.34 . . . . 0.0 111.144 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.416 ' HG2' ' OG1' ' A' ' 2' ' ' THR . 52.9 mttt -59.15 134.73 57.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.56 -179.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 75.4 p . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.242 -0.885 . . . . 0.0 111.111 -179.97 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 51.6 p-10 . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.861 0.363 . . . . 0.0 111.211 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.675 HG22 ' HD2' ' A' ' 24' ' ' LYS . 72.4 p -77.64 54.45 1.21 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.437 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 77.2 t60 -81.32 59.14 3.86 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.102 179.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.548 ' HA ' ' HB3' ' A' ' 23' ' ' CYS . 0.1 OUTLIER -46.99 101.01 0.25 Allowed Pre-proline 0 CA--C 1.531 0.241 0 CA-C-O 121.198 0.523 . . . . 0.0 112.386 -179.019 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.461 ' HB2' ' H ' ' A' ' 6' ' ' ILE . 68.1 Cg_endo -98.64 -131.23 0.01 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.954 0 C-N-CA 123.784 2.989 . . . . 0.0 111.691 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.557 HG13 HG23 ' A' ' 8' ' ' ILE . 2.8 pt -65.76 -19.54 25.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.562 178.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 64.0 m 64.58 48.74 2.53 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.94 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.557 HG23 HG13 ' A' ' 6' ' ' ILE . 29.4 pt -57.9 137.15 20.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.042 179.283 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.476 ' HA ' ' HA ' ' A' ' 21' ' ' MET . 23.0 t80 -63.06 135.24 57.13 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.539 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -148.79 141.52 24.56 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.933 0.397 . . . . 0.0 110.17 179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 47.8 t -134.47 124.57 25.82 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.663 -178.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.554 ' O ' ' HA ' ' A' ' 17' ' ' SER . . . -75.99 119.27 5.62 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.417 -0.897 . . . . 0.0 111.053 178.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.682 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 20.0 p -72.72 -49.75 29.15 Favored 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 122.096 0.951 . . . . 0.0 112.459 -178.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.682 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 2.9 m -121.32 -48.12 2.22 Favored 'General case' 0 N--CA 1.425 -1.683 0 CA-C-N 113.236 -1.802 . . . . 0.0 112.247 -172.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 36.9 m170 -61.0 -87.12 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 178.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.827 ' H ' ' HD3' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -91.5 86.0 5.92 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 177.257 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.554 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 57.2 m -62.68 61.3 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -177.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.827 ' HD3' ' HB2' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -150.63 140.22 21.59 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.743 178.471 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 90.1 m -100.1 132.85 45.22 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.889 179.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 176.7 154.77 12.23 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.986 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.476 ' HA ' ' HA ' ' A' ' 9' ' ' PHE . 86.8 mtp -56.11 136.34 52.54 Favored 'General case' 0 C--N 1.333 -0.145 0 N-CA-C 110.187 -0.301 . . . . 0.0 110.187 179.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 21.8 m -122.28 132.91 54.65 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.153 -178.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.548 ' HB3' ' HA ' ' A' ' 4' ' ' PHE . 24.3 m -119.93 -60.42 1.71 Allowed 'General case' 0 N--CA 1.462 0.161 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.644 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.675 ' HD2' HG22 ' A' ' 2' ' ' THR . 28.1 mtmt -58.03 -50.06 74.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.016 -178.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 91.5 m . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.274 -0.869 . . . . 0.0 111.067 -179.889 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.443 ' HB2' ' HA ' ' A' ' 24' ' ' LYS . 57.7 m-20 . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.516 0.198 . . . . 0.0 111.101 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 76.5 p -110.25 -153.13 0.51 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.66 0.267 . . . . 0.0 111.134 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 35.5 m170 -82.89 -42.11 18.14 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.171 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -130.63 57.24 29.98 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.982 -179.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.526 ' HB2' ' H ' ' A' ' 6' ' ' ILE . 61.2 Cg_endo -71.24 -138.24 0.01 OUTLIER 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 122.344 2.029 . . . . 0.0 112.208 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.526 ' H ' ' HB2' ' A' ' 5' ' ' PRO . 41.0 mm -79.59 -37.71 18.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.431 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.814 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 1.7 m 64.46 47.86 2.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.118 -179.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 35.2 pt -61.12 133.2 26.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.632 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 24.1 t80 -80.8 134.98 35.88 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.753 -0.658 . . . . 0.0 109.899 179.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.9 p -145.18 140.78 28.17 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 121.267 0.556 . . . . 0.0 111.267 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 52.3 t -124.21 122.52 38.0 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.757 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.552 ' HA3' ' O ' ' A' ' 16' ' ' ARG . . . -60.42 112.55 4.64 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.319 -0.944 . . . . 0.0 111.485 179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.728 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -67.67 -75.23 0.1 Allowed 'General case' 0 CA--C 1.505 -0.756 0 CA-C-O 122.539 1.162 . . . . 0.0 113.711 -178.907 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.728 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -100.44 -45.31 5.6 Favored 'General case' 0 N--CA 1.427 -1.581 0 CA-C-N 112.338 -2.21 . . . . 0.0 112.427 -173.602 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.445 ' HB2' ' HD3' ' A' ' 16' ' ' ARG . 90.5 m-70 -60.28 -91.61 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 178.438 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.894 ' H ' ' HD3' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -91.38 103.84 16.43 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.523 -0.547 . . . . 0.0 109.523 177.722 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.9 p -69.41 67.43 0.2 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.002 0.429 . . . . 0.0 110.692 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.407 ' HE3' ' HG3' ' A' ' 16' ' ' ARG . 22.2 pttp -147.68 138.38 23.28 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.459 -179.168 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 79.0 m -100.95 138.36 38.1 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.827 178.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -177.99 157.2 21.23 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 120.253 -0.975 . . . . 0.0 113.258 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.4 mpp? -59.4 144.36 47.04 Favored 'General case' 0 C--N 1.332 -0.159 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 6.9 m -136.19 69.0 1.43 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.581 -178.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.814 ' HA ' ' HA ' ' A' ' 7' ' ' CYS . 84.2 m -64.3 -116.88 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.127 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.815 ' HZ3' ' H ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -52.68 142.25 18.92 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 120.942 0.401 . . . . 0.0 111.213 -179.498 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 69.8 p . . . . . 0 C--O 1.251 1.136 0 CA-C-O 118.262 -0.875 . . . . 0.0 111.139 -179.986 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.42 ' N ' ' HG3' ' A' ' 24' ' ' LYS . 7.6 t70 . . . . . 0 N--CA 1.484 1.237 0 CA-C-O 120.721 0.296 . . . . 0.0 111.013 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 85.6 m -137.06 -65.73 0.54 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.618 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.457 ' O ' ' HD2' ' A' ' 24' ' ' LYS . 77.9 t60 -78.53 65.12 3.74 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.886 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -51.95 124.42 28.52 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-O 121.032 0.444 . . . . 0.0 110.991 -179.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.652 ' HD3' ' HE3' ' A' ' 24' ' ' LYS . 65.3 Cg_endo -89.62 -145.98 0.03 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 122.912 2.408 . . . . 0.0 112.496 -179.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.408 ' H ' HG12 ' A' ' 6' ' ' ILE . 11.0 pt -74.37 -29.34 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 CA-C-O 121.259 0.552 . . . . 0.0 109.605 178.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.621 ' SG ' ' HB3' ' A' ' 21' ' ' MET . 23.2 t 58.03 51.56 8.71 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.382 179.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 31.6 pt -50.12 141.98 3.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.267 179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -62.47 147.49 48.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.804 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 17.4 p -149.23 131.13 15.19 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.21 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 47.5 t -135.71 107.47 7.03 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.89 0.376 . . . . 0.0 111.489 -179.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.47 ' HA3' ' O ' ' A' ' 16' ' ' ARG . . . -85.69 114.2 3.96 Favored Glycine 0 C--O 1.239 0.432 0 C-N-CA 120.847 -0.692 . . . . 0.0 111.534 178.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.665 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 0.9 OUTLIER -57.33 -82.58 0.01 OUTLIER 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 114.851 1.426 . . . . 0.0 114.851 -178.44 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.665 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -110.14 -63.88 1.33 Allowed 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 113.142 -1.845 . . . . 0.0 113.653 -172.743 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 52.1 t60 -51.2 -60.55 2.99 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.47 ' O ' ' HA3' ' A' ' 12' ' ' GLY . 0.0 OUTLIER -91.89 79.93 5.25 Favored 'General case' 0 C--O 1.218 -0.569 0 CA-C-N 115.28 -0.873 . . . . 0.0 109.33 176.575 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 65.1 m -67.96 57.95 0.07 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 120.701 0.286 . . . . 0.0 111.158 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.635 ' HB3' ' NZ ' ' A' ' 18' ' ' LYS . 0.2 OUTLIER -149.67 122.52 8.72 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.209 -179.555 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 92.1 m -126.7 130.71 50.91 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.142 0.496 . . . . 0.0 111.654 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 176.92 -154.84 16.94 Favored Glycine 0 N--CA 1.45 -0.413 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.96 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.621 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 80.0 mtp -96.98 126.16 41.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.743 0.306 . . . . 0.0 110.918 179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 49.1 m -93.64 75.14 4.36 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.638 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.425 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 78.8 m -72.47 -124.45 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.559 -0.291 . . . . 0.0 110.371 179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.841 ' HA ' ' HE2' ' A' ' 24' ' ' LYS . 7.9 mmpt? -68.35 136.38 53.3 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.774 0.321 . . . . 0.0 111.217 179.628 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 7.4 t . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.214 -0.898 . . . . 0.0 111.191 179.914 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 N--CA 1.488 1.459 0 CA-C-O 120.825 0.345 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.537 ' O ' ' HD3' ' A' ' 5' ' ' PRO . 4.3 t -72.1 139.91 48.63 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.086 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 79.9 t60 -71.17 -31.49 67.73 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.961 -179.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -120.25 58.81 6.11 Favored Pre-proline 0 CA--C 1.535 0.402 0 N-CA-C 112.832 0.678 . . . . 0.0 112.832 -178.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.537 ' HD3' ' O ' ' A' ' 2' ' ' THR . 65.1 Cg_endo -72.93 -146.88 0.03 OUTLIER 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.313 2.009 . . . . 0.0 112.394 179.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.477 ' H ' ' HB2' ' A' ' 5' ' ' PRO . 23.5 pt -92.75 -37.32 8.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.979 179.527 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.749 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 57.5 m 63.95 45.07 4.42 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.929 -0.578 . . . . 0.0 112.119 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.441 ' O ' ' HB2' ' A' ' 22' ' ' CYS . 31.4 pt -75.26 133.62 31.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.18 178.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -70.93 133.59 46.53 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.718 -179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 3.3 p -162.82 144.32 10.1 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.817 0.341 . . . . 0.0 110.464 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.817 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 11.5 t -91.65 124.2 35.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.039 0.447 . . . . 0.0 110.985 -179.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.593 ' C ' ' H ' ' A' ' 18' ' ' LYS . . . 162.78 154.55 7.66 Favored Glycine 0 C--O 1.22 -0.747 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.961 -179.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.618 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 4.8 t -141.1 -92.52 0.15 Allowed 'General case' 0 CA--C 1.51 -0.595 0 CA-C-O 123.236 1.493 . . . . 0.0 111.635 178.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.618 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.5 OUTLIER -122.13 -123.7 0.27 Allowed 'General case' 0 N--CA 1.425 -1.677 0 CA-C-N 111.185 -2.734 . . . . 0.0 108.503 -176.542 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.436 ' H ' ' HB2' ' A' ' 14' ' ' CYS . 46.8 m170 -61.17 -49.81 75.69 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 107.092 -1.448 . . . . 0.0 107.092 176.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.878 ' H ' ' HD2' ' A' ' 16' ' ' ARG . 0.4 OUTLIER -91.68 137.07 32.66 Favored 'General case' 0 N--CA 1.456 -0.165 0 CA-C-N 114.875 -1.057 . . . . 0.0 108.942 176.795 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.578 ' HB3' ' HA2' ' A' ' 12' ' ' GLY . 60.8 m -80.19 130.03 34.93 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.694 0.283 . . . . 0.0 111.319 -179.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.593 ' H ' ' C ' ' A' ' 12' ' ' GLY . 13.7 mmmm -119.8 118.57 31.18 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.935 0.398 . . . . 0.0 110.86 179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.817 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 85.4 m -62.57 127.75 32.77 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.417 -179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 174.4 -179.53 45.68 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.891 179.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 93.9 mmm -63.32 135.27 56.91 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.724 0.297 . . . . 0.0 110.35 179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 8' ' ' ILE . 20.6 m -116.61 53.83 0.87 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.167 -179.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.749 ' HA ' ' HA ' ' A' ' 7' ' ' CYS . 84.8 m -58.78 -74.22 0.07 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.555 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.587 ' O ' ' HD3' ' A' ' 24' ' ' LYS . 0.1 OUTLIER -68.59 152.06 45.89 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.88 0.372 . . . . 0.0 111.53 -179.668 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 85.1 m . . . . . 0 C--O 1.248 1.025 0 CA-C-O 118.271 -0.871 . . . . 0.0 110.829 -179.774 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . 0.427 ' H3 ' ' HB3' ' A' ' 24' ' ' LYS . 1.5 m-20 . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.785 0.326 . . . . 0.0 111.081 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 82.7 p -75.37 -135.33 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.173 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 -69.61 76.57 0.42 Allowed 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.49 -0.323 . . . . 0.0 110.607 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -44.76 128.83 5.17 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.709 -179.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.501 ' HB2' ' H ' ' A' ' 6' ' ' ILE . 94.4 Cg_endo -87.41 -137.7 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 123.093 2.529 . . . . 0.0 113.543 -178.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.683 HG13 HG23 ' A' ' 8' ' ' ILE . 0.5 OUTLIER -124.45 33.28 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.171 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.025 -179.886 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.758 ' HA ' ' HB2' ' A' ' 23' ' ' CYS . 62.5 m 59.98 27.31 16.69 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.474 -0.785 . . . . 0.0 112.134 179.726 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.683 HG23 HG13 ' A' ' 6' ' ' ILE . 16.3 pt -61.39 142.92 15.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.946 0.403 . . . . 0.0 110.828 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 21.8 t80 -68.1 124.52 23.65 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.787 178.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 35.9 m -125.18 113.72 18.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.929 0.395 . . . . 0.0 111.344 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.419 ' CB ' ' HA ' ' A' ' 19' ' ' CYS . 42.1 t -136.38 111.84 9.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.96 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.436 ' O ' ' HA ' ' A' ' 17' ' ' SER . . . -69.91 129.69 21.58 Favored Glycine 0 N--CA 1.448 -0.521 0 C-N-CA 120.35 -0.929 . . . . 0.0 111.125 178.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.686 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 17.2 p -68.68 -50.91 47.28 Favored 'General case' 0 CA--C 1.503 -0.843 0 N-CA-C 113.366 0.876 . . . . 0.0 113.366 -178.467 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.686 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 3.1 m -121.59 -61.29 1.53 Allowed 'General case' 0 N--CA 1.428 -1.531 0 CA-C-N 113.922 -1.49 . . . . 0.0 113.618 -172.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.472 ' HD2' ' NH1' ' A' ' 16' ' ' ARG . 66.4 t60 -62.6 -62.35 1.8 Allowed 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.541 ' O ' ' N ' ' A' ' 18' ' ' LYS . 9.1 mpt_? -91.39 62.08 4.55 Favored 'General case' 0 C--O 1.218 -0.586 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.087 177.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.436 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 65.9 m -61.79 59.78 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.627 0 O-C-N 123.424 0.453 . . . . 0.0 111.414 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.541 ' N ' ' O ' ' A' ' 16' ' ' ARG . 15.4 ptpt -149.71 135.69 18.77 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.626 -179.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.419 ' HA ' ' CB ' ' A' ' 11' ' ' CYS . 67.5 m -99.05 135.67 40.13 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.455 -0.339 . . . . 0.0 110.763 178.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 176.98 144.68 5.39 Favored Glycine 0 C--N 1.331 0.283 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.757 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 60.9 mtm -64.48 123.42 19.18 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.792 0.33 . . . . 0.0 110.724 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.416 ' SG ' HG13 ' A' ' 8' ' ' ILE . 13.0 p -89.53 41.36 1.03 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.734 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.758 ' HB2' ' HA ' ' A' ' 7' ' ' CYS . 4.6 t -89.67 55.89 3.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.883 -179.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.427 ' HB3' ' H3 ' ' A' ' 1' ' ' ASP . 54.0 mtmt -55.81 118.42 4.56 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.793 0.33 . . . . 0.0 110.458 179.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.412 HG23 ' O ' ' A' ' 25' ' ' THR . 2.0 t . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.545 -0.74 . . . . 0.0 111.513 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.5 p30 . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.952 0.405 . . . . 0.0 111.26 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.657 ' OG1' ' HB3' ' A' ' 5' ' ' PRO . 41.2 p -77.63 148.0 35.29 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.395 179.931 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 47.7 m170 -66.38 -39.11 88.89 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -179.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -132.41 61.43 57.17 Favored Pre-proline 0 CA--C 1.533 0.3 0 N-CA-C 112.873 0.694 . . . . 0.0 112.873 -178.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.657 ' HB3' ' OG1' ' A' ' 2' ' ' THR . 72.9 Cg_endo -76.8 169.62 21.38 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.729 2.286 . . . . 0.0 113.162 179.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.412 ' H ' HG12 ' A' ' 6' ' ' ILE . 7.0 pt -82.06 -28.58 9.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.322 178.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.612 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 34.8 t 63.62 52.75 2.18 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.486 -0.779 . . . . 0.0 111.834 179.349 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 26.9 pt -60.3 141.44 16.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.39 179.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 24.0 t80 -60.71 143.84 53.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.694 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.454 ' SG ' ' O ' ' A' ' 20' ' ' GLY . 26.8 p -149.91 120.98 7.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.768 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 47.6 t -135.64 120.48 18.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.939 0.399 . . . . 0.0 111.008 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.888 ' HA3' ' HG2' ' A' ' 16' ' ' ARG . . . -68.94 133.68 27.0 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.028 179.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.586 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 0.6 OUTLIER -58.35 -76.79 0.04 OUTLIER 'General case' 0 CA--C 1.508 -0.66 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 -178.831 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.586 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.1 OUTLIER -119.87 -56.55 2.02 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-N 113.395 -1.729 . . . . 0.0 112.907 -173.16 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 42.6 m170 -56.02 -70.19 0.12 Allowed 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 108.698 -0.852 . . . . 0.0 108.698 179.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.895 ' H ' ' HD3' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -91.49 50.72 1.77 Allowed 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 177.069 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.651 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 77.4 p -58.33 71.9 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.267 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.773 -178.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.886 ' HE3' ' HB2' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -148.82 141.0 23.98 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.977 -1.011 . . . . 0.0 111.808 179.678 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 69.6 m -102.89 136.2 43.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.86 179.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.454 ' O ' ' SG ' ' A' ' 10' ' ' CYS . . . -177.4 152.83 12.43 Favored Glycine 0 C--O 1.224 -0.5 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.009 -179.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.597 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 63.5 mtm -82.12 125.11 30.49 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.984 0.392 . . . . 0.0 111.519 -179.608 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 59.9 m -86.48 61.94 7.12 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.817 179.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.612 ' HA ' ' HA ' ' A' ' 7' ' ' CYS . 51.4 m -51.19 -45.88 61.96 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -179.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 48.4 mttp -48.88 -46.08 42.01 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.773 0.32 . . . . 0.0 111.282 -179.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 65.5 p . . . . . 0 C--O 1.249 1.075 0 CA-C-O 118.403 -0.808 . . . . 0.0 110.958 -179.888 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 55.2 m-20 . . . . . 0 N--CA 1.487 1.389 0 CA-C-O 120.835 0.35 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 89.0 m -136.14 -51.23 0.71 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.049 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 18.0 p-80 -81.16 54.99 2.39 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.069 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -51.54 107.8 0.91 Allowed Pre-proline 0 C--N 1.332 -0.193 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.02 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.661 ' HD2' ' HB3' ' A' ' 23' ' ' CYS . 76.0 Cg_endo -87.4 -129.92 0.01 OUTLIER 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 122.935 2.423 . . . . 0.0 112.061 179.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.457 ' H ' ' HB2' ' A' ' 5' ' ' PRO . 12.3 pt -70.27 -28.85 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-O 120.969 0.414 . . . . 0.0 110.01 179.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.523 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 95.0 m 60.97 50.05 5.38 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.813 179.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.411 HG23 ' CD1' ' A' ' 6' ' ' ILE . 24.7 pt -51.06 131.02 11.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.519 -0.31 . . . . 0.0 110.452 179.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -61.89 146.79 48.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.151 0.501 . . . . 0.0 111.221 -179.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 25.1 p -155.4 139.07 16.06 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.912 -179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 41.8 t -135.36 117.27 15.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.117 0.484 . . . . 0.0 111.639 -179.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.453 ' N ' ' SG ' ' A' ' 19' ' ' CYS . . . -93.69 92.82 1.64 Allowed Glycine 0 N--CA 1.448 -0.537 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 178.584 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.691 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 18.7 p -72.68 -50.26 26.11 Favored 'General case' 0 CA--C 1.504 -0.808 0 N-CA-C 113.158 0.799 . . . . 0.0 113.158 -178.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.691 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 3.0 m -121.15 -50.39 2.14 Favored 'General case' 0 N--CA 1.428 -1.572 0 CA-C-N 113.727 -1.579 . . . . 0.0 113.087 -172.349 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 40.8 m170 -57.47 -83.66 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 178.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.701 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 0.6 OUTLIER -91.1 126.67 36.25 Favored 'General case' 0 C--O 1.22 -0.493 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 176.783 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 77.9 p -77.61 55.38 1.31 Allowed 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.291 179.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.701 ' HG2' ' HB3' ' A' ' 16' ' ' ARG . 13.9 ptmm? -148.29 125.54 11.51 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 112.081 0.4 . . . . 0.0 112.081 -179.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.453 ' SG ' ' N ' ' A' ' 12' ' ' GLY . 84.4 m -126.32 126.16 43.47 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.938 0.399 . . . . 0.0 111.387 179.037 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 176.16 -152.26 12.62 Favored Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.057 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 61.3 mtm -92.35 122.28 34.66 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.791 0.329 . . . . 0.0 111.212 179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 35.7 m -87.52 55.38 3.49 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.814 179.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.661 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 63.2 m -53.77 -66.77 0.33 Allowed 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.162 -179.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.6 ' O ' ' HD2' ' A' ' 24' ' ' LYS . 1.8 pptp? -72.84 145.36 47.0 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.065 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 72.2 p . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.229 -0.891 . . . . 0.0 111.071 -179.859 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.8 p30 . . . . . 0 N--CA 1.486 1.356 0 CA-C-O 120.849 0.357 . . . . 0.0 111.236 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 40.1 p -61.57 121.7 13.41 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.067 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -76.61 -24.93 53.4 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.268 -179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 18.1 t80 -143.53 59.95 8.05 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 120.906 0.384 . . . . 0.0 111.337 -179.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.486 ' HB2' ' H ' ' A' ' 6' ' ' ILE . 56.5 Cg_endo -71.58 -144.65 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 122.394 2.063 . . . . 0.0 112.049 179.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.486 ' H ' ' HB2' ' A' ' 5' ' ' PRO . 13.4 pt -102.99 -38.52 5.42 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 120.952 0.406 . . . . 0.0 110.638 179.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.477 ' SG ' ' HB3' ' A' ' 21' ' ' MET . 15.4 t 56.62 51.02 11.71 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.197 179.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.412 ' O ' ' SG ' ' A' ' 22' ' ' CYS . 27.8 pt -53.04 149.23 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.415 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 22.2 t80 -71.21 82.4 0.73 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.031 179.41 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 21.3 m -67.09 141.58 57.41 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.807 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 26.1 t -136.01 115.45 12.69 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.952 0.406 . . . . 0.0 110.987 -179.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -88.92 97.41 2.32 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.97 -0.633 . . . . 0.0 111.523 179.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.692 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 0.1 OUTLIER -66.11 -76.41 0.08 Allowed 'General case' 0 CA--C 1.507 -0.68 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -178.808 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.692 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -104.58 -48.02 3.92 Favored 'General case' 0 N--CA 1.432 -1.361 0 CA-C-N 112.711 -2.041 . . . . 0.0 112.922 -173.332 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -55.97 -83.79 0.01 OUTLIER 'General case' 0 C--O 1.232 0.164 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.551 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.674 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 11.3 mpt_? -91.21 120.14 31.88 Favored 'General case' 0 C--O 1.221 -0.432 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 176.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.9 m -76.95 55.47 1.11 Allowed 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 120.85 -0.34 . . . . 0.0 110.123 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.674 ' HG2' ' HB3' ' A' ' 16' ' ' ARG . 21.9 pttp -148.66 129.74 14.48 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.715 -179.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 80.0 m -125.77 128.69 48.11 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.29 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -171.92 -150.15 7.04 Favored Glycine 0 CA--C 1.519 0.331 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.864 179.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.477 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 68.6 mtm -94.17 132.46 38.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.914 0.388 . . . . 0.0 111.417 -179.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.412 ' SG ' ' O ' ' A' ' 8' ' ' ILE . 7.3 p -116.27 69.07 0.74 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.635 179.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.402 ' N ' ' SG ' ' A' ' 7' ' ' CYS . 88.0 m -62.08 -118.07 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.153 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.609 ' O ' ' HD2' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -58.67 151.78 20.15 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.916 0.389 . . . . 0.0 111.499 -179.593 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 8.1 t . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.227 -0.892 . . . . 0.0 111.172 -179.661 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.425 0.155 . . . . 0.0 111.059 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.525 ' O ' ' HD3' ' A' ' 5' ' ' PRO . 75.5 m -51.4 -43.27 61.89 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.764 0.316 . . . . 0.0 111.749 -179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 16.8 m80 -50.5 -51.69 45.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.828 -179.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -145.98 71.56 13.55 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 120.77 0.319 . . . . 0.0 110.813 -179.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.525 ' HD3' ' O ' ' A' ' 2' ' ' THR . 94.1 Cg_endo -80.51 -150.86 0.04 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.406 0 C-N-CA 122.457 2.105 . . . . 0.0 112.528 -179.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.499 HD12 HG23 ' A' ' 8' ' ' ILE . 18.7 pt -136.2 -40.1 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.61 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.748 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 8.8 t 57.36 52.83 8.2 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.312 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.499 HG23 HD12 ' A' ' 6' ' ' ILE . 26.6 pt -57.3 149.93 4.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.545 179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -52.69 129.53 29.83 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.329 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -165.36 133.32 3.1 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.281 -179.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.617 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 42.8 t -84.73 130.76 34.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.559 -179.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.511 ' HA3' ' O ' ' A' ' 16' ' ' ARG . . . -72.02 103.18 1.25 Allowed Glycine 0 N--CA 1.45 -0.42 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 178.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.688 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 16.8 p -71.38 -50.97 26.74 Favored 'General case' 0 CA--C 1.505 -0.766 0 N-CA-C 114.282 1.215 . . . . 0.0 114.282 -177.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.688 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 3.2 m -121.22 -62.56 1.42 Allowed 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 114.245 -1.343 . . . . 0.0 113.802 -171.58 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.552 ' HB3' ' CZ ' ' A' ' 16' ' ' ARG . 39.2 m170 -52.75 -75.78 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 179.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.552 ' CZ ' ' HB3' ' A' ' 15' ' ' HIS . 0.0 OUTLIER -91.13 106.83 18.79 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 176.737 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 46.1 t -74.25 52.91 0.49 Allowed 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.713 0.292 . . . . 0.0 111.409 -179.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.509 ' HD2' ' N ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -150.69 134.53 16.66 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.799 179.793 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.617 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 86.5 m -75.02 132.45 41.35 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.648 178.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -174.54 -136.5 2.26 Favored Glycine 0 C--O 1.225 -0.417 0 C-N-CA 120.625 -0.798 . . . . 0.0 111.933 179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 84.0 mtp -114.4 120.24 39.64 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.662 0.231 . . . . 0.0 110.452 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 73.0 m -89.84 117.16 28.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.839 0.352 . . . . 0.0 110.504 179.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.748 ' HA ' ' HA ' ' A' ' 7' ' ' CYS . 75.9 m -84.31 -126.26 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.87 -179.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.742 ' HD2' ' H ' ' A' ' 25' ' ' THR . 0.0 OUTLIER -56.75 -33.11 66.23 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 111.681 0.252 . . . . 0.0 111.681 -179.822 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.742 ' H ' ' HD2' ' A' ' 24' ' ' LYS . 9.9 t . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.193 -0.908 . . . . 0.0 111.035 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 51.7 p30 . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.417 0.151 . . . . 0.0 111.162 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.636 HG22 ' H ' ' A' ' 4' ' ' PHE . 90.6 m -125.56 132.97 52.46 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.852 0.358 . . . . 0.0 111.285 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 11.5 p80 -67.7 -30.1 69.53 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.969 179.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.636 ' H ' HG22 ' A' ' 2' ' ' THR . 22.0 t80 -143.63 73.62 17.1 Favored Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.506 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.564 ' HG3' ' HB ' ' A' ' 2' ' ' THR . 16.6 Cg_exo -66.07 -151.6 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.557 2.171 . . . . 0.0 112.74 -179.513 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 13.6 pt -87.27 -34.66 7.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.486 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.499 ' HA ' ' HB2' ' A' ' 23' ' ' CYS . 85.0 m 63.56 47.25 3.86 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.522 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 39.4 pt -82.24 146.25 7.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.722 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -67.47 136.97 55.45 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.667 -0.697 . . . . 0.0 110.235 179.146 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -168.81 148.62 4.31 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.853 0.358 . . . . 0.0 110.951 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 46.7 t -121.93 125.82 47.24 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.374 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.623 ' HA3' ' HG2' ' A' ' 16' ' ' ARG . . . -69.01 116.05 6.96 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.435 -0.888 . . . . 0.0 111.448 178.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.698 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -67.44 -73.93 0.13 Allowed 'General case' 0 CA--C 1.507 -0.706 0 CA-C-O 122.535 1.16 . . . . 0.0 113.379 -179.068 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.698 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -103.31 -44.2 5.23 Favored 'General case' 0 N--CA 1.429 -1.501 0 CA-C-N 112.392 -2.185 . . . . 0.0 112.339 -173.782 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.4 ' HB3' ' HD2' ' A' ' 16' ' ' ARG . 17.8 t-160 -59.98 -89.5 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 178.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.914 ' H ' ' HD2' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -91.56 101.84 14.49 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 177.532 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 79.7 p -68.8 66.42 0.13 Allowed 'General case' 0 N--CA 1.465 0.296 0 CA-C-O 120.971 0.415 . . . . 0.0 110.777 -179.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.437 ' HE3' ' HB2' ' A' ' 16' ' ' ARG . 22.2 pttp -148.34 139.74 23.48 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.943 -0.572 . . . . 0.0 112.3 -179.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 87.4 m -105.83 126.56 52.31 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.794 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . 169.8 -145.34 9.18 Favored Glycine 0 C--N 1.333 0.378 0 C-N-CA 120.459 -0.877 . . . . 0.0 113.066 179.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 63.8 mtm -84.11 138.49 33.01 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.816 0.341 . . . . 0.0 111.024 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 63.6 m -121.84 57.21 1.05 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.997 0.427 . . . . 0.0 110.881 -179.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.499 ' HB2' ' HA ' ' A' ' 7' ' ' CYS . 4.2 t -99.12 90.81 4.72 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.218 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -41.84 126.28 3.06 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.977 -179.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 88.5 m . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.315 -0.85 . . . . 0.0 110.992 -179.827 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 62.6 t0 . . . . . 0 N--CA 1.486 1.346 0 CA-C-O 121.006 0.431 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.57 ' OG1' ' HB3' ' A' ' 5' ' ' PRO . 63.8 p -62.65 136.29 57.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.157 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -73.04 -25.91 61.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.343 -179.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 19.9 t80 -132.45 60.81 53.24 Favored Pre-proline 0 CA--C 1.535 0.369 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -179.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.57 ' HB3' ' OG1' ' A' ' 2' ' ' THR . 73.1 Cg_endo -78.06 -149.65 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.412 2.075 . . . . 0.0 112.32 179.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 10.2 pt -98.88 -33.57 4.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 121.228 0.537 . . . . 0.0 110.087 178.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.513 ' SG ' ' HB3' ' A' ' 21' ' ' MET . 19.1 t 60.43 55.41 3.49 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.279 -0.873 . . . . 0.0 112.089 178.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 27.0 pt -58.88 147.04 8.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.692 179.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 18.3 t80 -59.8 110.59 1.2 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.329 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 14.9 m -114.46 158.69 21.25 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.632 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.745 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 57.8 m -125.94 128.8 48.09 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.779 0.323 . . . . 0.0 111.301 179.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.609 ' H ' ' HA ' ' A' ' 19' ' ' CYS . . . -71.3 84.41 0.42 Allowed Glycine 0 C--N 1.332 0.319 0 N-CA-C 111.229 -0.748 . . . . 0.0 111.229 178.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.73 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 0.1 OUTLIER -60.51 -80.15 0.03 OUTLIER 'General case' 0 CA--C 1.509 -0.602 0 N-CA-C 114.646 1.35 . . . . 0.0 114.646 -178.171 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.73 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -98.45 -47.32 5.44 Favored 'General case' 0 N--CA 1.431 -1.396 0 CA-C-N 112.658 -2.064 . . . . 0.0 113.377 -172.85 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 89.5 m-70 -57.01 -93.63 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 178.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.882 ' H ' ' HD2' ' A' ' 16' ' ' ARG . 0.2 OUTLIER -91.0 124.28 35.12 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 177.04 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 42.9 t -73.38 57.71 0.53 Allowed 'General case' 0 N--CA 1.466 0.37 0 CA-C-O 120.805 0.336 . . . . 0.0 111.305 -178.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.3 ptmt -150.48 125.98 10.19 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.554 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.745 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 47.7 t -82.06 136.2 35.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.776 0.322 . . . . 0.0 110.725 179.215 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -163.68 151.96 21.68 Favored Glycine 0 CA--C 1.519 0.341 0 C-N-CA 120.989 -0.624 . . . . 0.0 112.716 -179.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.513 ' HB3' ' SG ' ' A' ' 7' ' ' CYS . 3.5 mpp? -62.22 113.77 3.07 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 122.548 -0.384 . . . . 0.0 110.514 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 7.3 p -74.56 82.71 2.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.013 -0.54 . . . . 0.0 111.512 -179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.452 ' HA ' ' CB ' ' A' ' 7' ' ' CYS . 92.1 m -69.14 -117.43 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.195 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.497 ' HD2' ' N ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -52.15 -37.86 55.81 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-O 120.602 0.239 . . . . 0.0 111.372 -179.29 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.465 ' H ' ' HD2' ' A' ' 24' ' ' LYS . 77.5 p . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.132 -0.937 . . . . 0.0 111.208 -179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 . . . . . 0 N--CA 1.485 1.309 0 CA-C-O 120.815 0.341 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 68.2 p -136.18 -147.68 0.27 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.271 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 19.7 m80 -74.28 -45.56 46.85 Favored 'General case' 0 C--O 1.231 0.093 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.16 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -145.45 63.29 9.54 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.979 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.496 ' HB2' ' H ' ' A' ' 6' ' ' ILE . 38.1 Cg_endo -65.22 -134.02 0.0 OUTLIER 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.675 2.25 . . . . 0.0 112.094 179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.669 HD13 ' H ' ' A' ' 6' ' ' ILE . 0.0 OUTLIER -78.07 -34.22 18.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 120.872 0.368 . . . . 0.0 110.605 179.333 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.811 ' HA ' ' HA ' ' A' ' 23' ' ' CYS . 99.0 m 60.14 49.93 6.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.081 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.529 HG23 HG13 ' A' ' 6' ' ' ILE . 27.4 pt -53.61 132.09 16.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.582 -0.735 . . . . 0.0 110.881 179.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -72.48 135.35 45.68 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.414 179.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 30.0 p -150.72 116.62 5.55 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.141 0.496 . . . . 0.0 110.758 179.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.765 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 42.6 t -82.08 129.1 34.71 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.039 -179.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.446 ' HA3' ' O ' ' A' ' 16' ' ' ARG . . . -62.29 101.37 0.37 Allowed Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.468 -0.872 . . . . 0.0 111.27 179.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.721 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 0.1 OUTLIER -64.61 -79.87 0.04 OUTLIER 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 114.541 1.311 . . . . 0.0 114.541 -178.484 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.721 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 0.0 OUTLIER -100.45 -51.24 3.67 Favored 'General case' 0 N--CA 1.431 -1.398 0 CA-C-N 112.72 -2.037 . . . . 0.0 113.295 -172.907 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 17.7 m80 -55.69 -84.34 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 178.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.605 ' HB3' ' HG2' ' A' ' 18' ' ' LYS . 0.9 OUTLIER -91.27 114.05 26.48 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 176.748 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.4 p -75.44 54.98 0.77 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.893 0.378 . . . . 0.0 110.519 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.605 ' HG2' ' HB3' ' A' ' 16' ' ' ARG . 7.4 ptpp? -149.48 132.5 16.22 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.127 -0.488 . . . . 0.0 112.068 -179.053 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.765 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 75.3 m -72.82 140.09 47.42 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.706 178.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -168.33 140.93 6.47 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 120.107 -1.044 . . . . 0.0 113.525 -179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.5 mpp? -70.69 133.91 47.04 Favored 'General case' 0 C--N 1.329 -0.301 0 O-C-N 122.702 -0.293 . . . . 0.0 110.408 179.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 2.8 p -120.39 123.69 43.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.847 0.356 . . . . 0.0 111.242 179.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.811 ' HA ' ' HA ' ' A' ' 7' ' ' CYS . 39.0 m -95.34 -63.45 1.16 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.143 -179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.66 ' NZ ' ' HB2' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -80.27 139.0 36.86 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.125 179.821 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 77.7 p . . . . . 0 C--O 1.25 1.13 0 CA-C-O 118.225 -0.893 . . . . 0.0 111.198 -179.67 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.2 p30 . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.767 0.318 . . . . 0.0 111.385 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 87.9 m -108.94 -48.14 3.33 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.922 179.909 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -74.17 72.14 1.7 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.719 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -51.82 109.48 1.42 Allowed Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.98 -179.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.546 ' HD3' ' HB2' ' A' ' 24' ' ' LYS . 92.7 Cg_endo -87.7 -140.02 0.02 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.459 0 C-N-CA 122.912 2.408 . . . . 0.0 112.672 -179.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.87 HG13 HG23 ' A' ' 8' ' ' ILE . 1.6 pt -135.28 36.31 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.91 179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.523 ' HA ' ' O ' ' A' ' 22' ' ' CYS . 35.8 m 54.21 27.54 7.96 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.798 -0.637 . . . . 0.0 111.627 -179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.87 HG23 HG13 ' A' ' 6' ' ' ILE . 28.0 pt -47.47 139.27 2.2 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.179 179.148 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -65.96 134.77 53.65 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.867 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -158.59 135.22 9.51 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.953 0.406 . . . . 0.0 110.753 179.353 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.592 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 65.8 m -80.54 132.02 35.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.112 -0.494 . . . . 0.0 112.084 -179.222 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' A' ' 16' ' ' ARG . . . -76.78 74.48 1.79 Allowed Glycine 0 N--CA 1.451 -0.304 0 N-CA-C 110.996 -0.841 . . . . 0.0 110.996 178.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.674 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 23.2 p -66.01 -50.31 64.68 Favored 'General case' 0 CA--C 1.504 -0.803 0 N-CA-C 114.016 1.117 . . . . 0.0 114.016 -178.035 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.674 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 3.5 m -115.59 -43.99 2.99 Favored 'General case' 0 N--CA 1.426 -1.641 0 CA-C-N 113.481 -1.69 . . . . 0.0 112.854 -171.773 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.5 ' HB2' HH11 ' A' ' 16' ' ' ARG . 42.5 m170 -65.84 -112.2 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 177.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.554 ' HD2' ' O ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -76.17 129.92 37.47 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 176.541 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 41.1 t -71.53 57.65 0.27 Allowed 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 120.731 0.3 . . . . 0.0 111.4 -178.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.599 ' HB2' ' NZ ' ' A' ' 18' ' ' LYS . 0.0 OUTLIER -151.43 133.45 15.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.88 -179.724 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.592 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 35.0 t -95.87 131.28 42.36 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 178.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -179.56 -159.81 24.16 Favored Glycine 0 C--N 1.329 0.169 0 C-N-CA 120.533 -0.842 . . . . 0.0 112.588 179.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 84.9 mtp -69.19 131.35 44.8 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.604 0.24 . . . . 0.0 110.363 179.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.523 ' O ' ' HA ' ' A' ' 7' ' ' CYS . 25.7 m -117.57 116.69 27.61 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.776 0.322 . . . . 0.0 110.96 -179.299 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . . . . . . . . . 3.2 m -126.36 107.99 10.82 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.999 179.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.546 ' HB2' ' HD3' ' A' ' 5' ' ' PRO . 29.2 mtpp -74.56 43.14 0.18 Allowed 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.764 -0.653 . . . . 0.0 111.404 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 77.5 p . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.238 -0.887 . . . . 0.0 111.018 179.868 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 36.2 t70 . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.776 0.322 . . . . 0.0 111.108 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 60.8 p -135.58 52.89 1.99 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.499 0.666 . . . . 0.0 110.941 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -88.11 75.46 8.67 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.977 -1.011 . . . . 0.0 110.544 179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . 0.409 ' HD1' ' O ' ' A' ' 4' ' ' PHE . 2.2 p90 -44.96 104.77 0.41 Allowed Pre-proline 0 CA--C 1.534 0.33 0 CA-C-O 121.35 0.595 . . . . 0.0 111.684 -179.264 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -97.56 -151.36 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 123.414 2.743 . . . . 0.0 112.856 -179.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.459 HD11 HD13 ' A' ' 8' ' ' ILE . 3.7 pt -72.11 -13.69 16.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.964 178.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 9.3 t 67.84 41.52 2.14 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.045 -0.98 . . . . 0.0 111.946 179.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.459 HD13 HD11 ' A' ' 6' ' ' ILE . 25.0 pt -82.22 140.35 16.57 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.978 0.418 . . . . 0.0 111.482 179.278 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PHE . . . . . 0.738 ' HA ' ' HA ' ' A' ' 21' ' ' MET . 25.7 t80 -60.92 144.2 53.51 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.307 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.424 ' O ' ' O ' ' A' ' 20' ' ' GLY . 30.3 p -157.74 115.5 3.05 Favored 'General case' 0 CA--C 1.531 0.236 0 CA-C-O 120.892 0.377 . . . . 0.0 111.532 -179.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.752 ' HA ' ' HA ' ' A' ' 19' ' ' CYS . 78.0 m -83.86 123.27 29.74 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 121.014 -0.274 . . . . 0.0 111.105 179.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.75 ' HA3' ' O ' ' A' ' 16' ' ' ARG . . . -65.88 113.68 5.96 Favored Glycine 0 N--CA 1.45 -0.367 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 178.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . 0.66 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 18.6 p -64.84 -48.33 74.73 Favored 'General case' 0 CA--C 1.509 -0.614 0 N-CA-C 115.713 1.745 . . . . 0.0 115.713 -177.03 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.66 ' N ' ' SG ' ' A' ' 13' ' ' CYS . 4.1 m -118.83 -110.15 0.35 Allowed 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 -170.03 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -47.17 -44.8 22.31 Favored 'General case' 0 CA--C 1.518 -0.255 0 CA-C-O 121.045 0.45 . . . . 0.0 109.93 -178.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.75 ' O ' ' HA3' ' A' ' 12' ' ' GLY . 42.8 ttt85 -90.84 46.86 1.36 Allowed 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.458 178.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.638 ' HA ' ' O ' ' A' ' 12' ' ' GLY . 79.2 p -59.55 65.84 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.243 0.617 . . . . 0.0 111.711 -178.822 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 16' ' ' ARG . 21.7 ptmt -151.68 129.83 11.91 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.448 -0.796 . . . . 0.0 111.689 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.752 ' HA ' ' HA ' ' A' ' 11' ' ' CYS . 50.1 m -73.8 133.97 43.31 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.797 0.332 . . . . 0.0 110.778 178.728 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . 0.424 ' O ' ' O ' ' A' ' 10' ' ' CYS . . . 178.43 141.58 4.37 Favored Glycine 0 C--O 1.226 -0.364 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.218 -179.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.738 ' HA ' ' HA ' ' A' ' 9' ' ' PHE . 3.5 mpp? -62.39 135.46 57.45 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.93 0.365 . . . . 0.0 110.988 -179.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 34.6 m -75.84 42.37 0.24 Allowed 'General case' 0 N--CA 1.467 0.375 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.662 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' CYS . . . . . 0.49 ' SG ' ' HB3' ' A' ' 21' ' ' MET . 3.2 m -85.21 72.22 10.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.495 0.188 . . . . 0.0 111.17 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -50.57 108.18 0.21 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.821 0.343 . . . . 0.0 110.754 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 92.8 m . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.228 -0.891 . . . . 0.0 110.742 -179.794 . . . . . . . . 0 0 . 1 stop_ save_